Advanced Search (OLGA)

Gene: AGO1 (argonaute RISC component 1) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

AGO1

Name:

argonaute RISC component 1

RGD ID:

1312163

HGNC Page

HGNC:3262

Description:

Enables RNA binding activity; RNA polymerase II complex binding activity; and core promoter sequence-specific DNA binding activity. Involved in negative regulation of angiogenesis and regulation of gene expression. Located in cytoplasmic ribonucleoprotein granule and cytosol. Part of RISC complex and RISC-loading complex. Implicated in alcohol dependence.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

argonaute 1; argonaute 1, RISC catalytic component; argonaute RISC catalytic component 1; argonaute1; DKFZp686M13167; eIF-2C 1; EIF2C; eIF2C 1; EIF2C1; eukaryotic translation initiation factor 2C, 1; GERP95; Golgi Endoplasmic Reticulum protein 95 kDa; hAgo1; NEDLBAS; protein argonaute-1; putative RNA-binding protein Q99; Q99

RGD Orthologs

Alliance Orthologs

More Info

more info ...

More Info

Species	Gene symbol and name	Data Source	Assertion derived from	less info ...
Orthologs ¹				less info ...
Mus musculus (house mouse):	Ago1 (argonaute RISC catalytic subunit 1)	HGNC	EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Rattus norvegicus (Norway rat):	Ago1 (argonaute RISC component 1)	HGNC	Ensembl, HomoloGene, Inparanoid, NCBI, Panther
Chinchilla lanigera (long-tailed chinchilla):	Ago1 (argonaute RISC component 1)	NCBI	Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):	AGO1 (argonaute RISC component 1)	NCBI	Ortholog
Canis lupus familiaris (dog):	AGO1 (argonaute RISC component 1)	HGNC	Ensembl, HomoloGene, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Sus scrofa (pig):	AGO1 (argonaute RISC component 1)	HGNC	EggNOG, Ensembl, NCBI, OrthoDB, Treefam
Chlorocebus sabaeus (green monkey):	AGO1 (argonaute RISC component 1)	NCBI	Ortholog
Heterocephalus glaber (naked mole-rat):	Ago1 (argonaute RISC component 1)	NCBI	Ortholog
Other homologs ²
Mus musculus (house mouse):	Ago2 (argonaute RISC catalytic subunit 2)	HGNC	OrthoMCL
Mus musculus (house mouse):	Ago4 (argonaute RISC catalytic subunit 4)	HGNC	OrthoMCL
Mus musculus (house mouse):	Ago3 (argonaute RISC catalytic subunit 3)	HGNC	OrthoMCL
Sus scrofa (pig):	AGO2 (argonaute RISC catalytic component 2)	HGNC	OrthoDB
Alliance orthologs ³
Rattus norvegicus (Norway rat):	Ago1 (argonaute RISC component 1)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Mus musculus (house mouse):	Ago1 (argonaute RISC catalytic subunit 1)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Danio rerio (zebrafish):	ago1 (argonaute RISC component 1)	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid\|ZFIN)
Drosophila melanogaster (fruit fly):	AGO1	Alliance	DIOPT (Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Caenorhabditis elegans (roundworm):	alg-1	Alliance	DIOPT (Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Caenorhabditis elegans (roundworm):	alg-2	Alliance	DIOPT (Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):	ago1	Alliance	DIOPT (Ensembl Compara\|OMA\|OrthoFinder\|PANTHER\|PhylomeDB)
Xenopus laevis (African clawed frog):	ago1.L	Alliance	DIOPT (Xenbase)
Xenopus laevis (African clawed frog):	ago1.S	Alliance	DIOPT (Xenbase)

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	1	35,869,761 - 35,930,532 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	1	35,869,808 - 35,930,532 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	1	36,335,362 - 36,396,133 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	1	36,121,397 - 36,162,486 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	1	36,017,902 - 36,058,992	NCBI
Celera	1	34,623,239 - 34,664,327 (+)	NCBI		Celera
Cytogenetic Map	1	p34.3	NCBI
HuRef	1	34,466,263 - 34,506,900 (+)	NCBI		HuRef
CHM1_1	1	36,465,187 - 36,506,280 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	1	35,732,654 - 35,793,426 (+)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGO1	Human	alcohol dependence	susceptibility	IAGP		401900681	DNA:SNP:intron:A>G(rs595961)(human)	RGD

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGO1	Human	Charcot-Marie-Tooth disease dominant intermediate C		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Charcot-Marie-Tooth disease dominant intermediate C	ClinVar	PMID:28492532
AGO1	Human	genetic disease		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Inborn genetic diseases	ClinVar	PMID:23809764 more ...
AGO1	Human	genetic disease		IAGP	(Homo sapiens) more ...	8554872	ClinVar Annotator: match by term: Inborn genetic diseases	ClinVar
AGO1	Human	genetic disease		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Inborn genetic diseases	ClinVar	PMID:25741868
AGO1	Human	intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar	PMID:25356899 more ...
AGO1	Human	intellectual disability		IAGP	(Homo sapiens) and (Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar	PMID:34930816
AGO1	Human	intellectual disability		IAGP	(Homo sapiens) more ...	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar
AGO1	Human	intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar	PMID:27620904 and PMID:34930816
AGO1	Human	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Neurodevelopmental disorder with language delay and behavioral abnormalities and with or without seizures	ClinVar	PMID:23020937 more ...
AGO1	Human	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES		IAGP	(Homo sapiens) more ...	8554872	ClinVar Annotator: match by term: Neurodevelopmental disorder with language delay and behavioral abnormalities and with or without seizures	ClinVar	PMID:25741868
AGO1	Human	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES		IAGP	(Homo sapiens) and (Homo sapiens)	8554872	ClinVar Annotator: match by term: Neurodevelopmental disorder with language delay and behavioral abnormalities and with or without seizures	ClinVar	PMID:34930816
AGO1	Human	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES		IAGP	(Homo sapiens) more ...	8554872	ClinVar Annotator: match by term: AGO1-related condition	ClinVar	PMID:28492532
AGO1	Human	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES		IAGP	(Homo sapiens) more ...	8554872	ClinVar Annotator: match by term: AGO1-related condition	ClinVar	PMID:25741868 and PMID:28492532
AGO1	Human	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Neurodevelopmental disorder with language delay and behavioral abnormalities and with or without seizures	ClinVar	PMID:27620904 and PMID:34930816
AGO1	Human	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Neurodevelopmental disorder with language delay and behavioral abnormalities and with or without seizures	ClinVar	PMID:25356899 more ...
AGO1	Human	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES		IAGP	(Homo sapiens) more ...	8554872	ClinVar Annotator: match by term: Neurodevelopmental disorder with language delay and behavioral abnormalities and with or without seizures	ClinVar
AGO1	Human	Neurodevelopmental Disorders		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Neurodevelopmental abnormality	ClinVar	PMID:23020937 more ...
AGO1	Human	Neurodevelopmental Disorders		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Neurodevelopmental disorder	ClinVar	PMID:25741868 and PMID:30213762

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGO1	Human	malignant mesothelioma		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:25756049

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGO1	Human	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES		IAGP		7240710		OMIM

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGO1	Human	(+)-catechin	multiple interactions	EXP		6480464	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of AGO1 mRNA	CTD	PMID:24763279
AGO1	Human	(1->4)-beta-D-glucan	multiple interactions	ISO	Ago1 (Mus musculus)	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AGO1 mRNA	CTD	PMID:36331819
AGO1	Human	1,2-dimethylhydrazine	decreases expression	ISO	Ago1 (Mus musculus)	6480464	1 and 2-Dimethylhydrazine results in decreased expression of AGO1 mRNA	CTD	PMID:22206623
AGO1	Human	1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine	decreases expression	ISO	Ago1 (Rattus norvegicus)	6480464	chlorcyclizine results in decreased expression of AGO1 mRNA	CTD	PMID:21058326
AGO1	Human	17alpha-ethynylestradiol	increases expression	ISO	Ago1 (Rattus norvegicus)	6480464	Ethinyl Estradiol results in increased expression of AGO1 mRNA	CTD	PMID:29097150
AGO1	Human	17beta-estradiol	affects expression	EXP		6480464	Estradiol affects the expression of AGO1 mRNA	CTD	PMID:22574217
AGO1	Human	17beta-estradiol	increases expression	ISO	Ago1 (Mus musculus)	6480464	Estradiol results in increased expression of AGO1 mRNA	CTD	PMID:39298647
AGO1	Human	17beta-estradiol	multiple interactions	ISO	Ago1 (Rattus norvegicus)	6480464	[bisphenol A co-treated with Estradiol] results in decreased expression of AGO1 mRNA	CTD	PMID:26496021
AGO1	Human	4,4'-diaminodiphenylmethane	increases expression	ISO	Ago1 (Mus musculus)	6480464	4 and 4'-diaminodiphenylmethane results in increased expression of AGO1 mRNA	CTD	PMID:18648102
AGO1	Human	4,4'-sulfonyldiphenol	decreases expression	ISO	Ago1 (Mus musculus)	6480464	bisphenol S results in decreased expression of AGO1 mRNA	CTD	PMID:39298647
AGO1	Human	4,4'-sulfonyldiphenol	multiple interactions	ISO	Ago1 (Rattus norvegicus)	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of AGO1 mRNA	CTD	PMID:36041667
AGO1	Human	aconitine	increases expression	ISO	Ago1 (Rattus norvegicus)	6480464	Aconitine results in increased expression of AGO1 protein	CTD	PMID:33236894
AGO1	Human	acrylamide	decreases expression	EXP		6480464	Acrylamide results in decreased expression of AGO1 mRNA	CTD	PMID:32763439
AGO1	Human	aflatoxin B1	decreases methylation	EXP		6480464	Aflatoxin B1 results in decreased methylation of AGO1 gene	CTD	PMID:27153756
AGO1	Human	aflatoxin B1	increases methylation	EXP		6480464	Aflatoxin B1 results in increased methylation of AGO1 exon	CTD	PMID:30157460
AGO1	Human	all-trans-retinoic acid	increases expression	EXP		6480464	Tretinoin results in increased expression of AGO1 mRNA	CTD	PMID:16140955 and PMID:33167477
AGO1	Human	amitrole	decreases expression	ISO	Ago1 (Rattus norvegicus)	6480464	Amitrole results in decreased expression of AGO1 mRNA	CTD	PMID:38685447
AGO1	Human	amphetamine	decreases expression	ISO	Ago1 (Rattus norvegicus)	6480464	Amphetamine results in decreased expression of AGO1 mRNA	CTD	PMID:30779732
AGO1	Human	arsenite(3-)	increases expression	ISO	Ago1 (Mus musculus)	6480464	arsenite results in increased expression of AGO1 protein	CTD	PMID:37955338
AGO1	Human	benzene	increases expression	EXP		6480464	Benzene results in increased expression of AGO1 mRNA	CTD	PMID:19162166
AGO1	Human	bisphenol A	multiple interactions	ISO	Ago1 (Rattus norvegicus)	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of AGO1 mRNA and [bisphenol A co-treated with Estradiol] results in decreased expression of AGO1 mRNA	CTD	PMID:26496021 and PMID:36041667
AGO1	Human	bisphenol A	affects expression	ISO	Ago1 (Rattus norvegicus)	6480464	bisphenol A affects the expression of AGO1 mRNA	CTD	PMID:32145629
AGO1	Human	bisphenol A	decreases expression	ISO	Ago1 (Rattus norvegicus)	6480464	bisphenol A results in decreased expression of AGO1 mRNA	CTD	PMID:30816183 and PMID:32528016
AGO1	Human	bisphenol F	multiple interactions	ISO	Ago1 (Rattus norvegicus)	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of AGO1 mRNA	CTD	PMID:36041667
AGO1	Human	cadmium dichloride	increases expression	EXP		6480464	Cadmium Chloride results in increased expression of AGO1 mRNA	CTD	PMID:38382870
AGO1	Human	carbamazepine	affects expression	EXP		6480464	Carbamazepine affects the expression of AGO1 mRNA	CTD	PMID:25979313
AGO1	Human	carbon nanotube	decreases expression	ISO	Ago1 (Mus musculus)	6480464	Nanotubes more ...	CTD	PMID:25554681
AGO1	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to AGO1 gene]	CTD	PMID:28238834
AGO1	Human	chlorpyrifos	increases expression	ISO	Ago1 (Mus musculus)	6480464	Chlorpyrifos results in increased expression of AGO1 mRNA	CTD	PMID:37019170
AGO1	Human	choline	multiple interactions	ISO	Ago1 (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AGO1 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AGO1 gene	CTD	PMID:20938992
AGO1	Human	cisplatin	decreases expression	EXP		6480464	Cisplatin results in decreased expression of AGO1 mRNA	CTD	PMID:27594783
AGO1	Human	cisplatin	multiple interactions	EXP		6480464	[Cisplatin co-treated with jinfukang] results in increased expression of AGO1 mRNA	CTD	PMID:27392435
AGO1	Human	cobalt dichloride	decreases expression	EXP		6480464	cobaltous chloride results in decreased expression of AGO1 mRNA	CTD	PMID:19320972
AGO1	Human	cyclosporin A	decreases expression	EXP		6480464	Cyclosporine results in decreased expression of AGO1 mRNA	CTD	PMID:20106945
AGO1	Human	Dibutyl phosphate	affects expression	EXP		6480464	di-n-butylphosphoric acid affects the expression of AGO1 mRNA	CTD	PMID:37042841
AGO1	Human	dicrotophos	increases expression	EXP		6480464	dicrotophos results in increased expression of AGO1 mRNA	CTD	PMID:28302478
AGO1	Human	dioxygen	multiple interactions	ISO	Ago1 (Mus musculus)	6480464	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AGO1 mRNA	CTD	PMID:30529165
AGO1	Human	folic acid	multiple interactions	ISO	Ago1 (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AGO1 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AGO1 gene	CTD	PMID:20938992
AGO1	Human	gentamycin	increases expression	ISO	Ago1 (Rattus norvegicus)	6480464	Gentamicins results in increased expression of AGO1 mRNA	CTD	PMID:22061828
AGO1	Human	ivermectin	decreases expression	EXP		6480464	Ivermectin results in decreased expression of AGO1 protein	CTD	PMID:32959892
AGO1	Human	L-methionine	multiple interactions	ISO	Ago1 (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AGO1 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AGO1 gene	CTD	PMID:20938992
AGO1	Human	lead(0)	affects expression	EXP		6480464	Lead affects the expression of AGO1 mRNA	CTD	PMID:28903495
AGO1	Human	menadione	affects expression	EXP		6480464	Vitamin K 3 affects the expression of AGO1 mRNA	CTD	PMID:20044591
AGO1	Human	methylmercury chloride	decreases expression	EXP		6480464	methylmercuric chloride results in decreased expression of AGO1 mRNA	CTD	PMID:28001369
AGO1	Human	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	Ago1 (Mus musculus)	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AGO1 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of AGO1 mRNA	CTD	PMID:36331819
AGO1	Human	pregnenolone 16alpha-carbonitrile	increases expression	ISO	Ago1 (Mus musculus)	6480464	Pregnenolone Carbonitrile results in increased expression of AGO1 mRNA	CTD	PMID:22698814
AGO1	Human	SB 431542	multiple interactions	EXP		6480464	[LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of AGO1 protein	CTD	PMID:37664457
AGO1	Human	sodium arsenite	decreases expression	ISO	Ago1 (Mus musculus)	6480464	sodium arsenite results in decreased expression of AGO1 mRNA	CTD	PMID:16014739
AGO1	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of AGO1 mRNA	CTD	PMID:38568856
AGO1	Human	sodium arsenite	multiple interactions	EXP		6480464	sodium arsenite promotes the reaction [H3-3A protein binds to AGO1 protein]	CTD	PMID:37734572
AGO1	Human	tetrachloromethane	decreases expression	ISO	Ago1 (Rattus norvegicus)	6480464	Carbon Tetrachloride results in decreased expression of AGO1 mRNA	CTD	PMID:31150632
AGO1	Human	tetrachloromethane	decreases expression	ISO	Ago1 (Mus musculus)	6480464	Carbon Tetrachloride results in decreased expression of AGO1 mRNA	CTD	PMID:31919559
AGO1	Human	thimerosal	decreases expression	EXP		6480464	Thimerosal results in decreased expression of AGO1 mRNA	CTD	PMID:27188386
AGO1	Human	thiram	decreases expression	EXP		6480464	Thiram results in decreased expression of AGO1 mRNA	CTD	PMID:38568856
AGO1	Human	titanium dioxide	increases expression	ISO	Ago1 (Mus musculus)	6480464	titanium dioxide results in increased expression of AGO1 mRNA	CTD	PMID:23557971
AGO1	Human	triptonide	increases expression	ISO	Ago1 (Mus musculus)	6480464	triptonide results in increased expression of AGO1 mRNA	CTD	PMID:33045310
AGO1	Human	troglitazone	decreases expression	ISO	Ago1 (Mus musculus)	6480464	troglitazone results in decreased expression of AGO1 mRNA	CTD	PMID:28973697
AGO1	Human	tungsten	decreases expression	ISO	Ago1 (Mus musculus)	6480464	Tungsten results in decreased expression of AGO1 mRNA	CTD	PMID:30912803
AGO1	Human	urethane	increases expression	EXP		6480464	Urethane results in increased expression of AGO1 mRNA	CTD	PMID:28818685
AGO1	Human	valproic acid	decreases expression	EXP		6480464	Valproic Acid results in decreased expression of AGO1 mRNA	CTD	PMID:26272509
AGO1	Human	vorinostat	decreases expression	EXP		6480464	vorinostat results in decreased expression of AGO1 mRNA	CTD	PMID:27188386

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGO1	Human	miRNA metabolic process	acts_upstream_of_or_within	IEA	UniProtKB:Q8CJG1 and ensembl:ENSMUSP00000095498	150520179		Ensembl	GO_REF:0000107
AGO1	Human	miRNA processing	involved_in	IMP		150520179	PMID:22795694	BHF-UCL	PMID:22795694
AGO1	Human	miRNA-mediated gene silencing by inhibition of translation	involved_in	IDA		150520179	PMID:18771919	UniProt	PMID:18771919
AGO1	Human	miRNA-mediated gene silencing by mRNA destabilization	NOT\|involved_in	IDA		150520179	PMID:15260970	BHF-UCL	PMID:15260970
AGO1	Human	negative regulation of angiogenesis	involved_in	IMP		150520179	PMID:23426184	BHF-UCL	PMID:23426184
AGO1	Human	nuclear-transcribed mRNA catabolic process	involved_in	IDA		150520179	PMID:18771919	UniProt	PMID:18771919
AGO1	Human	positive regulation of gene expression	involved_in	ISO	Ago1 (Mus musculus)	9068941	PMID:26764146	BHF-UCL	PMID:26764146
AGO1	Human	positive regulation of gene expression	acts_upstream_of_or_within	IEA	UniProtKB:Q8CJG1 and ensembl:ENSMUSP00000095498	150520179		Ensembl	GO_REF:0000107
AGO1	Human	positive regulation of non-canonical NF-kappaB signal transduction	involved_in	IEA	UniProtKB:Q8CJG1 and ensembl:ENSMUSP00000095498	150520179		Ensembl	GO_REF:0000107
AGO1	Human	positive regulation of transcription by RNA polymerase II	involved_in	IMP		150520179	PMID:25336585	BHF-UCL	PMID:25336585
AGO1	Human	positive regulation of transcription by RNA polymerase II	acts_upstream_of_or_within	IEA	UniProtKB:Q8CJG1 and ensembl:ENSMUSP00000095498	150520179		Ensembl	GO_REF:0000107
AGO1	Human	pre-miRNA processing	involved_in	IDA		150520179	PMID:19966796	BHF-UCL	PMID:19966796
AGO1	Human	pre-miRNA processing	involved_in	IBA	MGI:2446632 more ...	150520179		GO_Central	GO_REF:0000033
AGO1	Human	regulation of mRNA stability		ISO	Ago1 (Rattus norvegicus)	9068941		RGD	PMID:26846850 and REF_RGD_ID:11526737
AGO1	Human	regulation of mRNA stability	involved_in	IEA	UniProtKB:A0A8I5Y871 and ensembl:ENSRNOP00000077744	150520179		Ensembl	GO_REF:0000107
AGO1	Human	regulation of translation	involved_in	IEA	UniProtKB-KW:KW-0810	150520179		UniProt	GO_REF:0000043
AGO1	Human	regulatory ncRNA-mediated gene silencing	involved_in	IEA	UniProtKB-KW:KW-0943	150520179		UniProt	GO_REF:0000043
AGO1	Human	regulatory ncRNA-mediated post-transcriptional gene silencing	involved_in	IBA	FB:FBgn0087035 more ...	150520179		GO_Central	GO_REF:0000033
AGO1	Human	RISC complex assembly	involved_in	IDA		150520179	PMID:19966796	BHF-UCL	PMID:19966796
AGO1	Human	siRNA-mediated gene silencing by mRNA destabilization	NOT\|involved_in	IDA		150520179	PMID:15260970	BHF-UCL	PMID:15260970
AGO1	Human	translational initiation	involved_in	IEA	UniProtKB-KW:KW-0396	150520179		UniProt	GO_REF:0000043

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGO1	Human	cytoplasm	located_in	IEA	UniProtKB-KW:KW-0963	150520179		UniProt	GO_REF:0000043
AGO1	Human	cytoplasm	is_active_in	IBA	FB:FBgn0087035 more ...	150520179		GO_Central	GO_REF:0000033
AGO1	Human	cytoplasm	located_in	IDA		150520179	PMID:15260970 more ...	MGI	PMID:15260970 more ...
AGO1	Human	cytoplasmic ribonucleoprotein granule	is_active_in	IBA	FB:FBgn0087035 more ...	150520179		GO_Central	GO_REF:0000033
AGO1	Human	cytoplasmic ribonucleoprotein granule	located_in	IDA		150520179		HPA	GO_REF:0000052
AGO1	Human	cytosol	located_in	IDA		150520179		HPA	GO_REF:0000052
AGO1	Human	cytosol	located_in	IEA	UniProtKB:Q8CJG1 and ensembl:ENSMUSP00000095498	150520179		Ensembl	GO_REF:0000107
AGO1	Human	cytosol	located_in	TAS		150520179		Reactome	Reactome:R-HSA-1606561 more ...
AGO1	Human	nucleoplasm	located_in	TAS		150520179		Reactome	Reactome:R-HSA-5578742
AGO1	Human	nucleus	is_active_in	IBA	FB:FBgn0004872 more ...	150520179		GO_Central	GO_REF:0000033
AGO1	Human	nucleus	located_in	IEA	UniProtKB:Q8CJG1 and ensembl:ENSMUSP00000095498	150520179		Ensembl	GO_REF:0000107
AGO1	Human	nucleus	located_in	IC	GO:0001046	150520179	PMID:25336585	BHF-UCL	PMID:25336585
AGO1	Human	P-body	located_in	IEA	UniProtKB:Q8CJG1 and ensembl:ENSMUSP00000095498	150520179		Ensembl	GO_REF:0000107
AGO1	Human	P-body	located_in	IEA	UniProtKB-SubCell:SL-0230	150520179		UniProt	GO_REF:0000044
AGO1	Human	ribonucleoprotein complex	part_of	IEA	UniProtKB-KW:KW-0687	150520179		UniProt	GO_REF:0000043
AGO1	Human	RISC complex	part_of	IBA	FB:FBgn0087035 more ...	150520179		GO_Central	GO_REF:0000033
AGO1	Human	RISC complex	part_of	IEA	UniProtKB:Q8CJG1 and ensembl:ENSMUSP00000095498	150520179		Ensembl	GO_REF:0000107
AGO1	Human	RISC complex	part_of	IDA		150520179	PMID:15260970 more ...	BHF-UCL	PMID:15260970 more ...
AGO1	Human	RISC complex	part_of	IEA	ARBA:ARBA00044873	150520179		UniProt	GO_REF:0000117
AGO1	Human	RISC-loading complex	part_of	IDA		150520179	PMID:19966796	BHF-UCL	PMID:19966796

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGO1	Human	core promoter sequence-specific DNA binding	enables	IMP		150520179	PMID:25336585	BHF-UCL	PMID:25336585
AGO1	Human	double-stranded RNA binding	enables	IDA		150520179	PMID:19966796	BHF-UCL	PMID:19966796
AGO1	Human	miRNA binding	enables	IDA		150520179	PMID:15260970	BHF-UCL	PMID:15260970
AGO1	Human	miRNA binding	enables	IEA	UniProtKB:Q8CJG1 and ensembl:ENSMUSP00000095498	150520179		Ensembl	GO_REF:0000107
AGO1	Human	miRNA binding	enables	IBA	FB:FBgn0262739 more ...	150520179		GO_Central	GO_REF:0000033
AGO1	Human	nucleic acid binding	enables	IEA	InterPro:IPR003165 and InterPro:IPR036397	150520179		InterPro	GO_REF:0000002
AGO1	Human	protein binding	enables	IPI	UniProtKB:Q8NDV7 more ...	150520179	PMID:19383768	IntAct	PMID:19383768
AGO1	Human	protein binding	enables	IPI	UniProtKB:Q66GS9	150520179	PMID:35709258	IntAct	PMID:35709258
AGO1	Human	protein binding	enables	IPI	UniProtKB:P08238 and UniProtKB:Q9UPY3	150520179	PMID:17932509	IntAct	PMID:17932509
AGO1	Human	protein binding	enables	IPI	UniProtKB:A6NIX2 more ...	150520179	PMID:20616046	UniProt	PMID:20616046
AGO1	Human	protein binding	enables	IPI	UniProtKB:O15397	150520179	PMID:19167051	IntAct	PMID:19167051
AGO1	Human	protein binding	enables	IPI	UniProtKB:Q6NTF7 more ...	150520179	PMID:22915799	UniProt	PMID:22915799
AGO1	Human	protein binding	enables	IPI	UniProtKB:P08238	150520179	PMID:25036637	IntAct	PMID:25036637
AGO1	Human	protein binding	enables	IPI	UniProtKB:Q9UPQ9-2	150520179	PMID:17891150	IntAct	PMID:17891150
AGO1	Human	protein binding	enables	IPI	UniProtKB:Q9UKV8	150520179	PMID:16756390	IntAct	PMID:16756390
AGO1	Human	protein binding	enables	IPI	UniProtKB:P20226	150520179	PMID:25336585	BHF-UCL	PMID:25336585
AGO1	Human	protein binding	enables	IPI	UniProtKB:P04156 and UniProtKB:Q8NDV7	150520179	PMID:22484317	IntAct	PMID:22484317
AGO1	Human	protein binding	enables	IPI	UniProtKB:Q8NDV7 and UniProtKB:Q9UPY3	150520179	PMID:19716330	IntAct	PMID:19716330
AGO1	Human	protein binding	enables	IPI	UniProtKB:Q9UGP4	150520179	PMID:28683311	IntAct	PMID:28683311
AGO1	Human	protein binding	enables	IPI	UniProtKB:Q9HCE1	150520179	PMID:16289642	UniProt	PMID:16289642
AGO1	Human	protein binding	enables	IPI	UniProtKB:Q8NDV7	150520179	PMID:19324964	IntAct	PMID:19324964
AGO1	Human	protein binding	enables	IPI	UniProtKB:P11940 more ...	150520179	PMID:17932509	UniProt	PMID:17932509
AGO1	Human	protein binding	enables	IPI	UniProtKB:P04156	150520179	PMID:18482256	IntAct	PMID:18482256
AGO1	Human	protein binding	enables	IPI	UniProtKB:Q9UPY3	150520179	PMID:12526743	IntAct	PMID:12526743
AGO1	Human	protein binding	enables	IPI	UniProtKB:Q8NDV7 more ...	150520179	PMID:35271311	IntAct	PMID:35271311
AGO1	Human	protein binding	enables	IPI	UniProtKB:P08238 more ...	150520179	PMID:33961781	IntAct	PMID:33961781
AGO1	Human	protein binding	enables	IPI	UniProtKB:P53041	150520179	PMID:28330616	IntAct	PMID:28330616
AGO1	Human	regulatory RNA binding	enables	IEA	ARBA:ARBA00029094	150520179		UniProt	GO_REF:0000117
AGO1	Human	RNA binding	enables	IEA	UniProtKB-KW:KW-0694	150520179		UniProt	GO_REF:0000043
AGO1	Human	RNA binding	enables	IEA	UniProtKB:Q8CJG1 and ensembl:ENSMUSP00000095498	150520179		Ensembl	GO_REF:0000107
AGO1	Human	RNA binding	enables	IEA	InterPro:IPR003100	150520179		InterPro	GO_REF:0000002
AGO1	Human	RNA binding	enables	HDA		150520179	PMID:22681889	UniProt	PMID:22681889
AGO1	Human	RNA binding	enables	IDA		150520179	PMID:23809764	UniProt	PMID:23809764
AGO1	Human	RNA endonuclease activity	NOT\|enables	IDA		150520179	PMID:23809764	UniProt	PMID:23809764
AGO1	Human	RNA polymerase II cis-regulatory region sequence-specific DNA binding	enables	IEA	UniProtKB:Q8CJG1 and ensembl:ENSMUSP00000095498	150520179		Ensembl	GO_REF:0000107
AGO1	Human	RNA polymerase II complex binding	enables	IDA		150520179	PMID:25336585	BHF-UCL	PMID:25336585
AGO1	Human	single-stranded RNA binding	enables	IDA		150520179	PMID:19966796	BHF-UCL	PMID:19966796
AGO1	Human	single-stranded RNA binding	enables	IBA	FB:FBgn0087035 more ...	150520179		GO_Central	GO_REF:0000033
AGO1	Human	transcription cis-regulatory region binding	enables	IEA	UniProtKB:Q8CJG1 and ensembl:ENSMUSP00000095498	150520179		Ensembl	GO_REF:0000107
AGO1	Human	translation initiation factor activity	enables	IEA	UniProtKB-KW:KW-0396	150520179		UniProt	GO_REF:0000043

RGD Manual Annotations

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGO1	Human	microRNA pathway		TAS		4144862		RGD

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGO1	Human	Aggressive behavior		IAGP		8699517		HPO	MIM:620292 and PMID:34930816
AGO1	Human	Almond-shaped palpebral fissure		IAGP		8699517		HPO	MIM:620292 and PMID:34930816
AGO1	Human	Anxiety		IAGP		8699517		HPO	MIM:620292 and PMID:34930816
AGO1	Human	Attention deficit hyperactivity disorder		IAGP		8699517		HPO	MIM:620292 and PMID:34930816
AGO1	Human	Autistic behavior		IAGP		8699517		HPO	MIM:620292 and PMID:34930816
AGO1	Human	Autosomal dominant inheritance		IAGP		8699517		HPO	MIM:620292 and PMID:23020937
AGO1	Human	Bilateral tonic-clonic seizure		IAGP		8699517		HPO	MIM:620292 and PMID:30213762
AGO1	Human	Bulbous nose		IAGP		8699517		HPO	MIM:620292 and PMID:30213762
AGO1	Human	Delayed ability to walk		IAGP		8699517		HPO	MIM:620292 and PMID:25356899
AGO1	Human	Delayed speech and language development		IAGP		8699517		HPO	MIM:620292 more ...
AGO1	Human	Downslanted palpebral fissures		IAGP		8699517		HPO	MIM:620292 and PMID:30213762
AGO1	Human	Epicanthus		IAGP		8699517		HPO	MIM:620292 and PMID:27620904
AGO1	Human	Febrile seizure (within the age range of 3 months to 6 years)		IAGP		8699517		HPO	MIM:620292 and PMID:30213762
AGO1	Human	Feeding difficulties		IAGP		8699517		HPO	MIM:620292 and PMID:34930816
AGO1	Human	Focal impaired awareness seizure		IAGP		8699517		HPO	MIM:620292 and PMID:30213762
AGO1	Human	Gastroesophageal reflux		IAGP		8699517		HPO	MIM:620292 and PMID:34930816
AGO1	Human	Global developmental delay		IAGP		8699517		HPO	MIM:620292 more ...
AGO1	Human	Globus pallidus calcification		IAGP		8699517		HPO	MIM:620292 and PMID:30213762
AGO1	Human	High forehead		IAGP		8699517		HPO	MIM:620292 and PMID:34930816
AGO1	Human	Hyperactivity		IAGP		8699517		HPO	MIM:620292 and PMID:27620904
AGO1	Human	Hypotonia		IAGP		8699517		HPO	MIM:620292 more ...
AGO1	Human	Infantile onset		IAGP		8699517		HPO	MIM:620292 and PMID:30213762
AGO1	Human	Intellectual disability		IAGP		8699517		HPO	MIM:620292 and PMID:27620904
AGO1	Human	Intellectual disability, moderate		IAGP		8699517		HPO	MIM:620292 more ...
AGO1	Human	Macrotia		IAGP		8699517		HPO	MIM:620292 and PMID:27620904
AGO1	Human	Mild short stature		IAGP		8699517		HPO	MIM:620292 and PMID:30213762
AGO1	Human	Motor delay		IAGP		8699517		HPO	MIM:620292 and PMID:34930816
AGO1	Human	Motor stereotypy		IAGP		8699517		HPO	MIM:620292 and PMID:27620904
AGO1	Human	Round face		IAGP		8699517		HPO	MIM:620292 and PMID:30213762
AGO1	Human	Seizure		IAGP		8699517		HPO	MIM:620292 more ...
AGO1	Human	Short nose		IAGP		8699517		HPO	MIM:620292 and PMID:34930816
AGO1	Human	Sleep abnormality		IAGP		8699517		HPO	MIM:620292 more ...
AGO1	Human	Status epilepticus		IAGP		8699517		HPO	MIM:620292 and PMID:25356899
AGO1	Human	Strabismus		IAGP		8699517		HPO	MIM:620292 and PMID:34930816
AGO1	Human	Telecanthus		IAGP		8699517		HPO	MIM:620292 and PMID:30213762
AGO1	Human	Thin upper lip vermilion		IAGP		8699517		HPO	MIM:620292 and PMID:34930816
AGO1	Human	Wide nasal bridge		IAGP		8699517		HPO	MIM:620292 and PMID:30213762

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGO1	Human	Intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar
AGO1	Human	Intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar
AGO1	Human	Intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Mental deficiency	ClinVar
AGO1	Human	Intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar
AGO1	Human	Intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar	PMID:25356899 more ...
AGO1	Human	Intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar	PMID:34930816
AGO1	Human	Intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar	PMID:27620904 and PMID:34930816
AGO1	Human	Intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar	PMID:34930816
AGO1	Human	Neurodevelopmental abnormality		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Neurodevelopmental abnormality	ClinVar	PMID:23020937 more ...

#	Reference Title	Reference Citation
1.	Argonaute proteins at a glance.	Ender C and Meister G, J Cell Sci. 2010 Jun 1;123(Pt 11):1819-23.
2.	Association of microRNA biogenesis pathway gene variants and alcohol dependence risk.	Gedik H, etal., DNA Cell Biol. 2015 Mar;34(3):220-6. doi: 10.1089/dna.2014.2549. Epub 2014 Dec 11.
3.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
4.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
5.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:9417904	PMID:10512872	PMID:10534406	PMID:11726686	PMID:12230974	PMID:12414724	PMID:12477932	PMID:12526743	PMID:12906857	PMID:14702039	PMID:15152257	PMID:15260970
PMID:15489334	PMID:15908945	PMID:15937477	PMID:16196087	PMID:16289642	PMID:16710414	PMID:16756390	PMID:16936726	PMID:16936728	PMID:17267406	PMID:17400507	PMID:17482383
PMID:17891150	PMID:17932509	PMID:18345015	PMID:18482256	PMID:18771919	PMID:18779327	PMID:19047128	PMID:19138993	PMID:19167051	PMID:19269368	PMID:19324964	PMID:19380743
PMID:19383768	PMID:19393748	PMID:19470757	PMID:19716330	PMID:19723326	PMID:19767416	PMID:19851984	PMID:19913121	PMID:19946268	PMID:19966796	PMID:20014101	PMID:20211803
PMID:20308539	PMID:20616046	PMID:20628086	PMID:20671708	PMID:20721975	PMID:20732906	PMID:20819778	PMID:21145461	PMID:21244100	PMID:21846468	PMID:21873635	PMID:21906983
PMID:21948796	PMID:21963094	PMID:21988832	PMID:22025453	PMID:22231398	PMID:22474261	PMID:22484317	PMID:22647351	PMID:22658674	PMID:22681889	PMID:22795694	PMID:22858679
PMID:22915799	PMID:22961379	PMID:23019594	PMID:23426184	PMID:23535175	PMID:23665583	PMID:23696926	PMID:23746446	PMID:23748378	PMID:23809764	PMID:24086155	PMID:24457600
PMID:24778252	PMID:24816145	PMID:24949972	PMID:25036637	PMID:25313066	PMID:25336585	PMID:25595906	PMID:25656609	PMID:25963833	PMID:26242502	PMID:26318153	PMID:26344197
PMID:27518285	PMID:27542412	PMID:27669275	PMID:28330616	PMID:28363942	PMID:28555645	PMID:28683311	PMID:28718761	PMID:28781232	PMID:28813667	PMID:29256262	PMID:29395067
PMID:29487329	PMID:29507755	PMID:29509190	PMID:29845934	PMID:30213762	PMID:30770397	PMID:30858133	PMID:30995489	PMID:30997501	PMID:31330067	PMID:31343991	PMID:31586073
PMID:31629687	PMID:31666609	PMID:31724726	PMID:31910330	PMID:32143906	PMID:32393053	PMID:32400052	PMID:32673398	PMID:32752954	PMID:32807901	PMID:32812257	PMID:33233493
PMID:33327713	PMID:33600493	PMID:33832481	PMID:33838681	PMID:33961781	PMID:34244482	PMID:34288373	PMID:34709727	PMID:34732716	PMID:34930816	PMID:35013218	PMID:35060114
PMID:35063084	PMID:35140242	PMID:35271311	PMID:35325613	PMID:35709258	PMID:35803934	PMID:36142498	PMID:36215168	PMID:36232890	PMID:36273042	PMID:36736316	PMID:36990227
PMID:37071682	PMID:37314180	PMID:37704626	PMID:38172120	PMID:38334954	PMID:38697112

AGO1
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	1	35,869,761 - 35,930,532 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	1	35,869,808 - 35,930,532 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	1	36,335,362 - 36,396,133 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	1	36,121,397 - 36,162,486 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	1	36,017,902 - 36,058,992	NCBI
Celera	1	34,623,239 - 34,664,327 (+)	NCBI		Celera
Cytogenetic Map	1	p34.3	NCBI
HuRef	1	34,466,263 - 34,506,900 (+)	NCBI		HuRef
CHM1_1	1	36,465,187 - 36,506,280 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	1	35,732,654 - 35,793,426 (+)	NCBI		T2T-CHM13v2.0

Ago1
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	4	126,328,805 - 126,362,500 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	4	126,328,805 - 126,362,376 (-)	Ensembl		GRCm39 Ensembl
GRCm38	4	126,435,012 - 126,468,707 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	4	126,435,012 - 126,468,583 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	4	126,112,256 - 126,145,665 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	4	125,941,807 - 125,970,725 (-)	NCBI		MGSCv36	mm8
Celera	4	124,771,815 - 124,805,219 (-)	NCBI		Celera
Cytogenetic Map	4	D2.2	NCBI
cM Map	4	60.76	NCBI

Ago1
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	5	144,006,618 - 144,064,740 (-)	NCBI		GRCr8
mRatBN7.2	5	138,722,111 - 138,757,118 (-)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	5	138,722,111 - 138,773,546 (-)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	5	141,419,895 - 141,454,732 (-)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	5	143,189,892 - 143,224,724 (-)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	5	143,190,669 - 143,225,508 (-)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	5	144,444,390 - 144,479,430 (-)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	5	144,448,792 - 144,479,306 (-)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	5	148,214,328 - 148,246,407 (-)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	5	145,797,436 - 145,829,516 (-)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	5	145,806,727 - 145,840,972 (-)	NCBI
Celera	5	137,218,551 - 137,248,255 (-)	NCBI		Celera
Cytogenetic Map	5	q36	NCBI

Ago1
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955452	13,934,346 - 13,968,624 (+)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955452	13,935,028 - 13,967,281 (+)	NCBI	ChiLan1.0	ChiLan1.0

AGO1
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	1	190,922,849 - 190,963,905 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	1	190,038,742 - 190,085,087 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	1	35,148,984 - 35,196,252 (+)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	1	36,324,733 - 36,370,798 (+)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	1	36,324,733 - 36,360,832 (+)	Ensembl	panpan1.1		panPan2

AGO1
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	15	6,258,359 - 6,294,911 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	15	6,263,882 - 6,295,338 (-)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	15	6,501,590 - 6,538,192 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	15	6,394,522 - 6,431,156 (-)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	15	6,395,742 - 6,431,512 (-)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	15	6,247,517 - 6,284,126 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	15	6,321,049 - 6,352,856 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	15	6,330,625 - 6,367,229 (-)	NCBI		UU_Cfam_GSD_1.0

AGO1
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	6	91,984,303 - 92,215,149 (+)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	6	92,038,104 - 92,076,477 (+)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	6	85,325,648 - 85,365,454 (+)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

AGO1
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	20	96,929,985 - 96,971,074 (-)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	20	96,934,659 - 96,971,014 (-)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666033	19,754,613 - 19,801,453 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Ago1
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624764	18,904,639 - 18,940,594 (+)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624764	18,904,607 - 18,940,594 (+)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in AGO1
121 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
NM_012199.2(AGO1):c.1021-1826G>T	single nucleotide variant	Lung cancer [RCV000090818]	Chr1:35899648 [GRCh38] Chr1:36365249 [GRCh37] Chr1:1p34.3	uncertain significance
GRCh38/hg38 1p34.3(chr1:34753938-36055310)x1	copy number loss	See cases [RCV000137966]	Chr1:34753938..36055310 [GRCh38] Chr1:35219539..36520911 [GRCh37] Chr1:34992126..36293498 [NCBI36] Chr1:1p34.3	likely pathogenic
GRCh38/hg38 1p36.11-34.2(chr1:24381206-41401517)x3	copy number gain	See cases [RCV000138891]	Chr1:24381206..41401517 [GRCh38] Chr1:24707696..41886350 [GRCh37] Chr1:24580283..41658937 [NCBI36] Chr1:1p36.11-34.2	pathogenic
NM_012199.5(AGO1):c.2530G>C (p.Val844Leu)	single nucleotide variant	not provided [RCV003321241]	Chr1:35919563 [GRCh38] Chr1:36385164 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.73C>G (p.Arg25Gly)	single nucleotide variant	not provided [RCV000420638]	Chr1:35888474 [GRCh38] Chr1:36354075 [GRCh37] Chr1:1p34.3	uncertain significance
GRCh37/hg19 1p34.3(chr1:34830287-36945093)x1	copy number loss	See cases [RCV000448022]	Chr1:34830287..36945093 [GRCh37] Chr1:1p34.3	pathogenic
GRCh37/hg19 1p34.3(chr1:35950860-36465764)x1	copy number loss	See cases [RCV000448765]	Chr1:35950860..36465764 [GRCh37] Chr1:1p34.3	uncertain significance
GRCh37/hg19 1p36.33-q44(chr1:849467-249224684)x3	copy number gain	See cases [RCV000510383]	Chr1:849467..249224684 [GRCh37] Chr1:1p36.33-q44	pathogenic
NC_000001.10:g.(?_33241563)_(46663513_?)dup	duplication	Charcot-Marie-Tooth disease dominant intermediate C [RCV000708276]	Chr1:33241563..46663513 [GRCh37] Chr1:1p35.1-34.1	uncertain significance
GRCh37/hg19 1p36.33-q44(chr1:849467-249224684)	copy number gain	See cases [RCV000510926]	Chr1:849467..249224684 [GRCh37] Chr1:1p36.33-q44	pathogenic
Single allele	deletion	Gestational diabetes mellitus uncontrolled [RCV000161159]	Chr1:35902179..35922053 [GRCh38] Chr1:36367780..36387654 [GRCh37] Chr1:1p34.3	not provided
GRCh37/hg19 1p36.12-12(chr1:20608823-120546301)x3	copy number loss	not provided [RCV000762767]	Chr1:20608823..120546301 [GRCh37] Chr1:1p36.12-12	likely benign
NM_012199.5(AGO1):c.536TCT[1] (p.Phe180del)	microsatellite	Inborn genetic diseases [RCV000624497]\|Neurodevelopmental abnormality [RCV001264693]\|Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV003155252]\|See cases [RCV001420239]\|Seizure [RCV002286416]\|not provided [RCV000678336]	Chr1:35893695..35893697 [GRCh38] Chr1:36359296..36359298 [GRCh37] Chr1:1p34.3	pathogenic\|likely pathogenic\|conflicting interpretations of pathogenicity\|uncertain significance
NM_012199.5(AGO1):c.566C>T (p.Pro189Leu)	single nucleotide variant	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV004760682]\|not provided [RCV000660582]	Chr1:35893727 [GRCh38] Chr1:36359328 [GRCh37] Chr1:1p34.3	likely pathogenic\|conflicting interpretations of pathogenicity\|uncertain significance
GRCh37/hg19 1p36.33-q44(chr1:82154-249218992)x3	copy number gain	not provided [RCV000736305]	Chr1:82154..249218992 [GRCh37] Chr1:1p36.33-q44	pathogenic
GRCh37/hg19 1p35.2-34.3(chr1:31562164-37421958)x3	copy number gain	not provided [RCV000748949]	Chr1:31562164..37421958 [GRCh37] Chr1:1p35.2-34.3	pathogenic
NM_012199.5(AGO1):c.1599C>T (p.Val533=)	single nucleotide variant	not provided [RCV000978349]	Chr1:35913858 [GRCh38] Chr1:36379459 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.765C>T (p.Arg255=)	single nucleotide variant	not provided [RCV000905702]	Chr1:35894152 [GRCh38] Chr1:36359753 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.1698T>C (p.Asn566=)	single nucleotide variant	not provided [RCV000943860]	Chr1:35913957 [GRCh38] Chr1:36379558 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.2112G>A (p.Val704=)	single nucleotide variant	not provided [RCV000879533]	Chr1:35917676 [GRCh38] Chr1:36383277 [GRCh37] Chr1:1p34.3	likely benign
GRCh37/hg19 1p35.1-34.3(chr1:32859415-36454915)	copy number loss	not provided [RCV000767772]	Chr1:32859415..36454915 [GRCh37] Chr1:1p35.1-34.3	pathogenic
NM_012199.5(AGO1):c.432C>G (p.Ala144=)	single nucleotide variant	not provided [RCV000898216]	Chr1:35893198 [GRCh38] Chr1:36358799 [GRCh37] Chr1:1p34.3	benign
NM_012199.5(AGO1):c.1173C>T (p.Tyr391=)	single nucleotide variant	AGO1-related disorder [RCV004753068]\|not provided [RCV000879371]	Chr1:35901980 [GRCh38] Chr1:36367581 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.165C>T (p.Tyr55=)	single nucleotide variant	AGO1-related disorder [RCV003905984]\|not provided [RCV000970166]	Chr1:35888566 [GRCh38] Chr1:36354167 [GRCh37] Chr1:1p34.3	benign
NM_012199.5(AGO1):c.33C>T (p.Gly11=)	single nucleotide variant	AGO1-related disorder [RCV003923283]\|not provided [RCV000921347]	Chr1:35888434 [GRCh38] Chr1:36354035 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.1014C>G (p.Pro338=)	single nucleotide variant	AGO1-related disorder [RCV004753100]\|not provided [RCV000903673]	Chr1:35895263 [GRCh38] Chr1:36360864 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.183G>C (p.Pro61=)	single nucleotide variant	AGO1-related disorder [RCV004753089]\|not provided [RCV000893538]	Chr1:35888584 [GRCh38] Chr1:36354185 [GRCh37] Chr1:1p34.3	benign
GRCh37/hg19 1p36.22-21.1(chr1:103343285-103455144)x3	copy number gain	Global developmental delay [RCV000787285]	Chr1:103343285..103455144 [GRCh37] Chr1:1p36.22-21.1	uncertain significance
NM_012199.5(AGO1):c.2347C>T (p.Gln783Ter)	single nucleotide variant	not provided [RCV000993969]	Chr1:35919136 [GRCh38] Chr1:36384737 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.784+1G>A	single nucleotide variant	not provided [RCV001197640]	Chr1:35894172 [GRCh38] Chr1:36359773 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2431G>A (p.Ala811Thr)	single nucleotide variant	not provided [RCV004787376]	Chr1:35919220 [GRCh38] Chr1:36384821 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2135G>A (p.Arg712His)	single nucleotide variant	not provided [RCV003231698]	Chr1:35917699 [GRCh38] Chr1:36383300 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2342C>T (p.Thr781Met)	single nucleotide variant	AGO1-related Intellectual disability [RCV001839054]\|not specified [RCV001650482]	Chr1:35919131 [GRCh38] Chr1:36384732 [GRCh37] Chr1:1p34.3	likely pathogenic\|uncertain significance
NM_012199.5(AGO1):c.183G>A (p.Pro61=)	single nucleotide variant	AGO1-related disorder [RCV004753152]\|not provided [RCV000974593]	Chr1:35888584 [GRCh38] Chr1:36354185 [GRCh37] Chr1:1p34.3	benign\|likely benign
NM_012199.5(AGO1):c.1980C>T (p.Thr660=)	single nucleotide variant	not provided [RCV000907267]	Chr1:35915494 [GRCh38] Chr1:36381095 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.1482G>A (p.Gln494=)	single nucleotide variant	not provided [RCV000931014]	Chr1:35907019 [GRCh38] Chr1:36372620 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.2088C>T (p.Tyr696=)	single nucleotide variant	AGO1-related disorder [RCV004753104]\|not provided [RCV000906228]	Chr1:35917652 [GRCh38] Chr1:36383253 [GRCh37] Chr1:1p34.3	benign\|likely benign
NM_012199.5(AGO1):c.1923C>G (p.Ser641=)	single nucleotide variant	not provided [RCV000890502]	Chr1:35915437 [GRCh38] Chr1:36381038 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.2129A>T (p.His710Leu)	single nucleotide variant	not provided [RCV002467056]	Chr1:35917693 [GRCh38] Chr1:36383294 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1123GAG[1] (p.Glu376del)	microsatellite	AGO1-related disorder [RCV003416406]\|Intellectual disability [RCV001731166]\|not provided [RCV003328680]\|not specified [RCV001650475]	Chr1:35901574..35901576 [GRCh38] Chr1:36367175..36367177 [GRCh37] Chr1:1p34.3	pathogenic\|likely pathogenic\|uncertain significance
NM_012199.5(AGO1):c.650-2A>G	single nucleotide variant	AGO1-associated disorder [RCV001254059]\|Intellectual disability [RCV001731153]	Chr1:35894035 [GRCh38] Chr1:36359636 [GRCh37] Chr1:1p34.3	pathogenic\|likely pathogenic
NM_012199.5(AGO1):c.1663C>G (p.Pro555Ala)	single nucleotide variant	See cases [RCV001291698]	Chr1:35913922 [GRCh38] Chr1:36379523 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.569T>C (p.Leu190Pro)	single nucleotide variant	Neurodevelopmental abnormality [RCV001264711]\|Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV003155383]\|not provided [RCV003321817]	Chr1:35893730 [GRCh38] Chr1:36359331 [GRCh37] Chr1:1p34.3	pathogenic\|likely pathogenic
NC_000001.10:g.(?_33241563)_(46663513_?)dup	duplication	Charcot-Marie-Tooth disease, dominant intermediate C [RCV001308684]	Chr1:33241563..46663513 [GRCh37] Chr1:1p35.1-34.1	uncertain significance
NM_012199.5(AGO1):c.1073A>G (p.Gln358Arg)	single nucleotide variant	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV004796407]\|not provided [RCV001281588]	Chr1:35901526 [GRCh38] Chr1:36367127 [GRCh37] Chr1:1p34.3	pathogenic\|likely pathogenic\|uncertain significance
NM_012199.5(AGO1):c.758G>A (p.Arg253His)	single nucleotide variant	Intellectual disability [RCV001730187]\|not provided [RCV001773777]	Chr1:35894145 [GRCh38] Chr1:36359746 [GRCh37] Chr1:1p34.3	likely pathogenic\|uncertain significance
NM_012199.5(AGO1):c.583G>A (p.Glu195Lys)	single nucleotide variant	Intellectual disability [RCV001837037]\|Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV003155422]\|not provided [RCV003328681]	Chr1:35893744 [GRCh38] Chr1:36359345 [GRCh37] Chr1:1p34.3	pathogenic\|likely pathogenic
NM_012199.5(AGO1):c.595G>A (p.Gly199Ser)	single nucleotide variant	AGO1-related neurodevelopmental disorder [RCV003147642]\|Intellectual disability [RCV001730186]\|Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV003155424]\|not provided [RCV001821970]	Chr1:35893756 [GRCh38] Chr1:36359357 [GRCh37] Chr1:1p34.3	pathogenic\|likely pathogenic
NM_012199.5(AGO1):c.1802C>T (p.Ala601Val)	single nucleotide variant	not specified [RCV002246948]	Chr1:35914243 [GRCh38] Chr1:36379844 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.569T>G (p.Leu190Arg)	single nucleotide variant	Intellectual disability [RCV001730185]\|Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV003155423]	Chr1:35893730 [GRCh38] Chr1:36359331 [GRCh37] Chr1:1p34.3	pathogenic\|likely pathogenic
NM_012199.5(AGO1):c.2389A>T (p.Ile797Phe)	single nucleotide variant	Intellectual disability [RCV001731184]	Chr1:35919178 [GRCh38] Chr1:36384779 [GRCh37] Chr1:1p34.3	likely pathogenic
NM_012199.5(AGO1):c.25+7G>A	single nucleotide variant	not specified [RCV002246907]	Chr1:35883453 [GRCh38] Chr1:36349054 [GRCh37] Chr1:1p34.3	benign
NM_012199.5(AGO1):c.1217T>C (p.Val406Ala)	single nucleotide variant	Neurodevelopmental disorder [RCV002272870]	Chr1:35902024 [GRCh38] Chr1:36367625 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.591G>T (p.Trp197Cys)	single nucleotide variant	not provided [RCV001772482]	Chr1:35893752 [GRCh38] Chr1:36359353 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.907G>A (p.Glu303Lys)	single nucleotide variant	not provided [RCV001765764]	Chr1:35895156 [GRCh38] Chr1:36360757 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1111C>T (p.Pro371Ser)	single nucleotide variant	not provided [RCV001773824]	Chr1:35901564 [GRCh38] Chr1:36367165 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2081del (p.Lys694fs)	deletion	not provided [RCV001771003]	Chr1:35917642 [GRCh38] Chr1:36383243 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1436C>T (p.Ala479Val)	single nucleotide variant	not provided [RCV001771449]	Chr1:35906973 [GRCh38] Chr1:36372574 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1160A>T (p.Asn387Ile)	single nucleotide variant	not provided [RCV001758597]	Chr1:35901967 [GRCh38] Chr1:36367568 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2252A>T (p.His751Leu)	single nucleotide variant	Intellectual disability [RCV001731183]	Chr1:35918410 [GRCh38] Chr1:36384011 [GRCh37] Chr1:1p34.3	likely pathogenic
NM_012199.5(AGO1):c.2368del (p.Arg790fs)	deletion	not provided [RCV001757002]	Chr1:35919157 [GRCh38] Chr1:36384758 [GRCh37] Chr1:1p34.3	uncertain significance
GRCh37/hg19 1p35.1-33(chr1:33285582-47891811)	copy number gain	not specified [RCV002052781]	Chr1:33285582..47891811 [GRCh37] Chr1:1p35.1-33	pathogenic
GRCh37/hg19 1p34.3(chr1:36041366-39112237)	copy number loss	not specified [RCV002053236]	Chr1:36041366..39112237 [GRCh37] Chr1:1p34.3	uncertain significance
GRCh37/hg19 1p34.3(chr1:35950860-36635695)	copy number gain	not specified [RCV002053225]	Chr1:35950860..36635695 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1315C>T (p.Gln439Ter)	single nucleotide variant	not provided [RCV004787289]	Chr1:35902255 [GRCh38] Chr1:36367856 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1354G>A (p.Ala452Thr)	single nucleotide variant	Inborn genetic diseases [RCV003275815]	Chr1:35902294 [GRCh38] Chr1:36367895 [GRCh37] Chr1:1p34.3	likely pathogenic
NM_012199.5(AGO1):c.1406C>G (p.Thr469Arg)	single nucleotide variant	not provided [RCV003237064]	Chr1:35906943 [GRCh38] Chr1:36372544 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2122C>T (p.Arg708Cys)	single nucleotide variant	not provided [RCV002260831]	Chr1:35917686 [GRCh38] Chr1:36383287 [GRCh37] Chr1:1p34.3	uncertain significance
GRCh37/hg19 1p34.3(chr1:35104233-37357913)x1	copy number loss	not provided [RCV002474552]	Chr1:35104233..37357913 [GRCh37] Chr1:1p34.3	pathogenic
NM_012199.5(AGO1):c.2495G>C (p.Ser832Thr)	single nucleotide variant	not provided [RCV004588615]	Chr1:35919528 [GRCh38] Chr1:36385129 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.521C>T (p.Pro174Leu)	single nucleotide variant	not provided [RCV003235892]	Chr1:35893682 [GRCh38] Chr1:36359283 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.595G>T (p.Gly199Cys)	single nucleotide variant	Inborn genetic diseases [RCV002356036]	Chr1:35893756 [GRCh38] Chr1:36359357 [GRCh37] Chr1:1p34.3	likely pathogenic\|uncertain significance
NM_012199.5(AGO1):c.*10G>A	single nucleotide variant	not provided [RCV002508443]	Chr1:35919617 [GRCh38] Chr1:36385218 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.853C>T (p.Arg285Cys)	single nucleotide variant	not provided [RCV002608188]	Chr1:35894383 [GRCh38] Chr1:36359984 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2413C>T (p.Arg805Cys)	single nucleotide variant	not provided [RCV004780788]	Chr1:35919202 [GRCh38] Chr1:36384803 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.442G>A (p.Gly148Ser)	single nucleotide variant	Inborn genetic diseases [RCV003200768]	Chr1:35893208 [GRCh38] Chr1:36358809 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1243A>G (p.Ile415Val)	single nucleotide variant	Inborn genetic diseases [RCV003180368]	Chr1:35902050 [GRCh38] Chr1:36367651 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.739C>A (p.Pro247Thr)	single nucleotide variant	Inborn genetic diseases [RCV003221149]	Chr1:35894126 [GRCh38] Chr1:36359727 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2042A>T (p.Glu681Val)	single nucleotide variant	Inborn genetic diseases [RCV004978802]\|not provided [RCV003219039]	Chr1:35917606 [GRCh38] Chr1:36383207 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.644T>C (p.Ile215Thr)	single nucleotide variant	not provided [RCV003321421]	Chr1:35893805 [GRCh38] Chr1:36359406 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.913A>G (p.Thr305Ala)	single nucleotide variant	Inborn genetic diseases [RCV003262471]	Chr1:35895162 [GRCh38] Chr1:36360763 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.513-1G>A	single nucleotide variant	not provided [RCV003328902]	Chr1:35893673 [GRCh38] Chr1:36359274 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.*10686T>C	single nucleotide variant	not provided [RCV003387618]	Chr1:35930293 [GRCh38] Chr1:36395894 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1637A>G (p.Gln546Arg)	single nucleotide variant	Inborn genetic diseases [RCV003344293]	Chr1:35913896 [GRCh38] Chr1:36379497 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1574C>T (p.Pro525Leu)	single nucleotide variant	Inborn genetic diseases [RCV003354882]	Chr1:35907111 [GRCh38] Chr1:36372712 [GRCh37] Chr1:1p34.3	uncertain significance
Single allele	inversion	Bilateral polymicrogyria [RCV003459046]	Chr1:33246132..61045156 [GRCh38] Chr1:1p35.1-31.3	likely pathogenic
NM_012199.5(AGO1):c.77G>A (p.Arg26Gln)	single nucleotide variant	AGO1-related disorder [RCV003405884]	Chr1:35888478 [GRCh38] Chr1:36354079 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.496C>T (p.His166Tyr)	single nucleotide variant	AGO1-related disorder [RCV003405806]	Chr1:35893262 [GRCh38] Chr1:36358863 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1135C>T (p.Arg379Cys)	single nucleotide variant	not provided [RCV003443549]	Chr1:35901588 [GRCh38] Chr1:36367189 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2132C>T (p.Thr711Ile)	single nucleotide variant	not provided [RCV003443431]	Chr1:35917696 [GRCh38] Chr1:36383297 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2163+5G>A	single nucleotide variant	not provided [RCV003442680]	Chr1:35917732 [GRCh38] Chr1:36383333 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.614G>T (p.Arg205Leu)	single nucleotide variant	not specified [RCV003388363]	Chr1:35893775 [GRCh38] Chr1:36359376 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.747G>A (p.Thr249=)	single nucleotide variant	not provided [RCV003406335]	Chr1:35894134 [GRCh38] Chr1:36359735 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.1238C>T (p.Ala413Val)	single nucleotide variant	Inborn genetic diseases [RCV004364901]\|Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV003493265]	Chr1:35902045 [GRCh38] Chr1:36367646 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1209G>A (p.Met403Ile)	single nucleotide variant	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV003764494]	Chr1:35902016 [GRCh38] Chr1:36367617 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1342G>A (p.Val448Ile)	single nucleotide variant	not provided [RCV005054642]	Chr1:35902282 [GRCh38] Chr1:36367883 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.904G>T (p.Val302Leu)	single nucleotide variant	not provided [RCV005063373]	Chr1:35895153 [GRCh38] Chr1:36360754 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2265+4G>T	single nucleotide variant	AGO1-related disorder [RCV003919571]	Chr1:35918427 [GRCh38] Chr1:36384028 [GRCh37] Chr1:1p34.3	benign
NM_012199.5(AGO1):c.2035del (p.His679fs)	deletion	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV004555401]	Chr1:35917598 [GRCh38] Chr1:36383199 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.784G>A (p.Gly262Ser)	single nucleotide variant	not provided [RCV004555070]	Chr1:35894171 [GRCh38] Chr1:36359772 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.681A>G (p.Pro227=)	single nucleotide variant	AGO1-related disorder [RCV003982033]	Chr1:35894068 [GRCh38] Chr1:36359669 [GRCh37] Chr1:1p34.3	benign
NM_012199.5(AGO1):c.2285A>G (p.His762Arg)	single nucleotide variant	Inborn genetic diseases [RCV004392058]	Chr1:35919074 [GRCh38] Chr1:36384675 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.416G>T (p.Arg139Leu)	single nucleotide variant	not provided [RCV004555046]	Chr1:35893182 [GRCh38] Chr1:36358783 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.538T>C (p.Phe180Leu)	single nucleotide variant	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV004586474]	Chr1:35893699 [GRCh38] Chr1:36359300 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1141-5T>A	single nucleotide variant	not specified [RCV004690654]	Chr1:35901943 [GRCh38] Chr1:36367544 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1410C>A (p.Asp470Glu)	single nucleotide variant	Inborn genetic diseases [RCV004617790]	Chr1:35906947 [GRCh38] Chr1:36372548 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1066G>A (p.Asp356Asn)	single nucleotide variant	Inborn genetic diseases [RCV004617799]	Chr1:35901519 [GRCh38] Chr1:36367120 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1249C>A (p.Gln417Lys)	single nucleotide variant	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV004595137]	Chr1:35902056 [GRCh38] Chr1:36367657 [GRCh37] Chr1:1p34.3	likely pathogenic
NM_012199.5(AGO1):c.851G>A (p.Arg284His)	single nucleotide variant	AGO1-related disorder [RCV004753956]	Chr1:35894381 [GRCh38] Chr1:36359982 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1594C>T (p.Arg532Cys)	single nucleotide variant	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV004771575]	Chr1:35913853 [GRCh38] Chr1:36379454 [GRCh37] Chr1:1p34.3	likely pathogenic
NM_012199.5(AGO1):c.49dup (p.Leu17fs)	duplication	AGO1-related disorder [RCV004752590]	Chr1:35888443..35888444 [GRCh38] Chr1:36354044..36354045 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.24A>T (p.Ala8=)	single nucleotide variant	not specified [RCV004766662]	Chr1:35883445 [GRCh38] Chr1:36349046 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2480A>G (p.His827Arg)	single nucleotide variant	not provided [RCV004769452]	Chr1:35919513 [GRCh38] Chr1:36385114 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1784A>C (p.Asp595Ala)	single nucleotide variant	AGO1-related disorder [RCV004732264]	Chr1:35914225 [GRCh38] Chr1:36379826 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2085C>A (p.Asp695Glu)	single nucleotide variant	not provided [RCV004769875]	Chr1:35917649 [GRCh38] Chr1:36383250 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.108C>G (p.Ile36Met)	single nucleotide variant	not provided [RCV004774968]	Chr1:35888509 [GRCh38] Chr1:36354110 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.785-1G>A	single nucleotide variant	not provided [RCV004773373]	Chr1:35894314 [GRCh38] Chr1:36359915 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2081A>C (p.Lys694Thr)	single nucleotide variant	not provided [RCV004770811]	Chr1:35917645 [GRCh38] Chr1:36383246 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2554C>T (p.Arg852Cys)	single nucleotide variant	not provided [RCV004773579]	Chr1:35919587 [GRCh38] Chr1:36385188 [GRCh37] Chr1:1p34.3	uncertain significance
GRCh37/hg19 1p34.3(chr1:35208698-36530353)x1	copy number loss	not provided [RCV004819710]	Chr1:35208698..36530353 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2471A>T (p.Glu824Val)	single nucleotide variant	Inborn genetic diseases [RCV004979562]	Chr1:35919504 [GRCh38] Chr1:36385105 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1527_1530dup (p.Ser511fs)	duplication	not provided [RCV005001661]	Chr1:35907061..35907062 [GRCh38] Chr1:36372662..36372663 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2027A>G (p.Gln676Arg)	single nucleotide variant	Inborn genetic diseases [RCV004979561]	Chr1:35915541 [GRCh38] Chr1:36381142 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1796C>G (p.Pro599Arg)	single nucleotide variant	not provided [RCV005004588]	Chr1:35914237 [GRCh38] Chr1:36379838 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1045C>A (p.Arg349Ser)	single nucleotide variant	not provided [RCV005063672]	Chr1:35901498 [GRCh38] Chr1:36367099 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1606dup (p.Thr536fs)	duplication	not provided [RCV005227403]	Chr1:35913864..35913865 [GRCh38] Chr1:36379465..36379466 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.308C>T (p.Ala103Val)	single nucleotide variant	not provided [RCV005065223]	Chr1:35892655 [GRCh38] Chr1:36358256 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2428C>T (p.Arg810Trp)	single nucleotide variant	not provided [RCV005233322]	Chr1:35919217 [GRCh38] Chr1:36384818 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.*57G>A	single nucleotide variant	not provided [RCV005245068]	Chr1:35919664 [GRCh38] Chr1:36385265 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.952C>T (p.Leu318Phe)	single nucleotide variant	not provided [RCV005004129]	Chr1:35895201 [GRCh38] Chr1:36360802 [GRCh37] Chr1:1p34.3	uncertain significance
GRCh37/hg19 1p36.33-q44(chr1:47851-249228449)x3	copy number gain	not provided [RCV000736295]	Chr1:47851..249228449 [GRCh37] Chr1:1p36.33-q44	pathogenic
NM_012199.5(AGO1):c.1512G>T (p.Arg504=)	single nucleotide variant	not provided [RCV000915512]	Chr1:35907049 [GRCh38] Chr1:36372650 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.1257C>T (p.Gly419=)	single nucleotide variant	AGO1-related disorder [RCV004753077]\|not provided [RCV000886896]	Chr1:35902064 [GRCh38] Chr1:36367665 [GRCh37] Chr1:1p34.3	benign\|likely benign
NM_012199.5(AGO1):c.29C>G (p.Ala10Gly)	single nucleotide variant	not provided [RCV004597719]	Chr1:35888430 [GRCh38] Chr1:36354031 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.760G>A (p.Val254Ile)	single nucleotide variant	Intellectual disability [RCV001731182]\|Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV003155425]\|not provided [RCV001786517]	Chr1:35894147 [GRCh38] Chr1:36359748 [GRCh37] Chr1:1p34.3	pathogenic\|likely pathogenic\|uncertain significance
GRCh37/hg19 1p34.3(chr1:35950860-36465764)	copy number loss	not specified [RCV002053205]	Chr1:35950860..36465764 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1376A>G (p.Gln459Arg)	single nucleotide variant	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV003330374]	Chr1:35902316 [GRCh38] Chr1:36367917 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1136G>A (p.Arg379His)	single nucleotide variant	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures [RCV003448639]	Chr1:35901589 [GRCh38] Chr1:36367190 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2246G>A (p.Cys749Tyr)	single nucleotide variant	AGO1-related disorder [RCV003392993]	Chr1:35918404 [GRCh38] Chr1:36384005 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.465G>A (p.Glu155=)	single nucleotide variant	AGO1-related disorder [RCV003964245]	Chr1:35893231 [GRCh38] Chr1:36358832 [GRCh37] Chr1:1p34.3	likely benign
NM_012199.5(AGO1):c.746C>T (p.Thr249Met)	single nucleotide variant	Inborn genetic diseases [RCV004392074]	Chr1:35894133 [GRCh38] Chr1:36359734 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.448A>T (p.Ile150Phe)	single nucleotide variant	Inborn genetic diseases [RCV004617769]	Chr1:35893214 [GRCh38] Chr1:36358815 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2558C>A (p.Thr853Asn)	single nucleotide variant	not provided [RCV004585863]	Chr1:35919591 [GRCh38] Chr1:36385192 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.342G>C (p.Glu114Asp)	single nucleotide variant	Inborn genetic diseases [RCV004617780]	Chr1:35893108 [GRCh38] Chr1:36358709 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.46C>A (p.Pro16Thr)	single nucleotide variant	not provided [RCV005052569]	Chr1:35888447 [GRCh38] Chr1:36354048 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1340A>C (p.Lys447Thr)	single nucleotide variant	Inborn genetic diseases [RCV004979563]	Chr1:35902280 [GRCh38] Chr1:36367881 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.1990T>A (p.Phe664Ile)	single nucleotide variant	Inborn genetic diseases [RCV004979554]	Chr1:35915504 [GRCh38] Chr1:36381105 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.530G>A (p.Arg177His)	single nucleotide variant	Inborn genetic diseases [RCV004979556]	Chr1:35893691 [GRCh38] Chr1:36359292 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.552G>T (p.Glu184Asp)	single nucleotide variant	Inborn genetic diseases [RCV004979555]	Chr1:35893713 [GRCh38] Chr1:36359314 [GRCh37] Chr1:1p34.3	uncertain significance
NM_012199.5(AGO1):c.2024C>T (p.Pro675Leu)	single nucleotide variant	Inborn genetic diseases [RCV004979564]	Chr1:35915538 [GRCh38] Chr1:36381139 [GRCh37] Chr1:1p34.3	uncertain significance

Confirmed Target Of

miRNA Gene	Mature miRNA	Method Name	Result Type	Data Type	Support Type	PMID
MIR107	hsa-miR-107	Mirecords	external_info	{changed}	NA	20042474

Predicted Target Of

	Summary Value
Count of predictions:	5878
Count of miRNA genes:	1388
Interacting mature miRNAs:	1864
Transcripts:	ENST00000373204, ENST00000373206
Prediction methods:	Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597255838	GWAS1351912_H	schizophrenia QTL GWAS1351912 (human)		4e-10	schizophrenia		1	35908222	35908223	Human

L18179

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	36,388,020 - 36,388,264	UniSTS	GRCh37
Build 36	1	36,160,607 - 36,160,851	RGD	NCBI36
Celera	1	34,662,448 - 34,662,692	RGD
Cytogenetic Map	1	p34.3	UniSTS
HuRef	1	34,505,021 - 34,505,265	UniSTS

RH104023

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	36,386,210 - 36,386,370	UniSTS	GRCh37
Build 36	1	36,158,797 - 36,158,957	RGD	NCBI36
Celera	1	34,660,638 - 34,660,798	RGD
Cytogenetic Map	1	p34.3	UniSTS
HuRef	1	34,503,211 - 34,503,371	UniSTS
GeneMap99-GB4 RH Map	1	111.15	UniSTS

G64298

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	36,389,763 - 36,389,896	UniSTS	GRCh37
Build 36	1	36,162,350 - 36,162,483	RGD	NCBI36
Celera	1	34,664,191 - 34,664,324	RGD
Cytogenetic Map	1	p34.3	UniSTS
HuRef	1	34,506,764 - 34,506,897	UniSTS

G20793

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	36,389,636 - 36,389,884	UniSTS	GRCh37
Build 36	1	36,162,223 - 36,162,471	RGD	NCBI36
Celera	1	34,664,064 - 34,664,312	RGD
Cytogenetic Map	1	p34.3	UniSTS
HuRef	1	34,506,637 - 34,506,885	UniSTS

A006G35

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	36,389,636 - 36,389,884	UniSTS	GRCh37
Build 36	1	36,162,223 - 36,162,471	RGD	NCBI36
Celera	1	34,664,064 - 34,664,312	RGD
Cytogenetic Map	1	p34.3	UniSTS
HuRef	1	34,506,637 - 34,506,885	UniSTS
GeneMap99-GB4 RH Map	1	108.11	UniSTS
NCBI RH Map	1	230.0	UniSTS

SHGC-74590

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	36,387,865 - 36,387,965	UniSTS	GRCh37
Build 36	1	36,160,452 - 36,160,552	RGD	NCBI36
Celera	1	34,662,293 - 34,662,393	RGD
Cytogenetic Map	1	p34.3	UniSTS
HuRef	1	34,504,866 - 34,504,966	UniSTS
TNG Radiation Hybrid Map	1	17156.0	UniSTS
GeneMap99-GB4 RH Map	1	110.22	UniSTS
NCBI RH Map	1	221.8	UniSTS

SHGC-74594

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	36,389,367 - 36,389,514	UniSTS	GRCh37
Build 36	1	36,161,954 - 36,162,101	RGD	NCBI36
Celera	1	34,663,795 - 34,663,942	RGD
Cytogenetic Map	1	p34.3	UniSTS
HuRef	1	34,506,368 - 34,506,515	UniSTS
TNG Radiation Hybrid Map	1	17156.0	UniSTS
GeneMap99-GB4 RH Map	1	110.58	UniSTS
NCBI RH Map	1	251.9	UniSTS

EIF2C1_617

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	1	36,385,677 - 36,386,574	UniSTS	GRCh37
Build 36	1	36,158,264 - 36,159,161	RGD	NCBI36
Celera	1	34,660,105 - 34,661,002	RGD
HuRef	1	34,502,678 - 34,503,575	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2439	2788	2253	4973	1726	2351	6	624	1951	465	2269	7306	6472	53	3734	1	852	1744	1617	175	1


RefSeq Transcripts	NM_001317122	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001317123	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_012199	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011541236	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017001016	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017001017	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017001018	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017001019	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054335969	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AF093097	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK000326	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK001622	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK002003	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK025726	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK027611	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK125879	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK314148	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL139286	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC063275	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471059	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068277	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CR936823	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CX781765	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	HY052874	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	U92986	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000373204 ⟹ ENSP00000362300

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	35,883,209 - 35,930,532 (+)	Ensembl

Ensembl Acc Id:

ENST00000373206 ⟹ ENSP00000362302

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	35,869,808 - 35,920,958 (+)	Ensembl

Ensembl Acc Id:

ENST00000635259 ⟹ ENSP00000489254

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	35,892,580 - 35,920,019 (+)	Ensembl

Ensembl Acc Id:

ENST00000674304 ⟹ ENSP00000501450

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	35,883,209 - 35,924,298 (+)	Ensembl

Ensembl Acc Id:

ENST00000674426 ⟹ ENSP00000501372

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	35,883,209 - 35,930,532 (+)	Ensembl

Ensembl Acc Id:

ENST00000699841 ⟹ ENSP00000514639

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	35,883,311 - 35,921,177 (+)	Ensembl

Ensembl Acc Id:

ENST00000699842 ⟹ ENSP00000514640

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	35,883,352 - 35,920,939 (+)	Ensembl

Ensembl Acc Id:

ENST00000699843 ⟹ ENSP00000514641

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	35,883,362 - 35,920,877 (+)	Ensembl

Ensembl Acc Id:

ENST00000699844 ⟹ ENSP00000514642

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	1	35,888,605 - 35,921,149 (+)	Ensembl

RefSeq Acc Id:

NM_001317122 ⟹ NP_001304051

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	35,883,209 - 35,930,532 (+)	NCBI
CHM1_1	1	36,465,173 - 36,506,281 (+)	NCBI
T2T-CHM13v2.0	1	35,746,102 - 35,793,426 (+)	NCBI

Sequence:

show sequence

ACTGGCAGCTGGCCGGGCGCTCGCAGTGGGAGCTGCTGCAGGCTCCGCGGCGGCGGCAACGGAGGCTGCGGGGGCGGCGGCGCGAGCGGCCGGGCTTGGTAGGGGAGCCGAGCCCGGCCCGGGATCCC
GAGCAGCGAGAGTGTGGGGTACCTAGGCCCCTCACGCTGGACTTCACAGTCTCCGGGCCGCCTGACCTCCGCACGGGTATATGGGATGGAAGCGGGACCCTCGGGAGCAGCTGCGGGCGCTTACCTGC
CCCCCCTGCAGCAGGTGTTCCAGGCACCTCGCCGGCCTGGCATTGGCACTGTGGGGAAACCAATCAAGCTCCTGGCCAATTACTTTGAGGTGGACATCCCTAAGATCGACGTGTACCACTACGAGGTG
GACATCAAGCCGGATAAGTGTCCCCGTAGAGTCAACCGGGAAGTGGTGGAATACATGGTCCAGCATTTCAAGCCTCAGATCTTTGGTGATCGCAAGCCTGTGTATGATGGAAAGAAGAACATTTACAC
TGTCACAGCACTGCCCATTGGCAACGAACGGGTCGACTTTGAGGTGACAATCCCTGGGGAAGGGAAGGATCGAATCTTTAAGGTCTCCATCAAGTGGCTAGCCATTGTGAGCTGGCGAATGCTGCATG
AGGCCCTGGTCAGCGGCCAGATCCCTGTTCCCTTGGAGTCTGTGCAAGCCCTGGATGTGGCCATGAGGCACCTGGCATCCATGAGGTACACCCCTGTGGGCCGCTCCTTCTTCTCACCGCCTGAGGGC
TACTACCACCCGCTGGGGGGTGGGCGCGAGGTCTGGTTCGGCTTTCACCAGTCTGTGCGCCCTGCCATGTGGAAGATGATGCTCAACATTGATGTCTCAGCCACTGCCTTTTATAAGGCACAGCCAGT
GATTGAGTTCATGTGTGAGGTGCTGGACATCAGGAACATAGATGAGCAGCCCAAGCCCCTCACGGACTCTCAGCGCGTTCGCTTCACCAAGGAGATCAAGGGCCTGAAGGTGGAAGTCACCCACTGTG
GACAGATGAAGAGGAAGTACCGCGTGTGTAATGTTACCCGTCGCCCTGCTAGCCATCAGACATTCCCCTTACAGCTGGAGAGTGGACAGACTGTGGAGTGCACAGTGGCACAGTATTTCAAGCAGAAA
TATAACCTTCAGCTCAAGTATCCCCATCTGCCCTGCCTACAAGTTGGCCAGGAACAAAAGCATACCTACCTTCCCCTAGAGGTCTGTAACATTGTGGCTGGGCAGCGCTGTATTAAAAAGCTGACCGA
CAACCAGACCTCGACCATGATAAAGGCCACAGCTAGATCCGCTCCAGACAGACAGGAGGAGATCAGTCGCCTGATGAAGAATGCCAGCTACAACTTAGATCCCTACATCCAGGAATTTGGGATCAAAG
TGAAGGATGACATGACGGAGGTGACAGGGCGAGTGCTGCCGGCGCCCATCTTGCAGTACGGCGGCCGGAACCGGGCCATTGCCACACCCAATCAGGGTGTCTGGGACATGCGGGGGAAACAGTTCTAC
AATGGGATTGAGATCAAAGTCTGGGCCATCGCCTGCTTCGCACCCCAAAAACAGTGTCGAGAAGAGGTGCTCAAGAACTTCACAGACCAGCTGCGGAAGATTTCCAAGGATGCGGGGATGCCTATCCA
GGGTCAACCTTGTTTCTGCAAATATGCACAGGGGGCAGACAGCGTGGAGCCTATGTTCCGGCATCTCAAGAACACCTACTCAGGGCTGCAGCTCATTATTGTCATCCTGCCAGGGAAGACGCCGGTGT
ATGCTGAGGTGAAACGTGTCGGAGATACACTCTTGGGAATGGCTACGCAGTGTGTGCAGGTGAAGAACGTGGTCAAGACCTCACCTCAGACTCTGTCCAACCTCTGCCTCAAGATCAATGTCAAACTT
GGTGGCATTAACAACATCCTAGTCCCACACCAGCGCTCTGCCGTTTTTCAACAGCCAGTGATATTCCTGGGAGCAGATGTTACACACCCCCCAGCAGGGGATGGGAAAAAACCTTCTATCACAGCAGT
GGTAGGCAGTATGGATGCCCACCCCAGCCGATACTGTGCTACTGTGCGGGTACAGCGACCACGGCAAGAGATCATTGAAGACTTGTCCTACATGGTGCGTGAGCTCCTCATCCAATTCTACAAGTCCA
CCCGTTTCAAGCCTACCCGCATCATCTTCTACCGAGATGGGGTGCCTGAAGGCCAGCTACCCCAGATACTCCACTATGAGCTACTGGCCATTCGTGATGCCTGCATCAAACTGGAAAAGGACTACCAG
CCTGGGATCACTTATATTGTGGTGCAGAAACGCCATCACACCCGCCTTTTCTGTGCTGACAAGAATGAGCGAATTGGGAAGAGTGGTAACATCCCAGCTGGGACCACAGTGGACACCAACATCACCCA
CCCATTTGAGTTTGACTTCTATCTGTGCAGCCACGCAGGCATCCAGGGCACCAGCCGACCATCCCATTACTATGTTCTTTGGGATGACAACCGTTTCACAGCAGATGAGCTCCAGATCCTGACGTACC
AGCTGTGCCACACTTACGTACGATGCACACGCTCTGTCTCTATCCCAGCACCTGCCTACTATGCCCGCCTGGTGGCTTTCCGGGCACGATACCACCTGGTGGACAAGGAGCATGACAGTGGAGAGGGG
AGCCACATATCGGGGCAGAGCAATGGGCGGGACCCCCAGGCCCTGGCCAAAGCCGTGCAGGTTCACCAGGATACTCTGCGCACCATGTACTTCGCTTGAAGGCAGAACGCTGTTACCTCACTGGATAG
AAGAAAGCTTTCCAAGCCCCAGGAGCTGTGCCACCCAAATCCAGAGGAAGCAAGGAGGAGGGAGGTGGGGTAGGGAGGAGTGTAGGATGCCTTGTTTCCTTCTATAGAGGTGGTGTAAGAGTGGGGAA
CAGGGCCAGCAAGACAGACCACCAGCCAGAAATCTCTGATATCAACCTCATGTCCCCCACCCCTCACCCCATCTTGTCACATCTGGCCCTGACCCCACTGGACCAAAAGGGGCAGCACTGGTGCCCAC
CATACACACAGGTGTCTCATGTGACTCACAGTGCTAAAGACTCATGCTTGACAGCTTGGTAAGGTCAACTCTGTAGCCCTGCAGACAAAAGCTGGTTAGGTTTGGGTTTGATACTTTAGATGGGAAAG
TGAGGGGCTTGAGAAAGTGGGTGGGAGGAGGGAAGGATTTTTTAGGAGCCTTAATCAGAAAAGGACTAGATTTGTTTAAGAAGAAAAATGAAACCAGACCCAGATCAATATTTTAGGATACTAGATGT
TTTAATGGGTTCAGAATCCAGTTTGTAGGAAGATTTTTTAATGGTTTTGGTTGCTCCTCCCCCAGCTGCCACCCCCCACCTTACCCTTATTCCTCTCTGTCCACATTTTCTGCCCCACCTTACTTCTC
CTCCCTGACAGACATCCAGCCCCTAGTAATACTTAAGGCACTATGGCACTTAGCTTTGAAGTGACACGACCCTGTCTTCCTTCCGCCCGCTGGTGGGTAACCAGTGCCTTCCCTGTAACGGTAATGCT
GCAGAACTGCAACCTTTTGTACCTTTCTTTGGGGAATGGGGTGGGGGTGGGAGAGGAGGTAGATGGGGAAGAAATACCCCAGACCCAACAAACCTCCAGCCAGAAAGCCAGCTATTTTGCATTTGAAG
GAATTGACTTCCTCATTCATTGAGCTTTTTAAAAGATCACAACCTCAAGATGGTTAAAATCCATTGACATTTGCACTTTCAAACATGACAAGTCTCGGAGCTGCTGAGATGACAGGCCCCTGGCCTTT
CCACTTATGCCTCCTTTTCTCCTTATTCCTCCTACCTCCCGCCCCGCCCAGGTCTGGAGTTACTTTCATAGCATTTTTCACTCTTGGCTTCTTTTCTCCCTTGATGGTCAAGTCTCTTATGTTTCAAT
ATTTCTTAACTGGGGTGTCTTATAACAAAAAACTCTTAGGTCTAAAATGAGAAAAAAGAGAGAAAACAAAATGTTATTTTTATACCATAACTTGAGTGTATTGCCAAAATTTGGAAATCCTTCCCATG
CCTGATGAGTTTATATCCCAGAAACATTGAGCCATCAGAATGAACTGTGTACCTGATTTGTTCTCTGACCTGGCTAGGTAGGGAGGGGGTGGTTATCGCCCCAAGATGGGGTCCAGGCTCCATCCTTC
CTCTGTGCAGATAATACCTTTTTCTTGCTATAGCCTCCCTCCTCTGCACTGTCCTGCACTCTTTCTTGCAAGTGCATCTTTTTCCTTCCCCTGGACTGTCCTCTGACCCTTTGGCTCATCCTAGATTG
CAGTGTGTCCTGTGGACAGGCTGGGGAATTTTGCTGCTCCCTATTGCTTCTGTTTACAAAAATGAATTTTTCCTGGTTTCCCACTAGGGCATGTGGGTGGGTGGCATGGACTTTTTTTTTTTTTTTTT
TTTGTCTTGAGACATGGGGTTTGGCTGTCTTGCAGGACTGGAGAAGGTGGTGGTTCTAGCTTGGTCTCTGTTGGCCTTGAAGCAAGCATCCCCCCTGCCCTTTTTCCTTGACTGTTCATTTTTTTCCT
GCCCCACTGCTTGGGATGGGGAGTTGCAACTTCAGTGTGGAATTTCCTCTTTGAGGAGCCTGGGCTTGGATCTATCCTGATCTGGTGATGAAGCCATGATTACTTTAGACCTAGCCCAGGCTTGGAGG
CCAGCTGGAGGAAGAAGGGTCTAAATCCTGGCCTGTAGAGTTAGAACTACCATTTCCTCCCCTTAGCTGCCCTTGTATGACCCGGATTTGCTATGCAAAACAATCTATCCCAGGTTCTGTTCTGGTTG
GCTACATTGTTCAGCAACTCACAAAACGTAGCACAAACATTCATTATGGAGAAAGCATCAGGACTGTTGAGTAACTCCTCCTTTACTTTTTTCCTGCTGGCTACAGCATGGGGTGCCCTATAGGCACA
AGCCCAGCTGAAGAACAGAATGGAGGGCTCTGGGAGGAGGCAGCTCACTGGAGAGCCTACATTCCTTACACAAGTGCCTAAAGAGAGTGATGCTAACACTCCATCTGCCCTGTCCATTGCCTTCATAT
ACAGTCTACTTCGTGTTCTGTCACCCTTTGGGGAGGGGAGTTCTCCTGGGACAGTGGGCTCTGCATGTTCTCCACTTGGATACATTTTGGGGCTAGGATCAGGGCACTATTCCTGGAGGGTCCAGTCA
TTCACCAGCATTTGCAAATGTCCATAGGGAGCAGGTGGCAGCCTCTACTCCCAGCAACAAGTTTGTGTTCTCTCCTTTTCTCTCTTTGCCTCACTCTCTCCAGTTGGTTTTCAGCTGGGGCTTGAAAT
GCATTTTTAGCCCTTTGACGTGGCTTATGCCATTCAAGAAATAAAAAGCAAGAGAATCAGCTTTGGGCAATGACAAGAAATGAGTTCTTACTCTGATTTTTTTGTAAAAAGATAATTTTTGAGACTTG
AAAAATACCCCGACCTTGAGATTATTCCTGTTTGAAAGGTGGTGCATGCAGATGGAGAAGTGGTGTTGGCAGCAAGCTTTGGCTCATGTGGATTTGGTTTAAGTGGTGCTTCTTACCCAAGCTTCAAG
GAAGTGCTTGGGGGACCCCCAGCCTCATCCTCTTAGTTGGGTCTCTTGTTCCCTTTGTACCACTGTTTTGCCTTCCTTTTCCTCTTCTCTCTTTGCCTGGCTTCCTTTCCCTTTTCTTCTATTCACTC
TGCTTGCTTGCTGGCCGGCCTGCCTGCCTGCCTGCCTGCCTGCCTGCCTGTCTGCCTATGTGATGATGAAATCTCTGCATGGCTGCAATGATCCCACTGTTAGCTGGCAGGGTCAGGCTTAGCTCCTT
GACTGCAGAAGACCAAGAACCTGTTCCCCAAGCCCAGAGATGTCCACCTGGGCTGGACTGCCCTCAAGCTTATACTAGAGAAGAGCAACTGACCTGCCCAACTTGTGTGAAGTCAGGAGGGTTTCTGG
CATTTTCCACACCTGTCCACTCCTTGGAGCTGGTTTCTCTCATTGCTTTTTCTAAATCTGGTTCTTTTTCTCTTTACCTGGGGCCTGGCTTTTCTGAGATTGTCTTAGGGTTGAGCTATTTGGGTATC
CTGGGTTTGAGTGTTAGGGGATGGACATAAAGGAAAAAGAGTGATGAGAAGAGAATGGAGAGAATTTGAATAAAAGGTGGGAAAGGAGAGCACTGTTCTTTGATTGTTTATCCAGTCCAACCTGATCC
ATTAGGGATCGAGGTGCTACACTGGCCTCCAGGGATAAGCCTGGGGCTACTGTTGCTGGGAACTTAGGCTTAACATAAAGCCGAAGAAGGTACCTAGAAATTTGAAACTTCCCTAAAAAGCTCCTAAT
GCCCACCTGCTAGATAGCTTCTCTGTGGCCTCCTATTTAGCTAAGCAGCAGTGTTTTTGGATACTTTTTTTTTCTGTTTGTGAATAAGGCCAGCACTCAAGATGGGCAGCCAAGGGTGCACTGACTAT
TAGCTGGCCCATAGGATATCTGTAAGGCTGGTGGGACAGTTTTGGACCTGGAATCATGTGTAACTAACAAGGTTGGACGTTTCTTCCCCATCAGGGTAGAAAAATCATCTCAAACTAGCCAAAAGGCA
GTTTTGGAAACTACATTGGGGGACGTTATTTTTATTTATATATGGGGCCTAGGCCAATCCAGGATGGTAGCTGGAATACCTTCCTTCTTAAAATCTGATCATGGCAGGGATATGCAGGGCACTTTTTA
CTATTTGGCCTTCTAAGCAGATTGGGAAGGAGGTATTTTCTGGTTTTCGCTTTCCTCCGACTTAATAGGACTTGCCTTCTCCCTGGGCAGGGAGAGAGGCTGGGTTGGTGCTCTCCCTTACTCTACTC
ATACTGACTTAGAGCCTCTGGCTGCTGTTTGGGCATCCAAGAAAGGGAGGGGAAGGAATGAGCTAAAAACAAAACAGAATGAGGTGGGAAAGGGAGATTTTCTTCTTTACAGAGGAAAATAGGAAACC
CTCCAAGAATTGTGCAAGTAAAGACATTTGTTGAATGCACTGAGTCCCTTGGTGTAGTAGCAATAAGGAAAAATGAAATTACTTTCCTGTGCACACAGTCCAGCCTAATTGGTATGTGATGTTGCACT
TAGCAGCCATGTGGTGGGCATGTGTGACTACTCTGGTTTTCACTTTAGTTTCTAAACTTTTTATCCCTCTCAAGTCCAGCATGGATGGGGAAATGTCTCTGGATCCCCACAGCTGTGTACTTGTTTGC
ATTTGTTTCCCTTTGAGATTTGTGTTTGTGTCCTGCTTTGAGCTGTACCTTGTCCAGTCCATTGTGAAATTATCCCAGCAGCTGTAATGTACAGTTCCTTCTGAAGCAAGCAACATCAGCAGCAGCAG
CAGCAGCAGCACAATTCTGTGTTTTATAAAGACAACAGTGGCTTCTATTTCTAAAGTGCGGTCTTTCTCTTTTTTTTTCCTACCAGCAAAACAAACTTTTGGGACTGATTACATCTCTAATAGATTTT
AGGTGAGAATAATACTGTAGATTGTTATGCAGGAATACTTCACAGAGCCTTCATTTATTCTTCATTCAACAAACATGCAAAGCACTGTGCCAGCAGTATTGTGGGGAGGGGAGGCACAATTCAAAATG
AGGAAAATAGTGTCCGTCTCATTAAGGGAATTAAGTTTGGTGGGGGATATGATTAGCCAAATAGTCCCCTGGCATAGGAGGAAGATAATGAGGGAGTGGAATAAGGCTACAACAACGAATATAGGGAG
GAAGGGACAGATTTGAGAGACGAGGTAGAATTAATAGGACTCGATGGCTGGTGGGAGGAGAAGACAGGAGTAGAGGTTAGCTCCCAGGTTTCTCCTTGACCATAGGAGTGTGTTGGGACATTCTGCCA
GTCAAGATGGGGGTGACGGGGAGACTGTAGAAGGAAGGTGGGGAGTTTTTGAAGAAACAGAATGTTGTATAGACTGAGTTTTGAGGTGTTTGTGGGGCAGTAAGGGTAAGGTGTCCAGTAAACACAGG
TTGGTGCTCAGGTAAGACTGTAAAACTGCATTTATAGATACAGGAGTCTTATAGATGGTAGTTAAAGCCATAGGCATGAATGAGATAGCTTAGAAAAAGAGAAGAGAAACTAGTATACAGCCCCCTAA
GAAACTCAATTTAAAGGTTCGGGGGAGGAAGCAGATCTTAAGGTGACAGATCACTGGTAGACAGTTTGTGGGTTTTTTGTTTCTTTGTTTAGCCAGTTTGGTGAGGTAGGAGAAGAAATCAGAGTAGA
AGAAGGTTCATGAAGGGAGTGATTAACAACATGAACTGCTGCAGAGAGGGAGTTCTTTTTTTTTCTGTGTGTTTTACCTTTCTACTCCCCATCTTTTGGGGATCTTGTAACTCTATGACTTACTTACG
TTATTCTCCAGTATTTCTTGAAAATGAGCATTGGAAAAACCAATTCTAAAATGGCTAAAACTAGGACTTTCAAGTTCACCACAACTACCACCAATTAGGAGATAATTGTAAAAGAATAAACAAAACCT
AATTTTGTTCCTAGCCAATATTATAAACCATGTTCCAGCATACTAGATAATAGTAGCATACTATATTTATTTCCATAATTTGTCTTCTTTAGAGCCTATGAACTCCTAGGAGCAGAAGCTATATTCTC
TTCATTTTTGTCATCTCAGGGTCATGGCATATACCAACAGATCAGTATGTGCAAATATAATTGAAATAGGCTAGTAGTCTGTGGTTTATGAGTATGGGCTGGGTGGGCAGTGGATCAAGAAGTGATAG
GAGTACACAGGATGAACTCAGAATTCCTGAATCTTCAGGTAAGCAGATACTTAACTACATTATCATTGTCTTTTCCCACTCACCCCAAGTTGGAGGTTCTATGGTTTTGTACTTTAAGCTGGTGGTAT
AATTGTCAAGCATGTAAATTCTGGCATTCTTCCTGGTACTGCTAGAGCATTGTTATTTCTATGCATGGGGGTAAGAAGGCTCAGAGAAGGATCCTGGCGGATACCCCAGTGAGAAATCGTCAGTGGCA
GCCAGTGTGTACATACGTGGACCTAGCATTCCTCTGGAGGCCAAGTGTTGTAAATTGGCCTGTGGCTATCATCTGGCAGACTCCCTTGGGAAAGAGCCAGCCAGCCCCATGCTTCTTTTCAGCAGCAA
GGGTTAGGGAGGTTGGTTGAACTTGAAGAGCAGATTGGACATGGAGCAGATTTTGACCAGTTGAAATAAGACATAAATTTATGACTCCGAGTGAGGCAGAAATAAAGAACTTAGCAGGGGGAATAGGA
GGAGGATGATTATGGCAAATTTTGCTATAAACTTTAGTTTTAGAAAAGATTGATATTGAAAAGCCTTCAGGATTTGCCTGTGGTTGCTACTCAAGTTAAAAAGACTGGGAGCCTGCATTGTTTGGTCC
TGGAGCTCAAGGTTTTCAGTGAAGGCTTGTCCTGGCACCTCTGGGCATTCCTTTTCATTACTGGTTGAGCATCCTTCCTTCTGCTCTGTCAATTGGCAAAATATGCTGGAGCACATTCTGGACTAGCA
GTTGCCTTGGGGTAGTCAGGCTGGGTATTTGTTTGGTATCTCTTGGTGTAGCAGACCCCAGAATCTCATGGCAATTAGGATTTGGTGGCTAAACGAAAGAGTTAGTGCAAGGAAAAGCCTAGTTGGAA
TTTCTGAGTCTGGGCCATCCTTAAGCTGCTGTCTACTGCCTGAATGGGAAGTAATGTCGAATTGGAAAATTAGCTCACCATTTTTGTTCTAGCTTTGCAGACATTTATTCCTCTGATGATAGGCTGAG
AAATGCCTAGGCCGGCTTAGAAGGCACACAGCATGACAGAAGTACTCCTTCAAAGCAGCTGTGTCAAGAAGGAAGAGCTGGAAAAGTGGATTTGCTGGGGAATTAGATGCATTTAGTTTTCCACTTAC
GCACAACTGCCTTCTCCAGTATATCATACCAAGGTTTTTTAGGCCTTTGTGGCTTACCCTGCAGGAACATACTGTGTCCTGTTGTTCTGGACTGTAGCATCTTCACCACCATCCTCTTGGCAATGGTT
TTTTGTTTGGGGTTTTTTTTTTTTTTTTTTTGGACAAAGTATAATAATATTGAGGGACCTTTCTAGGGAGCCTTTGGTCCTTTGTCCCCATTTTCCAAAGGGAGGGAACTTTCCTCTTAAAAGAGACA
GTGGGAACTTTTAGCCAGGTTTTTGGAAAAGGCCTGTGGGCTATTAATGAGAGTGAGCTGCAAAAGGAGGAAGGGTTTGTTTGGGTACTTTGAAGTACTTAGCTAGGTGTTTTCTACAGTATCTTATA
TAATTGCATCTTACAGCATCTTTACATGCGAAATAGTTTATCAGTTATCTTCAATTGCATATTACAAAATTCTGATTAAATTTTTCTTAAATAAGAAAACTATCATTTCATATGACAAGAAATCCTAA
TTTAATGTTACTCCAAGGTTGGTTAATTCAGTGGCTCAGTGATAACACCAAAGACTCAGTTTCTTGAAATTTTTTTGCTCTGCCATCCTCCATGTTTATCCTCACGCCAGTTCGCCTCATGGTCCCAA
TATGGCTACTGTAATTCTGGGAAGGAAATGCTGACAGAACCGTGTCTGGCAAAAGAGAGACAGATTTTTCTGTGTCCTTCTAAAGCAAGGAAGTCTTCCCCTGGAAGCTCCAACAGATACGGCCTCAT
GGCTTTGCTAGAAATGGGTCATCTCACTCCTGTCATTGGCAAAGCAAGTAAGATCATCCATCAGGAGTGGCTTAGATTAATGAATTATCCTTTGAGTCGTGTAGACTAGAAAGTTCAGTCATGTCTAC
TAGCAAGAAAGGAGATAAGGGCTGTTGGATAAGCAGCATCTGGTCTCAAAGGTACTTCAACTTTTACAGATGAGAAACATGAATCAGAGTGACTTTCCCAGGCTCACAGCAAGTAAGAGAGGGCCTTC
AGTGTTAGCTGTGTCTGTCCCTAAAGCCCATGTTTTATATTGTATCTTGCTAGAGTATAAAGTAACTTACTTTCTACCTTGTAGAAACTGATGGTCTAGGAGAAGAGATTTGAACTCAGGTGCCCAGT
TGACTCTAATCTTGGCCCATGTGAGAGGATTGTACTCAGTTGCTCTCCTCATCCAGTGATGTTTCTTGTCTAACACAAGAAGCCTAGGAGTAGAAAGTCCTAAGCAGAGTAGAATAATAGCGGCAGCA
GGGAGGGAAGTGTGAACTGTGTGTCCCTGAGCCTGACTTACTGGGCAGGGACATGACACTTAAAGCGGCAGCTGGCCACTCTGTCTTTCCTGCATGCACTGAGTATTTGGTAGCTCATTAGTGACCAG
TGATATTGATCATCTTTTCATGTGCTCACTTACTATCCCCATATCTTTGTTGTTTGCATCTTTTACCCATTGTATTTGTTGTTTTTGAGACAGTGTCTCACTCTGTCACCCAGGCTGGAGTGCAGTCT
CATGATCGCGGCTCACTGCAGTTTCTGCCTCCTGGGCTCAAGCAATCCTCCCACCTCAGCCTCCTGAGTAGCTGGGCTTACAGGCGCACACCACCATGCCCAGCTAATTAAAAAAAAAATTTTTTTTG
TAGCAGTTCGGTCTCATTAGTATTGCCCAGGCTGGCCTCTCTTAGCTTCAAGCTATCCTCCCGCCTCGGCCTCCCAAAGTGCTGGAATTACAGGCATAAGCCACAAGCCACTGGGCCCAGCCTCTTTT
ACCTGTTTCAAAATTGAGTTTTATTGAGTTGTAAGAGTTCTTTATTCATTTTAAACACAAGTCCTTTGTTGGATATATCTTTTACATCTATTTTTCCCAGTCTGTGGCTTGCCTTTTCATTTTGAAGA
GCAAAAGTTTAAAATTTTGTGAATTTATTAAAGCTCCGTTTGTTGCTTTTTTCTGTTCTAGTTTATACTTTTGTATCATATTTTAGGAAATTTTGCACTGGGTATTTGATGGCTCCTGAGGAGGTTCA
ACTTTCAGAGCGCACTGATTTCTCTGCACCTGAGATTTTGTACTATTTCTGTATTTCTTTCTTCTCAGAACAACCAGTGTCACCAGGTATGAGGGCAGAGTTTTAGCTTGTTTGCTGAGCCCCATTCT
TGAAGCTCATTTATTTATTCACCTATCTGTCCATCAATCCAACAAATATACTGAATGCTGCTATGTGCCAGGTACTGGCACTGTTCTAGGTACTGGGGCAATGACAGTTAAGATAATACCCAATGACC
CTGCTCTGTACCCTTAAGAGCAGACTCAGTTGGGAATGAGTTATCCAAATATAGGGTGTACATGTAGTCAGGAGAGAGCCTCATACAGCTTTGCCTTTGGCAGAATCCTTCAAACCTCTTTGTCTTCC
TACTTCTTGATATTACAAATCATGAGCCTTTCACATGCATTGACTCTAAAGAGGTGGGTTCCTGGATAGCAGAAGTAGATAGGAAGGCATCATTGACATTTACTGAGATGGATTGAATCAGAGGGTGT
AAATTCTGCTCCATCAATGTTGAAAAAGACTAGCCCACCCCAAAGGTTTATCACTGTCACCATGTCTAATGTCTATTCTGGAAGAAGCTGAAGAAGTCTGCCTTTGTTTAGGGAACCGGTTCCAGAAT
CAGAGGGGTTGAGGATATAAAAGACCCTTGCACAAGAGTTGGTATTTACCCTGTCAGATGCTGCTACCAAGATTTGGATTGTGTACAGTCGAGGATTAAAAATGACTTTTAAGATGCAGTGTTTCATC
TGGTGACATTTAATTTGATATTTTAAAATTGGGGAGGGTATTTTCAGCCATGGGGGTAGGGATGTGAAAGAAGAAGAAAGTAAGAATTGGAGTCAGATGTGGTTTTGAGTCCCATACATTTATTGTTT
AATATTATATGGTAAGTACTTTAAAATGGTAAATAGTAAATACTTGTGTTATTCACTAACATTTGGGGAGGATTTTCTCTGTGCTTTATGTATATTACCTAACCTTACAAACTGTGTAAGGTACATGC
TGTTCTCTCAATTTTTCAGATAAGAAAATTGAAGCCCAGAGAGATCAAGTGACTGATCCAAAGTCCCACAGTGAGGGGAACTGAAGATAGGATATTCTTTCTCCTTTTCCTCTTTAAAAAATTATTTT
GATTAAAAAAAACCGTATTACTGAAGCATAGGGACATGGGGAGAAATTATGAATGATTCCTCAGCCTGAATAAAATAGTATGTTTCATTAAGGCAACAAATATTTATTAAGGACCTAATATTTGCCTG
ACATTCAAGTGAGGTGGGGGGCACACAAGTAGTAAATAAATAACAGACTGGGCAAAGGGCTACCAAGGCAATACTGTAGTAGACTAACAGGTGCCCCACCATAGATGGGTGGTCCGGAAAAGGCGTCT
CAGATGTCTTTCGTTGAGACGCAAAAAAAAGCTGTGGGGTAGGGCGTAAGGGGAGGGTGGAGAAGAGAGAGAGGGTTCCTGGCCAAGGGAACCAAAAGCAGAGAAGCTCCAAGTCAGAAAAAAGCAGC
GGTTGGCCCGTTGGGAGAATTGGAAGCCAACCAGTATAGCTGTAGCACAGGCGGGGCCCATTTACGCCGTGCGTTTTCACCCTGGAAAGGAGTTTGGGTTTTCAAGTGTGACGAGGCGCTATTAAAGA
GTTTTAAACATGGAAA

hide sequence

RefSeq Acc Id:

NM_001317123 ⟹ NP_001304052

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	35,869,761 - 35,930,532 (+)	NCBI
CHM1_1	1	36,451,786 - 36,506,281 (+)	NCBI
T2T-CHM13v2.0	1	35,732,654 - 35,793,426 (+)	NCBI

Sequence:

show sequence

GGAGCCAAATGTGGACCTGTGAGGACGCCACGTGAGAGGGAAGCCCGTGAGGCAAGCGCCTCAG
GAGTGCGTGAGGCCCACGCAGAACTCGGGGAGCCTTTTATCCTGAGGACACAGGGGAAGAATTGGAGGACTATATTCAGCTGCGGGCGCTTACCTGCCCCCCCTGCAGCAGGTGTTCCAGGCACCTCG
CCGGCCTGGCATTGGCACTGTGGGGAAACCAATCAAGCTCCTGGCCAATTACTTTGAGGTGGACATCCCTAAGATCGACGTGTACCACTACGAGGTGGACATCAAGCCGGATAAGTGTCCCCGTAGAG
TCAACCGGGAAGTGGTGGAATACATGGTCCAGCATTTCAAGCCTCAGATCTTTGGTGATCGCAAGCCTGTGTATGATGGAAAGAAGAACATTTACACTGTCACAGCACTGCCCATTGGCAACGAACGG
GTCGACTTTGAGGTGACAATCCCTGGGGAAGGGAAGGATCGAATCTTTAAGGTCTCCATCAAGTGGCTAGCCATTGTGAGCTGGCGAATGCTGCATGAGGCCCTGGTCAGCGGCCAGATCCCTGTTCC
CTTGGAGTCTGTGCAAGCCCTGGATGTGGCCATGAGGCACCTGGCATCCATGAGGTACACCCCTGTGGGCCGCTCCTTCTTCTCACCGCCTGAGGGCTACTACCACCCGCTGGGGGGTGGGCGCGAGG
TCTGGTTCGGCTTTCACCAGTCTGTGCGCCCTGCCATGTGGAAGATGATGCTCAACATTGATGTCTCAGCCACTGCCTTTTATAAGGCACAGCCAGTGATTGAGTTCATGTGTGAGGTGCTGGACATC
AGGAACATAGATGAGCAGCCCAAGCCCCTCACGGACTCTCAGCGCGTTCGCTTCACCAAGGAGATCAAGGGCCTGAAGGTGGAAGTCACCCACTGTGGACAGATGAAGAGGAAGTACCGCGTGTGTAA
TGTTACCCGTCGCCCTGCTAGCCATCAGACATTCCCCTTACAGCTGGAGAGTGGACAGACTGTGGAGTGCACAGTGGCACAGTATTTCAAGCAGAAATATAACCTTCAGCTCAAGTATCCCCATCTGC
CCTGCCTACAAGTTGGCCAGGAACAAAAGCATACCTACCTTCCCCTAGAGGTCTGTAACATTGTGGCTGGGCAGCGCTGTATTAAAAAGCTGACCGACAACCAGACCTCGACCATGATAAAGGCCACA
GCTAGATCCGCTCCAGACAGACAGGAGGAGATCAGTCGCCTGATGAAGAATGCCAGCTACAACTTAGATCCCTACATCCAGGAATTTGGGATCAAAGTGAAGGATGACATGACGGAGGTGACAGGGCG
AGTGCTGCCGGCGCCCATCTTGCAGTACGGCGGCCGGAACCGGGCCATTGCCACACCCAATCAGGGTGTCTGGGACATGCGGGGGAAACAGTTCTACAATGGGATTGAGATCAAAGTCTGGGCCATCG
CCTGCTTCGCACCCCAAAAACAGTGTCGAGAAGAGGTGCTCAAGAACTTCACAGACCAGCTGCGGAAGATTTCCAAGGATGCGGGGATGCCTATCCAGGGTCAACCTTGTTTCTGCAAATATGCACAG
GGGGCAGACAGCGTGGAGCCTATGTTCCGGCATCTCAAGAACACCTACTCAGGGCTGCAGCTCATTATTGTCATCCTGCCAGGGAAGACGCCGGTGTATGCTGAGGTGAAACGTGTCGGAGATACACT
CTTGGGAATGGCTACGCAGTGTGTGCAGGTGAAGAACGTGGTCAAGACCTCACCTCAGACTCTGTCCAACCTCTGCCTCAAGATCAATGTCAAACTTGGTGGCATTAACAACATCCTAGTCCCACACC
AGCGCTCTGCCGTTTTTCAACAGCCAGTGATATTCCTGGGAGCAGATGTTACACACCCCCCAGCAGGGGATGGGAAAAAACCTTCTATCACAGCAGTGGTAGGCAGTATGGATGCCCACCCCAGCCGA
TACTGTGCTACTGTGCGGGTACAGCGACCACGGCAAGAGATCATTGAAGACTTGTCCTACATGGTGCGTGAGCTCCTCATCCAATTCTACAAGTCCACCCGTTTCAAGCCTACCCGCATCATCTTCTA
CCGAGATGGGGTGCCTGAAGGCCAGCTACCCCAGATACTCCACTATGAGCTACTGGCCATTCGTGATGCCTGCATCAAACTGGAAAAGGACTACCAGCCTGGGATCACTTATATTGTGGTGCAGAAAC
GCCATCACACCCGCCTTTTCTGTGCTGACAAGAATGAGCGAATTGGGAAGAGTGGTAACATCCCAGCTGGGACCACAGTGGACACCAACATCACCCACCCATTTGAGTTTGACTTCTATCTGTGCAGC
CACGCAGGCATCCAGGGCACCAGCCGACCATCCCATTACTATGTTCTTTGGGATGACAACCGTTTCACAGCAGATGAGCTCCAGATCCTGACGTACCAGCTGTGCCACACTTACGTACGATGCACACG
CTCTGTCTCTATCCCAGCACCTGCCTACTATGCCCGCCTGGTGGCTTTCCGGGCACGATACCACCTGGTGGACAAGGAGCATGACAGTGGAGAGGGGAGCCACATATCGGGGCAGAGCAATGGGCGGG
ACCCCCAGGCCCTGGCCAAAGCCGTGCAGGTTCACCAGGATACTCTGCGCACCATGTACTTCGCTTGAAGGCAGAACGCTGTTACCTCACTGGATAGAAGAAAGCTTTCCAAGCCCCAGGAGCTGTGC
CACCCAAATCCAGAGGAAGCAAGGAGGAGGGAGGTGGGGTAGGGAGGAGTGTAGGATGCCTTGTTTCCTTCTATAGAGGTGGTGTAAGAGTGGGGAACAGGGCCAGCAAGACAGACCACCAGCCAGAA
ATCTCTGATATCAACCTCATGTCCCCCACCCCTCACCCCATCTTGTCACATCTGGCCCTGACCCCACTGGACCAAAAGGGGCAGCACTGGTGCCCACCATACACACAGGTGTCTCATGTGACTCACAG
TGCTAAAGACTCATGCTTGACAGCTTGGTAAGGTCAACTCTGTAGCCCTGCAGACAAAAGCTGGTTAGGTTTGGGTTTGATACTTTAGATGGGAAAGTGAGGGGCTTGAGAAAGTGGGTGGGAGGAGG
GAAGGATTTTTTAGGAGCCTTAATCAGAAAAGGACTAGATTTGTTTAAGAAGAAAAATGAAACCAGACCCAGATCAATATTTTAGGATACTAGATGTTTTAATGGGTTCAGAATCCAGTTTGTAGGAA
GATTTTTTAATGGTTTTGGTTGCTCCTCCCCCAGCTGCCACCCCCCACCTTACCCTTATTCCTCTCTGTCCACATTTTCTGCCCCACCTTACTTCTCCTCCCTGACAGACATCCAGCCCCTAGTAATA
CTTAAGGCACTATGGCACTTAGCTTTGAAGTGACACGACCCTGTCTTCCTTCCGCCCGCTGGTGGGTAACCAGTGCCTTCCCTGTAACGGTAATGCTGCAGAACTGCAACCTTTTGTACCTTTCTTTG
GGGAATGGGGTGGGGGTGGGAGAGGAGGTAGATGGGGAAGAAATACCCCAGACCCAACAAACCTCCAGCCAGAAAGCCAGCTATTTTGCATTTGAAGGAATTGACTTCCTCATTCATTGAGCTTTTTA
AAAGATCACAACCTCAAGATGGTTAAAATCCATTGACATTTGCACTTTCAAACATGACAAGTCTCGGAGCTGCTGAGATGACAGGCCCCTGGCCTTTCCACTTATGCCTCCTTTTCTCCTTATTCCTC
CTACCTCCCGCCCCGCCCAGGTCTGGAGTTACTTTCATAGCATTTTTCACTCTTGGCTTCTTTTCTCCCTTGATGGTCAAGTCTCTTATGTTTCAATATTTCTTAACTGGGGTGTCTTATAACAAAAA
ACTCTTAGGTCTAAAATGAGAAAAAAGAGAGAAAACAAAATGTTATTTTTATACCATAACTTGAGTGTATTGCCAAAATTTGGAAATCCTTCCCATGCCTGATGAGTTTATATCCCAGAAACATTGAG
CCATCAGAATGAACTGTGTACCTGATTTGTTCTCTGACCTGGCTAGGTAGGGAGGGGGTGGTTATCGCCCCAAGATGGGGTCCAGGCTCCATCCTTCCTCTGTGCAGATAATACCTTTTTCTTGCTAT
AGCCTCCCTCCTCTGCACTGTCCTGCACTCTTTCTTGCAAGTGCATCTTTTTCCTTCCCCTGGACTGTCCTCTGACCCTTTGGCTCATCCTAGATTGCAGTGTGTCCTGTGGACAGGCTGGGGAATTT
TGCTGCTCCCTATTGCTTCTGTTTACAAAAATGAATTTTTCCTGGTTTCCCACTAGGGCATGTGGGTGGGTGGCATGGACTTTTTTTTTTTTTTTTTTTTGTCTTGAGACATGGGGTTTGGCTGTCTT
GCAGGACTGGAGAAGGTGGTGGTTCTAGCTTGGTCTCTGTTGGCCTTGAAGCAAGCATCCCCCCTGCCCTTTTTCCTTGACTGTTCATTTTTTTCCTGCCCCACTGCTTGGGATGGGGAGTTGCAACT
TCAGTGTGGAATTTCCTCTTTGAGGAGCCTGGGCTTGGATCTATCCTGATCTGGTGATGAAGCCATGATTACTTTAGACCTAGCCCAGGCTTGGAGGCCAGCTGGAGGAAGAAGGGTCTAAATCCTGG
CCTGTAGAGTTAGAACTACCATTTCCTCCCCTTAGCTGCCCTTGTATGACCCGGATTTGCTATGCAAAACAATCTATCCCAGGTTCTGTTCTGGTTGGCTACATTGTTCAGCAACTCACAAAACGTAG
CACAAACATTCATTATGGAGAAAGCATCAGGACTGTTGAGTAACTCCTCCTTTACTTTTTTCCTGCTGGCTACAGCATGGGGTGCCCTATAGGCACAAGCCCAGCTGAAGAACAGAATGGAGGGCTCT
GGGAGGAGGCAGCTCACTGGAGAGCCTACATTCCTTACACAAGTGCCTAAAGAGAGTGATGCTAACACTCCATCTGCCCTGTCCATTGCCTTCATATACAGTCTACTTCGTGTTCTGTCACCCTTTGG
GGAGGGGAGTTCTCCTGGGACAGTGGGCTCTGCATGTTCTCCACTTGGATACATTTTGGGGCTAGGATCAGGGCACTATTCCTGGAGGGTCCAGTCATTCACCAGCATTTGCAAATGTCCATAGGGAG
CAGGTGGCAGCCTCTACTCCCAGCAACAAGTTTGTGTTCTCTCCTTTTCTCTCTTTGCCTCACTCTCTCCAGTTGGTTTTCAGCTGGGGCTTGAAATGCATTTTTAGCCCTTTGACGTGGCTTATGCC
ATTCAAGAAATAAAAAGCAAGAGAATCAGCTTTGGGCAATGACAAGAAATGAGTTCTTACTCTGATTTTTTTGTAAAAAGATAATTTTTGAGACTTGAAAAATACCCCGACCTTGAGATTATTCCTGT
TTGAAAGGTGGTGCATGCAGATGGAGAAGTGGTGTTGGCAGCAAGCTTTGGCTCATGTGGATTTGGTTTAAGTGGTGCTTCTTACCCAAGCTTCAAGGAAGTGCTTGGGGGACCCCCAGCCTCATCCT
CTTAGTTGGGTCTCTTGTTCCCTTTGTACCACTGTTTTGCCTTCCTTTTCCTCTTCTCTCTTTGCCTGGCTTCCTTTCCCTTTTCTTCTATTCACTCTGCTTGCTTGCTGGCCGGCCTGCCTGCCTGC
CTGCCTGCCTGCCTGCCTGTCTGCCTATGTGATGATGAAATCTCTGCATGGCTGCAATGATCCCACTGTTAGCTGGCAGGGTCAGGCTTAGCTCCTTGACTGCAGAAGACCAAGAACCTGTTCCCCAA
GCCCAGAGATGTCCACCTGGGCTGGACTGCCCTCAAGCTTATACTAGAGAAGAGCAACTGACCTGCCCAACTTGTGTGAAGTCAGGAGGGTTTCTGGCATTTTCCACACCTGTCCACTCCTTGGAGCT
GGTTTCTCTCATTGCTTTTTCTAAATCTGGTTCTTTTTCTCTTTACCTGGGGCCTGGCTTTTCTGAGATTGTCTTAGGGTTGAGCTATTTGGGTATCCTGGGTTTGAGTGTTAGGGGATGGACATAAA
GGAAAAAGAGTGATGAGAAGAGAATGGAGAGAATTTGAATAAAAGGTGGGAAAGGAGAGCACTGTTCTTTGATTGTTTATCCAGTCCAACCTGATCCATTAGGGATCGAGGTGCTACACTGGCCTCCA
GGGATAAGCCTGGGGCTACTGTTGCTGGGAACTTAGGCTTAACATAAAGCCGAAGAAGGTACCTAGAAATTTGAAACTTCCCTAAAAAGCTCCTAATGCCCACCTGCTAGATAGCTTCTCTGTGGCCT
CCTATTTAGCTAAGCAGCAGTGTTTTTGGATACTTTTTTTTTCTGTTTGTGAATAAGGCCAGCACTCAAGATGGGCAGCCAAGGGTGCACTGACTATTAGCTGGCCCATAGGATATCTGTAAGGCTGG
TGGGACAGTTTTGGACCTGGAATCATGTGTAACTAACAAGGTTGGACGTTTCTTCCCCATCAGGGTAGAAAAATCATCTCAAACTAGCCAAAAGGCAGTTTTGGAAACTACATTGGGGGACGTTATTT
TTATTTATATATGGGGCCTAGGCCAATCCAGGATGGTAGCTGGAATACCTTCCTTCTTAAAATCTGATCATGGCAGGGATATGCAGGGCACTTTTTACTATTTGGCCTTCTAAGCAGATTGGGAAGGA
GGTATTTTCTGGTTTTCGCTTTCCTCCGACTTAATAGGACTTGCCTTCTCCCTGGGCAGGGAGAGAGGCTGGGTTGGTGCTCTCCCTTACTCTACTCATACTGACTTAGAGCCTCTGGCTGCTGTTTG
GGCATCCAAGAAAGGGAGGGGAAGGAATGAGCTAAAAACAAAACAGAATGAGGTGGGAAAGGGAGATTTTCTTCTTTACAGAGGAAAATAGGAAACCCTCCAAGAATTGTGCAAGTAAAGACATTTGT
TGAATGCACTGAGTCCCTTGGTGTAGTAGCAATAAGGAAAAATGAAATTACTTTCCTGTGCACACAGTCCAGCCTAATTGGTATGTGATGTTGCACTTAGCAGCCATGTGGTGGGCATGTGTGACTAC
TCTGGTTTTCACTTTAGTTTCTAAACTTTTTATCCCTCTCAAGTCCAGCATGGATGGGGAAATGTCTCTGGATCCCCACAGCTGTGTACTTGTTTGCATTTGTTTCCCTTTGAGATTTGTGTTTGTGT
CCTGCTTTGAGCTGTACCTTGTCCAGTCCATTGTGAAATTATCCCAGCAGCTGTAATGTACAGTTCCTTCTGAAGCAAGCAACATCAGCAGCAGCAGCAGCAGCAGCACAATTCTGTGTTTTATAAAG
ACAACAGTGGCTTCTATTTCTAAAGTGCGGTCTTTCTCTTTTTTTTTCCTACCAGCAAAACAAACTTTTGGGACTGATTACATCTCTAATAGATTTTAGGTGAGAATAATACTGTAGATTGTTATGCA
GGAATACTTCACAGAGCCTTCATTTATTCTTCATTCAACAAACATGCAAAGCACTGTGCCAGCAGTATTGTGGGGAGGGGAGGCACAATTCAAAATGAGGAAAATAGTGTCCGTCTCATTAAGGGAAT
TAAGTTTGGTGGGGGATATGATTAGCCAAATAGTCCCCTGGCATAGGAGGAAGATAATGAGGGAGTGGAATAAGGCTACAACAACGAATATAGGGAGGAAGGGACAGATTTGAGAGACGAGGTAGAAT
TAATAGGACTCGATGGCTGGTGGGAGGAGAAGACAGGAGTAGAGGTTAGCTCCCAGGTTTCTCCTTGACCATAGGAGTGTGTTGGGACATTCTGCCAGTCAAGATGGGGGTGACGGGGAGACTGTAGA
AGGAAGGTGGGGAGTTTTTGAAGAAACAGAATGTTGTATAGACTGAGTTTTGAGGTGTTTGTGGGGCAGTAAGGGTAAGGTGTCCAGTAAACACAGGTTGGTGCTCAGGTAAGACTGTAAAACTGCAT
TTATAGATACAGGAGTCTTATAGATGGTAGTTAAAGCCATAGGCATGAATGAGATAGCTTAGAAAAAGAGAAGAGAAACTAGTATACAGCCCCCTAAGAAACTCAATTTAAAGGTTCGGGGGAGGAAG
CAGATCTTAAGGTGACAGATCACTGGTAGACAGTTTGTGGGTTTTTTGTTTCTTTGTTTAGCCAGTTTGGTGAGGTAGGAGAAGAAATCAGAGTAGAAGAAGGTTCATGAAGGGAGTGATTAACAACA
TGAACTGCTGCAGAGAGGGAGTTCTTTTTTTTTCTGTGTGTTTTACCTTTCTACTCCCCATCTTTTGGGGATCTTGTAACTCTATGACTTACTTACGTTATTCTCCAGTATTTCTTGAAAATGAGCAT
TGGAAAAACCAATTCTAAAATGGCTAAAACTAGGACTTTCAAGTTCACCACAACTACCACCAATTAGGAGATAATTGTAAAAGAATAAACAAAACCTAATTTTGTTCCTAGCCAATATTATAAACCAT
GTTCCAGCATACTAGATAATAGTAGCATACTATATTTATTTCCATAATTTGTCTTCTTTAGAGCCTATGAACTCCTAGGAGCAGAAGCTATATTCTCTTCATTTTTGTCATCTCAGGGTCATGGCATA
TACCAACAGATCAGTATGTGCAAATATAATTGAAATAGGCTAGTAGTCTGTGGTTTATGAGTATGGGCTGGGTGGGCAGTGGATCAAGAAGTGATAGGAGTACACAGGATGAACTCAGAATTCCTGAA
TCTTCAGGTAAGCAGATACTTAACTACATTATCATTGTCTTTTCCCACTCACCCCAAGTTGGAGGTTCTATGGTTTTGTACTTTAAGCTGGTGGTATAATTGTCAAGCATGTAAATTCTGGCATTCTT
CCTGGTACTGCTAGAGCATTGTTATTTCTATGCATGGGGGTAAGAAGGCTCAGAGAAGGATCCTGGCGGATACCCCAGTGAGAAATCGTCAGTGGCAGCCAGTGTGTACATACGTGGACCTAGCATTC
CTCTGGAGGCCAAGTGTTGTAAATTGGCCTGTGGCTATCATCTGGCAGACTCCCTTGGGAAAGAGCCAGCCAGCCCCATGCTTCTTTTCAGCAGCAAGGGTTAGGGAGGTTGGTTGAACTTGAAGAGC
AGATTGGACATGGAGCAGATTTTGACCAGTTGAAATAAGACATAAATTTATGACTCCGAGTGAGGCAGAAATAAAGAACTTAGCAGGGGGAATAGGAGGAGGATGATTATGGCAAATTTTGCTATAAA
CTTTAGTTTTAGAAAAGATTGATATTGAAAAGCCTTCAGGATTTGCCTGTGGTTGCTACTCAAGTTAAAAAGACTGGGAGCCTGCATTGTTTGGTCCTGGAGCTCAAGGTTTTCAGTGAAGGCTTGTC
CTGGCACCTCTGGGCATTCCTTTTCATTACTGGTTGAGCATCCTTCCTTCTGCTCTGTCAATTGGCAAAATATGCTGGAGCACATTCTGGACTAGCAGTTGCCTTGGGGTAGTCAGGCTGGGTATTTG
TTTGGTATCTCTTGGTGTAGCAGACCCCAGAATCTCATGGCAATTAGGATTTGGTGGCTAAACGAAAGAGTTAGTGCAAGGAAAAGCCTAGTTGGAATTTCTGAGTCTGGGCCATCCTTAAGCTGCTG
TCTACTGCCTGAATGGGAAGTAATGTCGAATTGGAAAATTAGCTCACCATTTTTGTTCTAGCTTTGCAGACATTTATTCCTCTGATGATAGGCTGAGAAATGCCTAGGCCGGCTTAGAAGGCACACAG
CATGACAGAAGTACTCCTTCAAAGCAGCTGTGTCAAGAAGGAAGAGCTGGAAAAGTGGATTTGCTGGGGAATTAGATGCATTTAGTTTTCCACTTACGCACAACTGCCTTCTCCAGTATATCATACCA
AGGTTTTTTAGGCCTTTGTGGCTTACCCTGCAGGAACATACTGTGTCCTGTTGTTCTGGACTGTAGCATCTTCACCACCATCCTCTTGGCAATGGTTTTTTGTTTGGGGTTTTTTTTTTTTTTTTTTT
GGACAAAGTATAATAATATTGAGGGACCTTTCTAGGGAGCCTTTGGTCCTTTGTCCCCATTTTCCAAAGGGAGGGAACTTTCCTCTTAAAAGAGACAGTGGGAACTTTTAGCCAGGTTTTTGGAAAAG
GCCTGTGGGCTATTAATGAGAGTGAGCTGCAAAAGGAGGAAGGGTTTGTTTGGGTACTTTGAAGTACTTAGCTAGGTGTTTTCTACAGTATCTTATATAATTGCATCTTACAGCATCTTTACATGCGA
AATAGTTTATCAGTTATCTTCAATTGCATATTACAAAATTCTGATTAAATTTTTCTTAAATAAGAAAACTATCATTTCATATGACAAGAAATCCTAATTTAATGTTACTCCAAGGTTGGTTAATTCAG
TGGCTCAGTGATAACACCAAAGACTCAGTTTCTTGAAATTTTTTTGCTCTGCCATCCTCCATGTTTATCCTCACGCCAGTTCGCCTCATGGTCCCAATATGGCTACTGTAATTCTGGGAAGGAAATGC
TGACAGAACCGTGTCTGGCAAAAGAGAGACAGATTTTTCTGTGTCCTTCTAAAGCAAGGAAGTCTTCCCCTGGAAGCTCCAACAGATACGGCCTCATGGCTTTGCTAGAAATGGGTCATCTCACTCCT
GTCATTGGCAAAGCAAGTAAGATCATCCATCAGGAGTGGCTTAGATTAATGAATTATCCTTTGAGTCGTGTAGACTAGAAAGTTCAGTCATGTCTACTAGCAAGAAAGGAGATAAGGGCTGTTGGATA
AGCAGCATCTGGTCTCAAAGGTACTTCAACTTTTACAGATGAGAAACATGAATCAGAGTGACTTTCCCAGGCTCACAGCAAGTAAGAGAGGGCCTTCAGTGTTAGCTGTGTCTGTCCCTAAAGCCCAT
GTTTTATATTGTATCTTGCTAGAGTATAAAGTAACTTACTTTCTACCTTGTAGAAACTGATGGTCTAGGAGAAGAGATTTGAACTCAGGTGCCCAGTTGACTCTAATCTTGGCCCATGTGAGAGGATT
GTACTCAGTTGCTCTCCTCATCCAGTGATGTTTCTTGTCTAACACAAGAAGCCTAGGAGTAGAAAGTCCTAAGCAGAGTAGAATAATAGCGGCAGCAGGGAGGGAAGTGTGAACTGTGTGTCCCTGAG
CCTGACTTACTGGGCAGGGACATGACACTTAAAGCGGCAGCTGGCCACTCTGTCTTTCCTGCATGCACTGAGTATTTGGTAGCTCATTAGTGACCAGTGATATTGATCATCTTTTCATGTGCTCACTT
ACTATCCCCATATCTTTGTTGTTTGCATCTTTTACCCATTGTATTTGTTGTTTTTGAGACAGTGTCTCACTCTGTCACCCAGGCTGGAGTGCAGTCTCATGATCGCGGCTCACTGCAGTTTCTGCCTC
CTGGGCTCAAGCAATCCTCCCACCTCAGCCTCCTGAGTAGCTGGGCTTACAGGCGCACACCACCATGCCCAGCTAATTAAAAAAAAAATTTTTTTTGTAGCAGTTCGGTCTCATTAGTATTGCCCAGG
CTGGCCTCTCTTAGCTTCAAGCTATCCTCCCGCCTCGGCCTCCCAAAGTGCTGGAATTACAGGCATAAGCCACAAGCCACTGGGCCCAGCCTCTTTTACCTGTTTCAAAATTGAGTTTTATTGAGTTG
TAAGAGTTCTTTATTCATTTTAAACACAAGTCCTTTGTTGGATATATCTTTTACATCTATTTTTCCCAGTCTGTGGCTTGCCTTTTCATTTTGAAGAGCAAAAGTTTAAAATTTTGTGAATTTATTAA
AGCTCCGTTTGTTGCTTTTTTCTGTTCTAGTTTATACTTTTGTATCATATTTTAGGAAATTTTGCACTGGGTATTTGATGGCTCCTGAGGAGGTTCAACTTTCAGAGCGCACTGATTTCTCTGCACCT
GAGATTTTGTACTATTTCTGTATTTCTTTCTTCTCAGAACAACCAGTGTCACCAGGTATGAGGGCAGAGTTTTAGCTTGTTTGCTGAGCCCCATTCTTGAAGCTCATTTATTTATTCACCTATCTGTC
CATCAATCCAACAAATATACTGAATGCTGCTATGTGCCAGGTACTGGCACTGTTCTAGGTACTGGGGCAATGACAGTTAAGATAATACCCAATGACCCTGCTCTGTACCCTTAAGAGCAGACTCAGTT
GGGAATGAGTTATCCAAATATAGGGTGTACATGTAGTCAGGAGAGAGCCTCATACAGCTTTGCCTTTGGCAGAATCCTTCAAACCTCTTTGTCTTCCTACTTCTTGATATTACAAATCATGAGCCTTT
CACATGCATTGACTCTAAAGAGGTGGGTTCCTGGATAGCAGAAGTAGATAGGAAGGCATCATTGACATTTACTGAGATGGATTGAATCAGAGGGTGTAAATTCTGCTCCATCAATGTTGAAAAAGACT
AGCCCACCCCAAAGGTTTATCACTGTCACCATGTCTAATGTCTATTCTGGAAGAAGCTGAAGAAGTCTGCCTTTGTTTAGGGAACCGGTTCCAGAATCAGAGGGGTTGAGGATATAAAAGACCCTTGC
ACAAGAGTTGGTATTTACCCTGTCAGATGCTGCTACCAAGATTTGGATTGTGTACAGTCGAGGATTAAAAATGACTTTTAAGATGCAGTGTTTCATCTGGTGACATTTAATTTGATATTTTAAAATTG
GGGAGGGTATTTTCAGCCATGGGGGTAGGGATGTGAAAGAAGAAGAAAGTAAGAATTGGAGTCAGATGTGGTTTTGAGTCCCATACATTTATTGTTTAATATTATATGGTAAGTACTTTAAAATGGTA
AATAGTAAATACTTGTGTTATTCACTAACATTTGGGGAGGATTTTCTCTGTGCTTTATGTATATTACCTAACCTTACAAACTGTGTAAGGTACATGCTGTTCTCTCAATTTTTCAGATAAGAAAATTG
AAGCCCAGAGAGATCAAGTGACTGATCCAAAGTCCCACAGTGAGGGGAACTGAAGATAGGATATTCTTTCTCCTTTTCCTCTTTAAAAAATTATTTTGATTAAAAAAAACCGTATTACTGAAGCATAG
GGACATGGGGAGAAATTATGAATGATTCCTCAGCCTGAATAAAATAGTATGTTTCATTAAGGCAACAAATATTTATTAAGGACCTAATATTTGCCTGACATTCAAGTGAGGTGGGGGGCACACAAGTA
GTAAATAAATAACAGACTGGGCAAAGGGCTACCAAGGCAATACTGTAGTAGACTAACAGGTGCCCCACCATAGATGGGTGGTCCGGAAAAGGCGTCTCAGATGTCTTTCGTTGAGACGCAAAAAAAAG
CTGTGGGGTAGGGCGTAAGGGGAGGGTGGAGAAGAGAGAGAGGGTTCCTGGCCAAGGGAACCAAAAGCAGAGAAGCTCCAAGTCAGAAAAAAGCAGCGGTTGGCCCGTTGGGAGAATTGGAAGCCAAC
CAGTATAGCTGTAGCACAGGCGGGGCCCATTTACGCCGTGCGTTTTCACCCTGGAAAGGAGTTTGGGTTTTCAAGTGTGACGAGGCGCTATTAAAGAGTTTTAAACATGGAAA

hide sequence

RefSeq Acc Id:

NM_012199 ⟹ NP_036331

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	35,883,209 - 35,930,532 (+)	NCBI
GRCh37	1	36,335,412 - 36,395,211 (+)	NCBI
Build 36	1	36,121,397 - 36,162,486 (+)	NCBI Archive
HuRef	1	34,466,263 - 34,506,900 (+)	ENTREZGENE
CHM1_1	1	36,465,173 - 36,506,281 (+)	NCBI
T2T-CHM13v2.0	1	35,746,102 - 35,793,426 (+)	NCBI

Sequence:

show sequence

ACTGGCAGCTGGCCGGGCGCTCGCAGTGGGAGCTGCTGCAGGCTCCGCGGCGGCGGCAACGGAGGCTGCGGGGGCGGCGGCGCGAGCGGCCGGGCTTGGTAGGGGAGCCGAGCCCGGCCCGGGATCCC
GAGCAGCGAGAGTGTGGGGTACCTAGGCCCCTCACGCTGGACTTCACAGTCTCCGGGCCGCCTGACCTCCGCACGGGTATATGGGATGGAAGCGGGACCCTCGGGAGCAGCTGCGGGCGCTTACCTGC
CCCCCCTGCAGCAGGTGTTCCAGGCACCTCGCCGGCCTGGCATTGGCACTGTGGGGAAACCAATCAAGCTCCTGGCCAATTACTTTGAGGTGGACATCCCTAAGATCGACGTGTACCACTACGAGGTG
GACATCAAGCCGGATAAGTGTCCCCGTAGAGTCAACCGGGAAGTGGTGGAATACATGGTCCAGCATTTCAAGCCTCAGATCTTTGGTGATCGCAAGCCTGTGTATGATGGAAAGAAGAACATTTACAC
TGTCACAGCACTGCCCATTGGCAACGAACGGGTCGACTTTGAGGTGACAATCCCTGGGGAAGGGAAGGATCGAATCTTTAAGGTCTCCATCAAGTGGCTAGCCATTGTGAGCTGGCGAATGCTGCATG
AGGCCCTGGTCAGCGGCCAGATCCCTGTTCCCTTGGAGTCTGTGCAAGCCCTGGATGTGGCCATGAGGCACCTGGCATCCATGAGGTACACCCCTGTGGGCCGCTCCTTCTTCTCACCGCCTGAGGGC
TACTACCACCCGCTGGGGGGTGGGCGCGAGGTCTGGTTCGGCTTTCACCAGTCTGTGCGCCCTGCCATGTGGAAGATGATGCTCAACATTGATGTCTCAGCCACTGCCTTTTATAAGGCACAGCCAGT
GATTGAGTTCATGTGTGAGGTGCTGGACATCAGGAACATAGATGAGCAGCCCAAGCCCCTCACGGACTCTCAGCGCGTTCGCTTCACCAAGGAGATCAAGGGCCTGAAGGTGGAAGTCACCCACTGTG
GACAGATGAAGAGGAAGTACCGCGTGTGTAATGTTACCCGTCGCCCTGCTAGCCATCAGACATTCCCCTTACAGCTGGAGAGTGGACAGACTGTGGAGTGCACAGTGGCACAGTATTTCAAGCAGAAA
TATAACCTTCAGCTCAAGTATCCCCATCTGCCCTGCCTACAAGTTGGCCAGGAACAAAAGCATACCTACCTTCCCCTAGAGGTCTGTAACATTGTGGCTGGGCAGCGCTGTATTAAAAAGCTGACCGA
CAACCAGACCTCGACCATGATAAAGGCCACAGCTAGATCCGCTCCAGACAGACAGGAGGAGATCAGTCGCCTGATGAAGAATGCCAGCTACAACTTAGATCCCTACATCCAGGAATTTGGGATCAAAG
TGAAGGATGACATGACGGAGGTGACAGGGCGAGTGCTGCCGGCGCCCATCTTGCAGTACGGCGGCCGGAACCGGGCCATTGCCACACCCAATCAGGGTGTCTGGGACATGCGGGGGAAACAGTTCTAC
AATGGGATTGAGATCAAAGTCTGGGCCATCGCCTGCTTCGCACCCCAAAAACAGTGTCGAGAAGAGGTGCTCAAGAACTTCACAGACCAGCTGCGGAAGATTTCCAAGGATGCGGGGATGCCTATCCA
GGGTCAACCTTGTTTCTGCAAATATGCACAGGGGGCAGACAGCGTGGAGCCTATGTTCCGGCATCTCAAGAACACCTACTCAGGGCTGCAGCTCATTATTGTCATCCTGCCAGGGAAGACGCCGGTGT
ATGCTGAGGTGAAACGTGTCGGAGATACACTCTTGGGAATGGCTACGCAGTGTGTGCAGGTGAAGAACGTGGTCAAGACCTCACCTCAGACTCTGTCCAACCTCTGCCTCAAGATCAATGTCAAACTT
GGTGGCATTAACAACATCCTAGTCCCACACCAGCGCTCTGCCGTTTTTCAACAGCCAGTGATATTCCTGGGAGCAGATGTTACACACCCCCCAGCAGGGGATGGGAAAAAACCTTCTATCACAGCAGT
GGTAGGCAGTATGGATGCCCACCCCAGCCGATACTGTGCTACTGTGCGGGTACAGCGACCACGGCAAGAGATCATTGAAGACTTGTCCTACATGGTGCGTGAGCTCCTCATCCAATTCTACAAGTCCA
CCCGTTTCAAGCCTACCCGCATCATCTTCTACCGAGATGGGGTGCCTGAAGGCCAGCTACCCCAGATACTCCACTATGAGCTACTGGCCATTCGTGATGCCTGCATCAAACTGGAAAAGGACTACCAG
CCTGGGATCACTTATATTGTGGTGCAGAAACGCCATCACACCCGCCTTTTCTGTGCTGACAAGAATGAGCGAATTGGGAAGAGTGGTAACATCCCAGCTGGGACCACAGTGGACACCAACATCACCCA
CCCATTTGAGTTTGACTTCTATCTGTGCAGCCACGCAGGCATCCAGGGCACCAGCCGACCATCCCATTACTATGTTCTTTGGGATGACAACCGTTTCACAGCAGATGAGCTCCAGATCCTGACGTACC
AGCTGTGCCACACTTACGTACGATGCACACGCTCTGTCTCTATCCCAGCACCTGCCTACTATGCCCGCCTGGTGGCTTTCCGGGCACGATACCACCTGGTGGACAAGGAGCATGACAGTGGAGAGGGG
AGCCACATATCGGGGCAGAGCAATGGGCGGGACCCCCAGGCCCTGGCCAAAGCCGTGCAGGTTCACCAGGATACTCTGCGCACCATGTACTTCGCTTGAAGGCAGAACGCTGTTACCTCACTGGATAG
AAGAAAGCTTTCCAAGCCCCAGGAGCTGTGCCACCCAAATCCAGAGGAAGCAAGGAGGAGGGAGGTGGGGTAGGGAGGAGTGTAGGATGCCTTGTTTCCTTCTATAGAGGTGGTGTAAGAGTGGGGAA
CAGGGCCAGCAAGACAGACCACCAGCCAGAAATCTCTGATATCAACCTCATGTCCCCCACCCCTCACCCCATCTTGTCACATCTGGCCCTGACCCCACTGGACCAAAAGGGGCAGCACTGGTGCCCAC
CATACACACAGGTGTCTCATGTGACTCACAGTGCTAAAGACTCATGCTTGACAGCTTGGTAAGGTCAACTCTGTAGCCCTGCAGACAAAAGCTGGTTAGGTTTGGGTTTGATACTTTAGATGGGAAAG
TGAGGGGCTTGAGAAAGTGGGTGGGAGGAGGGAAGGATTTTTTAGGAGCCTTAATCAGAAAAGGACTAGATTTGTTTAAGAAGAAAAATGAAACCAGACCCAGATCAATATTTTAGGATACTAGATGT
TTTAATGGGTTCAGAATCCAGTTTGTAGGAAGATTTTTTAATGGTTTTGGTTGCTCCTCCCCCAGCTGCCACCCCCCACCTTACCCTTATTCCTCTCTGTCCACATTTTCTGCCCCACCTTACTTCTC
CTCCCTGACAGACATCCAGCCCCTAGTAATACTTAAGGCACTATGGCACTTAGCTTTGAAGTGACACGACCCTGTCTTCCTTCCGCCCGCTGGTGGGTAACCAGTGCCTTCCCTGTAACGGTAATGCT
GCAGAACTGCAACCTTTTGTACCTTTCTTTGGGGAATGGGGTGGGGGTGGGAGAGGAGGTAGATGGGGAAGAAATACCCCAGACCCAACAAACCTCCAGCCAGAAAGCCAGCTATTTTGCATTTGAAG
GAATTGACTTCCTCATTCATTGAGCTTTTTAAAAGATCACAACCTCAAGATGGTTAAAATCCATTGACATTTGCACTTTCAAACATGACAAGTCTCGGAGCTGCTGAGATGACAGGCCCCTGGCCTTT
CCACTTATGCCTCCTTTTCTCCTTATTCCTCCTACCTCCCGCCCCGCCCAGGTCTGGAGTTACTTTCATAGCATTTTTCACTCTTGGCTTCTTTTCTCCCTTGATGGTCAAGTCTCTTATGTTTCAAT
ATTTCTTAACTGGGGTGTCTTATAACAAAAAACTCTTAGGTCTAAAATGAGAAAAAAGAGAGAAAACAAAATGTTATTTTTATACCATAACTTGAGTGTATTGCCAAAATTTGGAAATCCTTCCCATG
CCTGATGAGTTTATATCCCAGAAACATTGAGCCATCAGAATGAACTGTGTACCTGATTTGTTCTCTGACCTGGCTAGGTAGGGAGGGGGTGGTTATCGCCCCAAGATGGGGTCCAGGCTCCATCCTTC
CTCTGTGCAGATAATACCTTTTTCTTGCTATAGCCTCCCTCCTCTGCACTGTCCTGCACTCTTTCTTGCAAGTGCATCTTTTTCCTTCCCCTGGACTGTCCTCTGACCCTTTGGCTCATCCTAGATTG
CAGTGTGTCCTGTGGACAGGCTGGGGAATTTTGCTGCTCCCTATTGCTTCTGTTTACAAAAATGAATTTTTCCTGGTTTCCCACTAGGGCATGTGGGTGGGTGGCATGGACTTTTTTTTTTTTTTTTT
TTTGTCTTGAGACATGGGGTTTGGCTGTCTTGCAGGACTGGAGAAGGTGGTGGTTCTAGCTTGGTCTCTGTTGGCCTTGAAGCAAGCATCCCCCCTGCCCTTTTTCCTTGACTGTTCATTTTTTTCCT
GCCCCACTGCTTGGGATGGGGAGTTGCAACTTCAGTGTGGAATTTCCTCTTTGAGGAGCCTGGGCTTGGATCTATCCTGATCTGGTGATGAAGCCATGATTACTTTAGACCTAGCCCAGGCTTGGAGG
CCAGCTGGAGGAAGAAGGGTCTAAATCCTGGCCTGTAGAGTTAGAACTACCATTTCCTCCCCTTAGCTGCCCTTGTATGACCCGGATTTGCTATGCAAAACAATCTATCCCAGGTTCTGTTCTGGTTG
GCTACATTGTTCAGCAACTCACAAAACGTAGCACAAACATTCATTATGGAGAAAGCATCAGGACTGTTGAGTAACTCCTCCTTTACTTTTTTCCTGCTGGCTACAGCATGGGGTGCCCTATAGGCACA
AGCCCAGCTGAAGAACAGAATGGAGGGCTCTGGGAGGAGGCAGCTCACTGGAGAGCCTACATTCCTTACACAAGTGCCTAAAGAGAGTGATGCTAACACTCCATCTGCCCTGTCCATTGCCTTCATAT
ACAGTCTACTTCGTGTTCTGTCACCCTTTGGGGAGGGGAGTTCTCCTGGGACAGTGGGCTCTGCATGTTCTCCACTTGGATACATTTTGGGGCTAGGATCAGGGCACTATTCCTGGAGGGTCCAGTCA
TTCACCAGCATTTGCAAATGTCCATAGGGAGCAGGTGGCAGCCTCTACTCCCAGCAACAAGTTTGTGTTCTCTCCTTTTCTCTCTTTGCCTCACTCTCTCCAGTTGGTTTTCAGCTGGGGCTTGAAAT
GCATTTTTAGCCCTTTGACGTGGCTTATGCCATTCAAGAAATAAAAAGCAAGAGAATCAGCTTTGGGCAATGACAAGAAATGAGTTCTTACTCTGATTTTTTTGTAAAAAGATAATTTTTGAGACTTG
AAAAATACCCCGACCTTGAGATTATTCCTGTTTGAAAGGTGGTGCATGCAGATGGAGAAGTGGTGTTGGCAGCAAGCTTTGGCTCATGTGGATTTGGTTTAAGTGGTGCTTCTTACCCAAGCTTCAAG
GAAGTGCTTGGGGGACCCCCAGCCTCATCCTCTTAGTTGGGTCTCTTGTTCCCTTTGTACCACTGTTTTGCCTTCCTTTTCCTCTTCTCTCTTTGCCTGGCTTCCTTTCCCTTTTCTTCTATTCACTC
TGCTTGCTTGCTGGCCGGCCTGCCTGCCTGCCTGCCTGCCTGCCTGCCTGTCTGCCTATGTGATGATGAAATCTCTGCATGGCTGCAATGATCCCACTGTTAGCTGGCAGGGTCAGGCTTAGCTCCTT
GACTGCAGAAGACCAAGAACCTGTTCCCCAAGCCCAGAGATGTCCACCTGGGCTGGACTGCCCTCAAGCTTATACTAGAGAAGAGCAACTGACCTGCCCAACTTGTGTGAAGTCAGGAGGGTTTCTGG
CATTTTCCACACCTGTCCACTCCTTGGAGCTGGTTTCTCTCATTGCTTTTTCTAAATCTGGTTCTTTTTCTCTTTACCTGGGGCCTGGCTTTTCTGAGATTGTCTTAGGGTTGAGCTATTTGGGTATC
CTGGGTTTGAGTGTTAGGGGATGGACATAAAGGAAAAAGAGTGATGAGAAGAGAATGGAGAGAATTTGAATAAAAGGTGGGAAAGGAGAGCACTGTTCTTTGATTGTTTATCCAGTCCAACCTGATCC
ATTAGGGATCGAGGTGCTACACTGGCCTCCAGGGATAAGCCTGGGGCTACTGTTGCTGGGAACTTAGGCTTAACATAAAGCCGAAGAAGGTACCTAGAAATTTGAAACTTCCCTAAAAAGCTCCTAAT
GCCCACCTGCTAGATAGCTTCTCTGTGGCCTCCTATTTAGCTAAGCAGCAGTGTTTTTGGATACTTTTTTTTTCTGTTTGTGAATAAGGCCAGCACTCAAGATGGGCAGCCAAGGGTGCACTGACTAT
TAGCTGGCCCATAGGATATCTGTAAGGCTGGTGGGACAGTTTTGGACCTGGAATCATGTGTAACTAACAAGGTTGGACGTTTCTTCCCCATCAGGGTAGAAAAATCATCTCAAACTAGCCAAAAGGCA
GTTTTGGAAACTACATTGGGGGACGTTATTTTTATTTATATATGGGGCCTAGGCCAATCCAGGATGGTAGCTGGAATACCTTCCTTCTTAAAATCTGATCATGGCAGGGATATGCAGGGCACTTTTTA
CTATTTGGCCTTCTAAGCAGATTGGGAAGGAGGTATTTTCTGGTTTTCGCTTTCCTCCGACTTAATAGGACTTGCCTTCTCCCTGGGCAGGGAGAGAGGCTGGGTTGGTGCTCTCCCTTACTCTACTC
ATACTGACTTAGAGCCTCTGGCTGCTGTTTGGGCATCCAAGAAAGGGAGGGGAAGGAATGAGCTAAAAACAAAACAGAATGAGGTGGGAAAGGGAGATTTTCTTCTTTACAGAGGAAAATAGGAAACC
CTCCAAGAATTGTGCAAGTAAAGACATTTGTTGAATGCACTGAGTCCCTTGGTGTAGTAGCAATAAGGAAAAATGAAATTACTTTCCTGTGCACACAGTCCAGCCTAATTGGTATGTGATGTTGCACT
TAGCAGCCATGTGGTGGGCATGTGTGACTACTCTGGTTTTCACTTTAGTTTCTAAACTTTTTATCCCTCTCAAGTCCAGCATGGATGGGGAAATGTCTCTGGATCCCCACAGCTGTGTACTTGTTTGC
ATTTGTTTCCCTTTGAGATTTGTGTTTGTGTCCTGCTTTGAGCTGTACCTTGTCCAGTCCATTGTGAAATTATCCCAGCAGCTGTAATGTACAGTTCCTTCTGAAGCAAGCAACATCAGCAGCAGCAG
CAGCAGCAGCACAATTCTGTGTTTTATAAAGACAACAGTGGCTTCTATTTCTAAAGTGCGGTCTTTCTCTTTTTTTTTCCTACCAGCAAAACAAACTTTTGGGACTGATTACATCTCTAATAGATTTT
AGGTGAGAATAATACTGTAGATTGTTATGCAGGAATACTTCACAGAGCCTTCATTTATTCTTCATTCAACAAACATGCAAAGCACTGTGCCAGCAGTATTGTGGGGAGGGGAGGCACAATTCAAAATG
AGGAAAATAGTGTCCGTCTCATTAAGGGAATTAAGTTTGGTGGGGGATATGATTAGCCAAATAGTCCCCTGGCATAGGAGGAAGATAATGAGGGAGTGGAATAAGGCTACAACAACGAATATAGGGAG
GAAGGGACAGATTTGAGAGACGAGGTAGAATTAATAGGACTCGATGGCTGGTGGGAGGAGAAGACAGGAGTAGAGGTTAGCTCCCAGGTTTCTCCTTGACCATAGGAGTGTGTTGGGACATTCTGCCA
GTCAAGATGGGGGTGACGGGGAGACTGTAGAAGGAAGGTGGGGAGTTTTTGAAGAAACAGAATGTTGTATAGACTGAGTTTTGAGGTGTTTGTGGGGCAGTAAGGGTAAGGTGTCCAGTAAACACAGG
TTGGTGCTCAGGTAAGACTGTAAAACTGCATTTATAGATACAGGAGTCTTATAGATGGTAGTTAAAGCCATAGGCATGAATGAGATAGCTTAGAAAAAGAGAAGAGAAACTAGTATACAGCCCCCTAA
GAAACTCAATTTAAAGGTTCGGGGGAGGAAGCAGATCTTAAGGTGACAGATCACTGGTAGACAGTTTGTGGGTTTTTTGTTTCTTTGTTTAGCCAGTTTGGTGAGGTAGGAGAAGAAATCAGAGTAGA
AGAAGGTTCATGAAGGGAGTGATTAACAACATGAACTGCTGCAGAGAGGGAGTTCTTTTTTTTTCTGTGTGTTTTACCTTTCTACTCCCCATCTTTTGGGGATCTTGTAACTCTATGACTTACTTACG
TTATTCTCCAGTATTTCTTGAAAATGAGCATTGGAAAAACCAATTCTAAAATGGCTAAAACTAGGACTTTCAAGTTCACCACAACTACCACCAATTAGGAGATAATTGTAAAAGAATAAACAAAACCT
AATTTTGTTCCTAGCCAATATTATAAACCATGTTCCAGCATACTAGATAATAGTAGCATACTATATTTATTTCCATAATTTGTCTTCTTTAGAGCCTATGAACTCCTAGGAGCAGAAGCTATATTCTC
TTCATTTTTGTCATCTCAGGGTCATGGCATATACCAACAGATCAGTATGTGCAAATATAATTGAAATAGGCTAGTAGTCTGTGGTTTATGAGTATGGGCTGGGTGGGCAGTGGATCAAGAAGTGATAG
GAGTACACAGGATGAACTCAGAATTCCTGAATCTTCAGGTAAGCAGATACTTAACTACATTATCATTGTCTTTTCCCACTCACCCCAAGTTGGAGGTTCTATGGTTTTGTACTTTAAGCTGGTGGTAT
AATTGTCAAGCATGTAAATTCTGGCATTCTTCCTGGTACTGCTAGAGCATTGTTATTTCTATGCATGGGGGTAAGAAGGCTCAGAGAAGGATCCTGGCGGATACCCCAGTGAGAAATCGTCAGTGGCA
GCCAGTGTGTACATACGTGGACCTAGCATTCCTCTGGAGGCCAAGTGTTGTAAATTGGCCTGTGGCTATCATCTGGCAGACTCCCTTGGGAAAGAGCCAGCCAGCCCCATGCTTCTTTTCAGCAGCAA
GGGTTAGGGAGGTTGGTTGAACTTGAAGAGCAGATTGGACATGGAGCAGATTTTGACCAGTTGAAATAAGACATAAATTTATGACTCCGAGTGAGGCAGAAATAAAGAACTTAGCAGGGGGAATAGGA
GGAGGATGATTATGGCAAATTTTGCTATAAACTTTAGTTTTAGAAAAGATTGATATTGAAAAGCCTTCAGGATTTGCCTGTGGTTGCTACTCAAGTTAAAAAGACTGGGAGCCTGCATTGTTTGGTCC
TGGAGCTCAAGGTTTTCAGTGAAGGCTTGTCCTGGCACCTCTGGGCATTCCTTTTCATTACTGGTTGAGCATCCTTCCTTCTGCTCTGTCAATTGGCAAAATATGCTGGAGCACATTCTGGACTAGCA
GTTGCCTTGGGGTAGTCAGGCTGGGTATTTGTTTGGTATCTCTTGGTGTAGCAGACCCCAGAATCTCATGGCAATTAGGATTTGGTGGCTAAACGAAAGAGTTAGTGCAAGGAAAAGCCTAGTTGGAA
TTTCTGAGTCTGGGCCATCCTTAAGCTGCTGTCTACTGCCTGAATGGGAAGTAATGTCGAATTGGAAAATTAGCTCACCATTTTTGTTCTAGCTTTGCAGACATTTATTCCTCTGATGATAGGCTGAG
AAATGCCTAGGCCGGCTTAGAAGGCACACAGCATGACAGAAGTACTCCTTCAAAGCAGCTGTGTCAAGAAGGAAGAGCTGGAAAAGTGGATTTGCTGGGGAATTAGATGCATTTAGTTTTCCACTTAC
GCACAACTGCCTTCTCCAGTATATCATACCAAGGTTTTTTAGGCCTTTGTGGCTTACCCTGCAGGAACATACTGTGTCCTGTTGTTCTGGACTGTAGCATCTTCACCACCATCCTCTTGGCAATGGTT
TTTTGTTTGGGGTTTTTTTTTTTTTTTTTTTGGACAAAGTATAATAATATTGAGGGACCTTTCTAGGGAGCCTTTGGTCCTTTGTCCCCATTTTCCAAAGGGAGGGAACTTTCCTCTTAAAAGAGACA
GTGGGAACTTTTAGCCAGGTTTTTGGAAAAGGCCTGTGGGCTATTAATGAGAGTGAGCTGCAAAAGGAGGAAGGGTTTGTTTGGGTACTTTGAAGTACTTAGCTAGGTGTTTTCTACAGTATCTTATA
TAATTGCATCTTACAGCATCTTTACATGCGAAATAGTTTATCAGTTATCTTCAATTGCATATTACAAAATTCTGATTAAATTTTTCTTAAATAAGAAAACTATCATTTCATATGACAAGAAATCCTAA
TTTAATGTTACTCCAAGGTTGGTTAATTCAGTGGCTCAGTGATAACACCAAAGACTCAGTTTCTTGAAATTTTTTTGCTCTGCCATCCTCCATGTTTATCCTCACGCCAGTTCGCCTCATGGTCCCAA
TATGGCTACTGTAATTCTGGGAAGGAAATGCTGACAGAACCGTGTCTGGCAAAAGAGAGACAGATTTTTCTGTGTCCTTCTAAAGCAAGGAAGTCTTCCCCTGGAAGCTCCAACAGATACGGCCTCAT
GGCTTTGCTAGAAATGGGTCATCTCACTCCTGTCATTGGCAAAGCAAGTAAGATCATCCATCAGGAGTGGCTTAGATTAATGAATTATCCTTTGAGTCGTGTAGACTAGAAAGTTCAGTCATGTCTAC
TAGCAAGAAAGGAGATAAGGGCTGTTGGATAAGCAGCATCTGGTCTCAAAGGTACTTCAACTTTTACAGATGAGAAACATGAATCAGAGTGACTTTCCCAGGCTCACAGCAAGTAAGAGAGGGCCTTC
AGTGTTAGCTGTGTCTGTCCCTAAAGCCCATGTTTTATATTGTATCTTGCTAGAGTATAAAGTAACTTACTTTCTACCTTGTAGAAACTGATGGTCTAGGAGAAGAGATTTGAACTCAGGTGCCCAGT
TGACTCTAATCTTGGCCCATGTGAGAGGATTGTACTCAGTTGCTCTCCTCATCCAGTGATGTTTCTTGTCTAACACAAGAAGCCTAGGAGTAGAAAGTCCTAAGCAGAGTAGAATAATAGCGGCAGCA
GGGAGGGAAGTGTGAACTGTGTGTCCCTGAGCCTGACTTACTGGGCAGGGACATGACACTTAAAGCGGCAGCTGGCCACTCTGTCTTTCCTGCATGCACTGAGTATTTGGTAGCTCATTAGTGACCAG
TGATATTGATCATCTTTTCATGTGCTCACTTACTATCCCCATATCTTTGTTGTTTGCATCTTTTACCCATTGTATTTGTTGTTTTTGAGACAGTGTCTCACTCTGTCACCCAGGCTGGAGTGCAGTCT
CATGATCGCGGCTCACTGCAGTTTCTGCCTCCTGGGCTCAAGCAATCCTCCCACCTCAGCCTCCTGAGTAGCTGGGCTTACAGGCGCACACCACCATGCCCAGCTAATTAAAAAAAAAATTTTTTTTG
TAGCAGTTCGGTCTCATTAGTATTGCCCAGGCTGGCCTCTCTTAGCTTCAAGCTATCCTCCCGCCTCGGCCTCCCAAAGTGCTGGAATTACAGGCATAAGCCACAAGCCACTGGGCCCAGCCTCTTTT
ACCTGTTTCAAAATTGAGTTTTATTGAGTTGTAAGAGTTCTTTATTCATTTTAAACACAAGTCCTTTGTTGGATATATCTTTTACATCTATTTTTCCCAGTCTGTGGCTTGCCTTTTCATTTTGAAGA
GCAAAAGTTTAAAATTTTGTGAATTTATTAAAGCTCCGTTTGTTGCTTTTTTCTGTTCTAGTTTATACTTTTGTATCATATTTTAGGAAATTTTGCACTGGGTATTTGATGGCTCCTGAGGAGGTTCA
ACTTTCAGAGCGCACTGATTTCTCTGCACCTGAGATTTTGTACTATTTCTGTATTTCTTTCTTCTCAGAACAACCAGTGTCACCAGGTATGAGGGCAGAGTTTTAGCTTGTTTGCTGAGCCCCATTCT
TGAAGCTCATTTATTTATTCACCTATCTGTCCATCAATCCAACAAATATACTGAATGCTGCTATGTGCCAGGTACTGGCACTGTTCTAGGTACTGGGGCAATGACAGTTAAGATAATACCCAATGACC
CTGCTCTGTACCCTTAAGAGCAGACTCAGTTGGGAATGAGTTATCCAAATATAGGGTGTACATGTAGTCAGGAGAGAGCCTCATACAGCTTTGCCTTTGGCAGAATCCTTCAAACCTCTTTGTCTTCC
TACTTCTTGATATTACAAATCATGAGCCTTTCACATGCATTGACTCTAAAGAGGTGGGTTCCTGGATAGCAGAAGTAGATAGGAAGGCATCATTGACATTTACTGAGATGGATTGAATCAGAGGGTGT
AAATTCTGCTCCATCAATGTTGAAAAAGACTAGCCCACCCCAAAGGTTTATCACTGTCACCATGTCTAATGTCTATTCTGGAAGAAGCTGAAGAAGTCTGCCTTTGTTTAGGGAACCGGTTCCAGAAT
CAGAGGGGTTGAGGATATAAAAGACCCTTGCACAAGAGTTGGTATTTACCCTGTCAGATGCTGCTACCAAGATTTGGATTGTGTACAGTCGAGGATTAAAAATGACTTTTAAGATGCAGTGTTTCATC
TGGTGACATTTAATTTGATATTTTAAAATTGGGGAGGGTATTTTCAGCCATGGGGGTAGGGATGTGAAAGAAGAAGAAAGTAAGAATTGGAGTCAGATGTGGTTTTGAGTCCCATACATTTATTGTTT
AATATTATATGGTAAGTACTTTAAAATGGTAAATAGTAAATACTTGTGTTATTCACTAACATTTGGGGAGGATTTTCTCTGTGCTTTATGTATATTACCTAACCTTACAAACTGTGTAAGGTACATGC
TGTTCTCTCAATTTTTCAGATAAGAAAATTGAAGCCCAGAGAGATCAAGTGACTGATCCAAAGTCCCACAGTGAGGGGAACTGAAGATAGGATATTCTTTCTCCTTTTCCTCTTTAAAAAATTATTTT
GATTAAAAAAAACCGTATTACTGAAGCATAGGGACATGGGGAGAAATTATGAATGATTCCTCAGCCTGAATAAAATAGTATGTTTCATTAAGGCAACAAATATTTATTAAGGACCTAATATTTGCCTG
ACATTCAAGTGAGGTGGGGGGCACACAAGTAGTAAATAAATAACAGACTGGGCAAAGGGCTACCAAGGCAATACTGTAGTAGACTAACAGGTGCCCCACCATAGATGGGTGGTCCGGAAAAGGCGTCT
CAGATGTCTTTCGTTGAGACGCAAAAAAAAGCTGTGGGGTAGGGCGTAAGGGGAGGGTGGAGAAGAGAGAGAGGGTTCCTGGCCAAGGGAACCAAAAGCAGAGAAGCTCCAAGTCAGAAAAAAGCAGC
GGTTGGCCCGTTGGGAGAATTGGAAGCCAACCAGTATAGCTGTAGCACAGGCGGGGCCCATTTACGCCGTGCGTTTTCACCCTGGAAAGGAGTTTGGGTTTTCAAGTGTGACGAGGCGCTATTAAAGA
GTTTTAAACATGGAAA

hide sequence

RefSeq Acc Id:

XM_011541236 ⟹ XP_011539538

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	35,883,209 - 35,930,532 (+)	NCBI

Sequence:

show sequence

GTGGGAGCTGCTGCAGGCTCCGCGGCGGCGGCAACGGAGGCTGCGGGGGCGGCGGCGCGAGCGG
CCGGGCTTGGTAGGGGAGCCGAGCCCGGCCCGGGATCCCGAGCAGCGAGAGTGTGGGGTACCTAGGCCCCTCACGCTGGACTTCACAGTCTCCGGGCCGCCTGACCTCCGCACGGGTATATGGGATGG
AAGCGGGACCCTCGGGAGCAGCTGCGGGCGCTTACCTGCCCCCCCTGCAGCAGGTGTTCCAGGCACCTCGCCGGCCTGGCATTGGCACTGTGGGGAAACCAATCAAGCTCCTGGCCAATTACTTTGAG
GTGGACATCCCTAAGATCGACGTGTACCACTACGAGGTGGACATCAAGCCGGATAAGTGTCCCCGTAGAGTCAACCGGGAAGTGGTGGAATACATGGTCCAGCATTTCAAGCCTCAGATCTTTGGTGA
TCGCAAGCCTGTGTATGATGGAAAGAAGAACATTTACACTGTCACAGCACTGCCCATTGGCAACGAACGGGTCGACTTTGAGGTGACAATCCCTGGGGAAGGGAAGGATCGAATCTTTAAGGTCTCCA
TCAAGTGGCTAGCCATTGTGAGCTGGCGAATGCTGCATGAGGCCCTGGTCAGCGGCCAGATCCCTGTTCCCTTGGAGTCTGTGCAAGCCCTGGATGTGGCCATGAGGCACCTGGCATCCATGAGGTAC
ACCCCTGTGGGCCGCTCCTTCTTCTCACCGCCTGAGGGCTACTACCACCCGCTGGGGGGTGGGCGCGAGGTCTGGTTCGGCTTTCACCAGTCTGTGCGCCCTGCCATGTGGAAGATGATGCTCAACAT
TGATGTCTCAGCCACTGCCTTTTATAAGGCACAGCCAGTGATTGAGTTCATGTGTGAGGTGCTGGACATCAGGAACATAGATGAGCAGCCCAAGCCCCTCACGGACTCTCAGCGCGTTCGCTTCACCA
AGGAGATCAAGGGCCTGAAGGTGGAAGTCACCCACTGTGGACAGATGAAGAGGAAGTACCGCGTGTGTAATGTTACCCGTCGCCCTGCTAGCCATCAGACATTCCCCTTACAGCTGGAGAGTGGACAG
ACTGTGGAGTGCACAGTGGCACAGTATTTCAAGCAGAAATATAACCTTCAGCTCAAGTATCCCCATCTGCCCTGCCTACAAGTTGGCCAGGAACAAAAGCATACCTACCTTCCCCTAGAGGTCTGTAA
CATTGTGGCTGGGCAGCGCTGTATTAAAAAGCTGACCGACAACCAGACCTCGACCATGATAAAGGCCACAGCTAGATCCGCTCCAGACAGACAGGAGGAGATCAGTCGCCTGATGAAGAATGCCAGCT
ACAACTTAGATCCCTACATCCAGGAATTTGGGATCAAAGTGAAGGATGACATGACGGAGGTGACAGGGCGAGTGCTGCCGGCGCCCATCTTGCAGTACGGCGGCCGGGTGAGCAGGAACCGGGCCATT
GCCACACCCAATCAGGGTGTCTGGGACATGCGGGGGAAACAGTTCTACAATGGGATTGAGATCAAAGTCTGGGCCATCGCCTGCTTCGCACCCCAAAAACAGTGTCGAGAAGAGGTGCTCAAGAACTT
CACAGACCAGCTGCGGAAGATTTCCAAGGATGCGGGGATGCCTATCCAGGGTCAACCTTGTTTCTGCAAATATGCACAGGGGGCAGACAGCGTGGAGCCTATGTTCCGGCATCTCAAGAACACCTACT
CAGGGCTGCAGCTCATTATTGTCATCCTGCCAGGGAAGACGCCGGTGTATGCTGAGGTGAAACGTGTCGGAGATACACTCTTGGGAATGGCTACGCAGTGTGTGCAGGTGAAGAACGTGGTCAAGACC
TCACCTCAGACTCTGTCCAACCTCTGCCTCAAGATCAATGTCAAACTTGGTGGCATTAACAACATCCTAGTCCCACACCAGCGCTCTGCCGTTTTTCAACAGCCAGTGATATTCCTGGGAGCAGATGT
TACACACCCCCCAGCAGGGGATGGGAAAAAACCTTCTATCACAGCAGTGGTAGGCAGTATGGATGCCCACCCCAGCCGATACTGTGCTACTGTGCGGGTACAGCGACCACGGCAAGAGATCATTGAAG
ACTTGTCCTACATGGTGCGTGAGCTCCTCATCCAATTCTACAAGTCCACCCGTTTCAAGCCTACCCGCATCATCTTCTACCGAGATGGGGTGCCTGAAGGCCAGCTACCCCAGATACTCCACTATGAG
CTACTGGCCATTCGTGATGCCTGCATCAAACTGGAAAAGGACTACCAGCCTGGGATCACTTATATTGTGGTGCAGAAACGCCATCACACCCGCCTTTTCTGTGCTGACAAGAATGAGCGAATTGGGAA
GAGTGGTAACATCCCAGCTGGGACCACAGTGGACACCAACATCACCCACCCATTTGAGTTTGACTTCTATCTGTGCAGCCACGCAGGCATCCAGGGCACCAGCCGACCATCCCATTACTATGTTCTTT
GGGATGACAACCGTTTCACAGCAGATGAGCTCCAGATCCTGACGTACCAGCTGTGCCACACTTACGTACGATGCACACGCTCTGTCTCTATCCCAGCACCTGCCTACTATGCCCGCCTGGTGGCTTTC
CGGGCACGATACCACCTGGTGGACAAGGAGCATGACAGTGGAGAGGGGAGCCACATATCGGGGCAGAGCAATGGGCGGGACCCCCAGGCCCTGGCCAAAGCCGTGCAGGTTCACCAGGATACTCTGCG
CACCATGTACTTCGCTTGAAGGCAGAACGCTGTTACCTCACTGGATAGAAGAAAGCTTTCCAAGCCCCAGGAGCTGTGCCACCCAAATCCAGAGGAAGCAAGGAGGAGGGAGGTGGGGTAGGGAGGAG
TGTAGGATGCCTTGTTTCCTTCTATAGAGGTGGTGTAAGAGTGGGGAACAGGGCCAGCAAGACAGACCACCAGCCAGAAATCTCTGATATCAACCTCATGTCCCCCACCCCTCACCCCATCTTGTCAC
ATCTGGCCCTGACCCCACTGGACCAAAAGGGGCAGCACTGGTGCCCACCATACACACAGGTGTCTCATGTGACTCACAGTGCTAAAGACTCATGCTTGACAGCTTGGTAAGGTCAACTCTGTAGCCCT
GCAGACAAAAGCTGGTTAGGTTTGGGTTTGATACTTTAGATGGGAAAGTGAGGGGCTTGAGAAAGTGGGTGGGAGGAGGGAAGGATTTTTTAGGAGCCTTAATCAGAAAAGGACTAGATTTGTTTAAG
AAGAAAAATGAAACCAGACCCAGATCAATATTTTAGGATACTAGATGTTTTAATGGGTTCAGAATCCAGTTTGTAGGAAGATTTTTTAATGGTTTTGGTTGCTCCTCCCCCAGCTGCCACCCCCCACC
TTACCCTTATTCCTCTCTGTCCACATTTTCTGCCCCACCTTACTTCTCCTCCCTGACAGACATCCAGCCCCTAGTAATACTTAAGGCACTATGGCACTTAGCTTTGAAGTGACACGACCCTGTCTTCC
TTCCGCCCGCTGGTGGGTAACCAGTGCCTTCCCTGTAACGGTAATGCTGCAGAACTGCAACCTTTTGTACCTTTCTTTGGGGAATGGGGTGGGGGTGGGAGAGGAGGTAGATGGGGAAGAAATACCCC
AGACCCAACAAACCTCCAGCCAGAAAGCCAGCTATTTTGCATTTGAAGGAATTGACTTCCTCATTCATTGAGCTTTTTAAAAGATCACAACCTCAAGATGGTTAAAATCCATTGACATTTGCACTTTC
AAACATGACAAGTCTCGGAGCTGCTGAGATGACAGGCCCCTGGCCTTTCCACTTATGCCTCCTTTTCTCCTTATTCCTCCTACCTCCCGCCCCGCCCAGGTCTGGAGTTACTTTCATAGCATTTTTCA
CTCTTGGCTTCTTTTCTCCCTTGATGGTCAAGTCTCTTATGTTTCAATATTTCTTAACTGGGGTGTCTTATAACAAAAAACTCTTAGGTCTAAAATGAGAAAAAAGAGAGAAAACAAAATGTTATTTT
TATACCATAACTTGAGTGTATTGCCAAAATTTGGAAATCCTTCCCATGCCTGATGAGTTTATATCCCAGAAACATTGAGCCATCAGAATGAACTGTGTACCTGATTTGTTCTCTGACCTGGCTAGGTA
GGGAGGGGGTGGTTATCGCCCCAAGATGGGGTCCAGGCTCCATCCTTCCTCTGTGCAGATAATACCTTTTTCTTGCTATAGCCTCCCTCCTCTGCACTGTCCTGCACTCTTTCTTGCAAGTGCATCTT
TTTCCTTCCCCTGGACTGTCCTCTGACCCTTTGGCTCATCCTAGATTGCAGTGTGTCCTGTGGACAGGCTGGGGAATTTTGCTGCTCCCTATTGCTTCTGTTTACAAAAATGAATTTTTCCTGGTTTC
CCACTAGGGCATGTGGGTGGGTGGCATGGACTTTTTTTTTTTTTTTTTTTTGTCTTGAGACATGGGGTTTGGCTGTCTTGCAGGACTGGAGAAGGTGGTGGTTCTAGCTTGGTCTCTGTTGGCCTTGA
AGCAAGCATCCCCCCTGCCCTTTTTCCTTGACTGTTCATTTTTTTCCTGCCCCACTGCTTGGGATGGGGAGTTGCAACTTCAGTGTGGAATTTCCTCTTTGAGGAGCCTGGGCTTGGATCTATCCTGA
TCTGGTGATGAAGCCATGATTACTTTAGACCTAGCCCAGGCTTGGAGGCCAGCTGGAGGAAGAAGGGTCTAAATCCTGGCCTGTAGAGTTAGAACTACCATTTCCTCCCCTTAGCTGCCCTTGTATGA
CCCGGATTTGCTATGCAAAACAATCTATCCCAGGTTCTGTTCTGGTTGGCTACATTGTTCAGCAACTCACAAAACGTAGCACAAACATTCATTATGGAGAAAGCATCAGGACTGTTGAGTAACTCCTC
CTTTACTTTTTTCCTGCTGGCTACAGCATGGGGTGCCCTATAGGCACAAGCCCAGCTGAAGAACAGAATGGAGGGCTCTGGGAGGAGGCAGCTCACTGGAGAGCCTACATTCCTTACACAAGTGCCTA
AAGAGAGTGATGCTAACACTCCATCTGCCCTGTCCATTGCCTTCATATACAGTCTACTTCGTGTTCTGTCACCCTTTGGGGAGGGGAGTTCTCCTGGGACAGTGGGCTCTGCATGTTCTCCACTTGGA
TACATTTTGGGGCTAGGATCAGGGCACTATTCCTGGAGGGTCCAGTCATTCACCAGCATTTGCAAATGTCCATAGGGAGCAGGTGGCAGCCTCTACTCCCAGCAACAAGTTTGTGTTCTCTCCTTTTC
TCTCTTTGCCTCACTCTCTCCAGTTGGTTTTCAGCTGGGGCTTGAAATGCATTTTTAGCCCTTTGACGTGGCTTATGCCATTCAAGAAATAAAAAGCAAGAGAATCAGCTTTGGGCAATGACAAGAAA
TGAGTTCTTACTCTGATTTTTTTGTAAAAAGATAATTTTTGAGACTTGAAAAATACCCCGACCTTGAGATTATTCCTGTTTGAAAGGTGGTGCATGCAGATGGAGAAGTGGTGTTGGCAGCAAGCTTT
GGCTCATGTGGATTTGGTTTAAGTGGTGCTTCTTACCCAAGCTTCAAGGAAGTGCTTGGGGGACCCCCAGCCTCATCCTCTTAGTTGGGTCTCTTGTTCCCTTTGTACCACTGTTTTGCCTTCCTTTT
CCTCTTCTCTCTTTGCCTGGCTTCCTTTCCCTTTTCTTCTATTCACTCTGCTTGCTTGCTGGCCGGCCTGCCTGCCTGCCTGCCTGCCTGCCTGCCTGTCTGCCTATGTGATGATGAAATCTCTGCAT
GGCTGCAATGATCCCACTGTTAGCTGGCAGGGTCAGGCTTAGCTCCTTGACTGCAGAAGACCAAGAACCTGTTCCCCAAGCCCAGAGATGTCCACCTGGGCTGGACTGCCCTCAAGCTTATACTAGAG
AAGAGCAACTGACCTGCCCAACTTGTGTGAAGTCAGGAGGGTTTCTGGCATTTTCCACACCTGTCCACTCCTTGGAGCTGGTTTCTCTCATTGCTTTTTCTAAATCTGGTTCTTTTTCTCTTTACCTG
GGGCCTGGCTTTTCTGAGATTGTCTTAGGGTTGAGCTATTTGGGTATCCTGGGTTTGAGTGTTAGGGGATGGACATAAAGGAAAAAGAGTGATGAGAAGAGAATGGAGAGAATTTGAATAAAAGGTGG
GAAAGGAGAGCACTGTTCTTTGATTGTTTATCCAGTCCAACCTGATCCATTAGGGATCGAGGTGCTACACTGGCCTCCAGGGATAAGCCTGGGGCTACTGTTGCTGGGAACTTAGGCTTAACATAAAG
CCGAAGAAGGTACCTAGAAATTTGAAACTTCCCTAAAAAGCTCCTAATGCCCACCTGCTAGATAGCTTCTCTGTGGCCTCCTATTTAGCTAAGCAGCAGTGTTTTTGGATACTTTTTTTTTCTGTTTG
TGAATAAGGCCAGCACTCAAGATGGGCAGCCAAGGGTGCACTGACTATTAGCTGGCCCATAGGATATCTGTAAGGCTGGTGGGACAGTTTTGGACCTGGAATCATGTGTAACTAACAAGGTTGGACGT
TTCTTCCCCATCAGGGTAGAAAAATCATCTCAAACTAGCCAAAAGGCAGTTTTGGAAACTACATTGGGGGACGTTATTTTTATTTATATATGGGGCCTAGGCCAATCCAGGATGGTAGCTGGAATACC
TTCCTTCTTAAAATCTGATCATGGCAGGGATATGCAGGGCACTTTTTACTATTTGGCCTTCTAAGCAGATTGGGAAGGAGGTATTTTCTGGTTTTCGCTTTCCTCCGACTTAATAGGACTTGCCTTCT
CCCTGGGCAGGGAGAGAGGCTGGGTTGGTGCTCTCCCTTACTCTACTCATACTGACTTAGAGCCTCTGGCTGCTGTTTGGGCATCCAAGAAAGGGAGGGGAAGGAATGAGCTAAAAACAAAACAGAAT
GAGGTGGGAAAGGGAGATTTTCTTCTTTACAGAGGAAAATAGGAAACCCTCCAAGAATTGTGCAAGTAAAGACATTTGTTGAATGCACTGAGTCCCTTGGTGTAGTAGCAATAAGGAAAAATGAAATT
ACTTTCCTGTGCACACAGTCCAGCCTAATTGGTATGTGATGTTGCACTTAGCAGCCATGTGGTGGGCATGTGTGACTACTCTGGTTTTCACTTTAGTTTCTAAACTTTTTATCCCTCTCAAGTCCAGC
ATGGATGGGGAAATGTCTCTGGATCCCCACAGCTGTGTACTTGTTTGCATTTGTTTCCCTTTGAGATTTGTGTTTGTGTCCTGCTTTGAGCTGTACCTTGTCCAGTCCATTGTGAAATTATCCCAGCA
GCTGTAATGTACAGTTCCTTCTGAAGCAAGCAACATCAGCAGCAGCAGCAGCAGCAGCACAATTCTGTGTTTTATAAAGACAACAGTGGCTTCTATTTCTAAAGTGCGGTCTTTCTCTTTTTTTTTCC
TACCAGCAAAACAAACTTTTGGGACTGATTACATCTCTAATAGATTTTAGGTGAGAATAATACTGTAGATTGTTATGCAGGAATACTTCACAGAGCCTTCATTTATTCTTCATTCAACAAACATGCAA
AGCACTGTGCCAGCAGTATTGTGGGGAGGGGAGGCACAATTCAAAATGAGGAAAATAGTGTCCGTCTCATTAAGGGAATTAAGTTTGGTGGGGGATATGATTAGCCAAATAGTCCCCTGGCATAGGAG
GAAGATAATGAGGGAGTGGAATAAGGCTACAACAACGAATATAGGGAGGAAGGGACAGATTTGAGAGACGAGGTAGAATTAATAGGACTCGATGGCTGGTGGGAGGAGAAGACAGGAGTAGAGGTTAG
CTCCCAGGTTTCTCCTTGACCATAGGAGTGTGTTGGGACATTCTGCCAGTCAAGATGGGGGTGACGGGGAGACTGTAGAAGGAAGGTGGGGAGTTTTTGAAGAAACAGAATGTTGTATAGACTGAGTT
TTGAGGTGTTTGTGGGGCAGTAAGGGTAAGGTGTCCAGTAAACACAGGTTGGTGCTCAGGTAAGACTGTAAAACTGCATTTATAGATACAGGAGTCTTATAGATGGTAGTTAAAGCCATAGGCATGAA
TGAGATAGCTTAGAAAAAGAGAAGAGAAACTAGTATACAGCCCCCTAAGAAACTCAATTTAAAGGTTCGGGGGAGGAAGCAGATCTTAAGGTGACAGATCACTGGTAGACAGTTTGTGGGTTTTTTGT
TTCTTTGTTTAGCCAGTTTGGTGAGGTAGGAGAAGAAATCAGAGTAGAAGAAGGTTCATGAAGGGAGTGATTAACAACATGAACTGCTGCAGAGAGGGAGTTCTTTTTTTTTCTGTGTGTTTTACCTT
TCTACTCCCCATCTTTTGGGGATCTTGTAACTCTATGACTTACTTACGTTATTCTCCAGTATTTCTTGAAAATGAGCATTGGAAAAACCAATTCTAAAATGGCTAAAACTAGGACTTTCAAGTTCACC
ACAACTACCACCAATTAGGAGATAATTGTAAAAGAATAAACAAAACCTAATTTTGTTCCTAGCCAATATTATAAACCATGTTCCAGCATACTAGATAATAGTAGCATACTATATTTATTTCCATAATT
TGTCTTCTTTAGAGCCTATGAACTCCTAGGAGCAGAAGCTATATTCTCTTCATTTTTGTCATCTCAGGGTCATGGCATATACCAACAGATCAGTATGTGCAAATATAATTGAAATAGGCTAGTAGTCT
GTGGTTTATGAGTATGGGCTGGGTGGGCAGTGGATCAAGAAGTGATAGGAGTACACAGGATGAACTCAGAATTCCTGAATCTTCAGGTAAGCAGATACTTAACTACATTATCATTGTCTTTTCCCACT
CACCCCAAGTTGGAGGTTCTATGGTTTTGTACTTTAAGCTGGTGGTATAATTGTCAAGCATGTAAATTCTGGCATTCTTCCTGGTACTGCTAGAGCATTGTTATTTCTATGCATGGGGGTAAGAAGGC
TCAGAGAAGGATCCTGGCGGATACCCCAGTGAGAAATCGTCAGTGGCAGCCAGTGTGTACATACGTGGACCTAGCATTCCTCTGGAGGCCAAGTGTTGTAAATTGGCCTGTGGCTATCATCTGGCAGA
CTCCCTTGGGAAAGAGCCAGCCAGCCCCATGCTTCTTTTCAGCAGCAAGGGTTAGGGAGGTTGGTTGAACTTGAAGAGCAGATTGGACATGGAGCAGATTTTGACCAGTTGAAATAAGACATAAATTT
ATGACTCCGAGTGAGGCAGAAATAAAGAACTTAGCAGGGGGAATAGGAGGAGGATGATTATGGCAAATTTTGCTATAAACTTTAGTTTTAGAAAAGATTGATATTGAAAAGCCTTCAGGATTTGCCTG
TGGTTGCTACTCAAGTTAAAAAGACTGGGAGCCTGCATTGTTTGGTCCTGGAGCTCAAGGTTTTCAGTGAAGGCTTGTCCTGGCACCTCTGGGCATTCCTTTTCATTACTGGTTGAGCATCCTTCCTT
CTGCTCTGTCAATTGGCAAAATATGCTGGAGCACATTCTGGACTAGCAGTTGCCTTGGGGTAGTCAGGCTGGGTATTTGTTTGGTATCTCTTGGTGTAGCAGACCCCAGAATCTCATGGCAATTAGGA
TTTGGTGGCTAAACGAAAGAGTTAGTGCAAGGAAAAGCCTAGTTGGAATTTCTGAGTCTGGGCCATCCTTAAGCTGCTGTCTACTGCCTGAATGGGAAGTAATGTCGAATTGGAAAATTAGCTCACCA
TTTTTGTTCTAGCTTTGCAGACATTTATTCCTCTGATGATAGGCTGAGAAATGCCTAGGCCGGCTTAGAAGGCACACAGCATGACAGAAGTACTCCTTCAAAGCAGCTGTGTCAAGAAGGAAGAGCTG
GAAAAGTGGATTTGCTGGGGAATTAGATGCATTTAGTTTTCCACTTACGCACAACTGCCTTCTCCAGTATATCATACCAAGGTTTTTTAGGCCTTTGTGGCTTACCCTGCAGGAACATACTGTGTCCT
GTTGTTCTGGACTGTAGCATCTTCACCACCATCCTCTTGGCAATGGTTTTTTGTTTGGGGTTTTTTTTTTTTTTTTTTTGGACAAAGTATAATAATATTGAGGGACCTTTCTAGGGAGCCTTTGGTCC
TTTGTCCCCATTTTCCAAAGGGAGGGAACTTTCCTCTTAAAAGAGACAGTGGGAACTTTTAGCCAGGTTTTTGGAAAAGGCCTGTGGGCTATTAATGAGAGTGAGCTGCAAAAGGAGGAAGGGTTTGT
TTGGGTACTTTGAAGTACTTAGCTAGGTGTTTTCTACAGTATCTTATATAATTGCATCTTACAGCATCTTTACATGCGAAATAGTTTATCAGTTATCTTCAATTGCATATTACAAAATTCTGATTAAA
TTTTTCTTAAATAAGAAAACTATCATTTCATATGACAAGAAATCCTAATTTAATGTTACTCCAAGGTTGGTTAATTCAGTGGCTCAGTGATAACACCAAAGACTCAGTTTCTTGAAATTTTTTTGCTC
TGCCATCCTCCATGTTTATCCTCACGCCAGTTCGCCTCATGGTCCCAATATGGCTACTGTAATTCTGGGAAGGAAATGCTGACAGAACCGTGTCTGGCAAAAGAGAGACAGATTTTTCTGTGTCCTTC
TAAAGCAAGGAAGTCTTCCCCTGGAAGCTCCAACAGATACGGCCTCATGGCTTTGCTAGAAATGGGTCATCTCACTCCTGTCATTGGCAAAGCAAGTAAGATCATCCATCAGGAGTGGCTTAGATTAA
TGAATTATCCTTTGAGTCGTGTAGACTAGAAAGTTCAGTCATGTCTACTAGCAAGAAAGGAGATAAGGGCTGTTGGATAAGCAGCATCTGGTCTCAAAGGTACTTCAACTTTTACAGATGAGAAACAT
GAATCAGAGTGACTTTCCCAGGCTCACAGCAAGTAAGAGAGGGCCTTCAGTGTTAGCTGTGTCTGTCCCTAAAGCCCATGTTTTATATTGTATCTTGCTAGAGTATAAAGTAACTTACTTTCTACCTT
GTAGAAACTGATGGTCTAGGAGAAGAGATTTGAACTCAGGTGCCCAGTTGACTCTAATCTTGGCCCATGTGAGAGGATTGTACTCAGTTGCTCTCCTCATCCAGTGATGTTTCTTGTCTAACACAAGA
AGCCTAGGAGTAGAAAGTCCTAAGCAGAGTAGAATAATAGCGGCAGCAGGGAGGGAAGTGTGAACTGTGTGTCCCTGAGCCTGACTTACTGGGCAGGGACATGACACTTAAAGCGGCAGCTGGCCACT
CTGTCTTTCCTGCATGCACTGAGTATTTGGTAGCTCATTAGTGACCAGTGATATTGATCATCTTTTCATGTGCTCACTTACTATCCCCATATCTTTGTTGTTTGCATCTTTTACCCATTGTATTTGTT
GTTTTTGAGACAGTGTCTCACTCTGTCACCCAGGCTGGAGTGCAGTCTCATGATCGCGGCTCACTGCAGTTTCTGCCTCCTGGGCTCAAGCAATCCTCCCACCTCAGCCTCCTGAGTAGCTGGGCTTA
CAGGCGCACACCACCATGCCCAGCTAATTAAAAAAAAAATTTTTTTTGTAGCAGTTCGGTCTCATTAGTATTGCCCAGGCTGGCCTCTCTTAGCTTCAAGCTATCCTCCCGCCTCGGCCTCCCAAAGT
GCTGGAATTACAGGCATAAGCCACAAGCCACTGGGCCCAGCCTCTTTTACCTGTTTCAAAATTGAGTTTTATTGAGTTGTAAGAGTTCTTTATTCATTTTAAACACAAGTCCTTTGTTGGATATATCT
TTTACATCTATTTTTCCCAGTCTGTGGCTTGCCTTTTCATTTTGAAGAGCAAAAGTTTAAAATTTTGTGAATTTATTAAAGCTCCGTTTGTTGCTTTTTTCTGTTCTAGTTTATACTTTTGTATCATA
TTTTAGGAAATTTTGCACTGGGTATTTGATGGCTCCTGAGGAGGTTCAACTTTCAGAGCGCACTGATTTCTCTGCACCTGAGATTTTGTACTATTTCTGTATTTCTTTCTTCTCAGAACAACCAGTGT
CACCAGGTATGAGGGCAGAGTTTTAGCTTGTTTGCTGAGCCCCATTCTTGAAGCTCATTTATTTATTCACCTATCTGTCCATCAATCCAACAAATATACTGAATGCTGCTATGTGCCAGGTACTGGCA
CTGTTCTAGGTACTGGGGCAATGACAGTTAAGATAATACCCAATGACCCTGCTCTGTACCCTTAAGAGCAGACTCAGTTGGGAATGAGTTATCCAAATATAGGGTGTACATGTAGTCAGGAGAGAGCC
TCATACAGCTTTGCCTTTGGCAGAATCCTTCAAACCTCTTTGTCTTCCTACTTCTTGATATTACAAATCATGAGCCTTTCACATGCATTGACTCTAAAGAGGTGGGTTCCTGGATAGCAGAAGTAGAT
AGGAAGGCATCATTGACATTTACTGAGATGGATTGAATCAGAGGGTGTAAATTCTGCTCCATCAATGTTGAAAAAGACTAGCCCACCCCAAAGGTTTATCACTGTCACCATGTCTAATGTCTATTCTG
GAAGAAGCTGAAGAAGTCTGCCTTTGTTTAGGGAACCGGTTCCAGAATCAGAGGGGTTGAGGATATAAAAGACCCTTGCACAAGAGTTGGTATTTACCCTGTCAGATGCTGCTACCAAGATTTGGATT
GTGTACAGTCGAGGATTAAAAATGACTTTTAAGATGCA

hide sequence

RefSeq Acc Id:

XM_054335969 ⟹ XP_054191944

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	1	35,746,102 - 35,793,426 (+)	NCBI


Protein RefSeqs	NP_001304051	(Get FASTA)	NCBI Sequence Viewer
	NP_001304052	(Get FASTA)	NCBI Sequence Viewer
	NP_036331	(Get FASTA)	NCBI Sequence Viewer
	XP_011539538	(Get FASTA)	NCBI Sequence Viewer
	XP_054191944	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAF00068	(Get FASTA)	NCBI Sequence Viewer
	AAH63275	(Get FASTA)	NCBI Sequence Viewer
	BAG36835	(Get FASTA)	NCBI Sequence Viewer
	BAG50952	(Get FASTA)	NCBI Sequence Viewer
	EAX07396	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000362300
	ENSP00000362300.4
	ENSP00000362302
	ENSP00000501372
GenBank Protein	Q9UL18	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:	NP_036331 ⟸ NM_012199
- Peptide Label:	isoform 1
- UniProtKB:	Q5TA57 (UniProtKB/Swiss-Prot), Q6P4S0 (UniProtKB/Swiss-Prot), Q9UL18 (UniProtKB/Swiss-Prot), B2RAD8 (UniProtKB/TrEMBL)
- Sequence:	show sequence MEAGPSGAAAGAYLPPLQQVFQAPRRPGIGTVGKPIKLLANYFEVDIPKIDVYHYEVDIKPDKCPRRVNREVVEYMVQHFKPQIFGDRKPVYDGKKNIYTVTALPIGNERVDFEVTIPGEGKDRIFKV SIKWLAIVSWRMLHEALVSGQIPVPLESVQALDVAMRHLASMRYTPVGRSFFSPPEGYYHPLGGGREVWFGFHQSVRPAMWKMMLNIDVSATAFYKAQPVIEFMCEVLDIRNIDEQPKPLTDSQRVRF TKEIKGLKVEVTHCGQMKRKYRVCNVTRRPASHQTFPLQLESGQTVECTVAQYFKQKYNLQLKYPHLPCLQVGQEQKHTYLPLEVCNIVAGQRCIKKLTDNQTSTMIKATARSAPDRQEEISRLMKNA SYNLDPYIQEFGIKVKDDMTEVTGRVLPAPILQYGGRNRAIATPNQGVWDMRGKQFYNGIEIKVWAIACFAPQKQCREEVLKNFTDQLRKISKDAGMPIQGQPCFCKYAQGADSVEPMFRHLKNTYSG LQLIIVILPGKTPVYAEVKRVGDTLLGMATQCVQVKNVVKTSPQTLSNLCLKINVKLGGINNILVPHQRSAVFQQPVIFLGADVTHPPAGDGKKPSITAVVGSMDAHPSRYCATVRVQRPRQEIIEDL SYMVRELLIQFYKSTRFKPTRIIFYRDGVPEGQLPQILHYELLAIRDACIKLEKDYQPGITYIVVQKRHHTRLFCADKNERIGKSGNIPAGTTVDTNITHPFEFDFYLCSHAGIQGTSRPSHYYVLWD DNRFTADELQILTYQLCHTYVRCTRSVSIPAPAYYARLVAFRARYHLVDKEHDSGEGSHISGQSNGRDPQALAKAVQVHQDTLRTMYFA hide sequence

RefSeq Acc Id:	XP_011539538 ⟸ XM_011541236
- Peptide Label:	isoform X1
- UniProtKB:	B2RAD8 (UniProtKB/TrEMBL)
- Sequence:	show sequence MEAGPSGAAAGAYLPPLQQVFQAPRRPGIGTVGKPIKLLANYFEVDIPKIDVYHYEVDIKPDKCPRRVNREVVEYMVQHFKPQIFGDRKPVYDGKKNIYTVTALPIGNERVDFEVTIPGEGKDRIFKV SIKWLAIVSWRMLHEALVSGQIPVPLESVQALDVAMRHLASMRYTPVGRSFFSPPEGYYHPLGGGREVWFGFHQSVRPAMWKMMLNIDVSATAFYKAQPVIEFMCEVLDIRNIDEQPKPLTDSQRVRF TKEIKGLKVEVTHCGQMKRKYRVCNVTRRPASHQTFPLQLESGQTVECTVAQYFKQKYNLQLKYPHLPCLQVGQEQKHTYLPLEVCNIVAGQRCIKKLTDNQTSTMIKATARSAPDRQEEISRLMKNA SYNLDPYIQEFGIKVKDDMTEVTGRVLPAPILQYGGRVSRNRAIATPNQGVWDMRGKQFYNGIEIKVWAIACFAPQKQCREEVLKNFTDQLRKISKDAGMPIQGQPCFCKYAQGADSVEPMFRHLKNT YSGLQLIIVILPGKTPVYAEVKRVGDTLLGMATQCVQVKNVVKTSPQTLSNLCLKINVKLGGINNILVPHQRSAVFQQPVIFLGADVTHPPAGDGKKPSITAVVGSMDAHPSRYCATVRVQRPRQEII EDLSYMVRELLIQFYKSTRFKPTRIIFYRDGVPEGQLPQILHYELLAIRDACIKLEKDYQPGITYIVVQKRHHTRLFCADKNERIGKSGNIPAGTTVDTNITHPFEFDFYLCSHAGIQGTSRPSHYYV LWDDNRFTADELQILTYQLCHTYVRCTRSVSIPAPAYYARLVAFRARYHLVDKEHDSGEGSHISGQSNGRDPQALAKAVQVHQDTLRTMYFA hide sequence

RefSeq Acc Id:	NP_001304052 ⟸ NM_001317123
- Peptide Label:	isoform 2
- UniProtKB:	B3KME0 (UniProtKB/TrEMBL), Q5TA58 (UniProtKB/TrEMBL)
- Sequence:	show sequence MVQHFKPQIFGDRKPVYDGKKNIYTVTALPIGNERVDFEVTIPGEGKDRIFKVSIKWLAIVSWRMLHEALVSGQIPVPLESVQALDVAMRHLASMRYTPVGRSFFSPPEGYYHPLGGGREVWFGFHQS VRPAMWKMMLNIDVSATAFYKAQPVIEFMCEVLDIRNIDEQPKPLTDSQRVRFTKEIKGLKVEVTHCGQMKRKYRVCNVTRRPASHQTFPLQLESGQTVECTVAQYFKQKYNLQLKYPHLPCLQVGQE QKHTYLPLEVCNIVAGQRCIKKLTDNQTSTMIKATARSAPDRQEEISRLMKNASYNLDPYIQEFGIKVKDDMTEVTGRVLPAPILQYGGRNRAIATPNQGVWDMRGKQFYNGIEIKVWAIACFAPQKQ CREEVLKNFTDQLRKISKDAGMPIQGQPCFCKYAQGADSVEPMFRHLKNTYSGLQLIIVILPGKTPVYAEVKRVGDTLLGMATQCVQVKNVVKTSPQTLSNLCLKINVKLGGINNILVPHQRSAVFQQ PVIFLGADVTHPPAGDGKKPSITAVVGSMDAHPSRYCATVRVQRPRQEIIEDLSYMVRELLIQFYKSTRFKPTRIIFYRDGVPEGQLPQILHYELLAIRDACIKLEKDYQPGITYIVVQKRHHTRLFC ADKNERIGKSGNIPAGTTVDTNITHPFEFDFYLCSHAGIQGTSRPSHYYVLWDDNRFTADELQILTYQLCHTYVRCTRSVSIPAPAYYARLVAFRARYHLVDKEHDSGEGSHISGQSNGRDPQALAKA VQVHQDTLRTMYFA hide sequence

RefSeq Acc Id:	NP_001304051 ⟸ NM_001317122
- Peptide Label:	isoform 1x
- UniProtKB:	B2RAD8 (UniProtKB/TrEMBL), A0A6I8PTZ8 (UniProtKB/TrEMBL)
- Sequence:	show sequence MEAGPSGAAAGAYLPPLQQVFQAPRRPGIGTVGKPIKLLANYFEVDIPKIDVYHYEVDIKPDKC PRRVNREVVEYMVQHFKPQIFGDRKPVYDGKKNIYTVTALPIGNERVDFEVTIPGEGKDRIFKVSIKWLAIVSWRMLHEALVSGQIPVPLESVQALDVAMRHLASMRYTPVGRSFFSPPEGYYHPLGG GREVWFGFHQSVRPAMWKMMLNIDVSATAFYKAQPVIEFMCEVLDIRNIDEQPKPLTDSQRVRFTKEIKGLKVEVTHCGQMKRKYRVCNVTRRPASHQTFPLQLESGQTVECTVAQYFKQKYNLQLKY PHLPCLQVGQEQKHTYLPLEVCNIVAGQRCIKKLTDNQTSTMIKATARSAPDRQEEISRLMKNASYNLDPYIQEFGIKVKDDMTEVTGRVLPAPILQYGGRNRAIATPNQGVWDMRGKQFYNGIEIKV WAIACFAPQKQCREEVLKNFTDQLRKISKDAGMPIQGQPCFCKYAQGADSVEPMFRHLKNTYSGLQLIIVILPGKTPVYAEVKRVGDTLLGMATQCVQVKNVVKTSPQTLSNLCLKINVKLGGINNIL VPHQRSAVFQQPVIFLGADVTHPPAGDGKKPSITAVVGSMDAHPSRYCATVRVQRPRQEIIEDLSYMVRELLIQFYKSTRFKPTRIIFYRDGVPEGQLPQILHYELLAIRDACIKLEKDYQPGITYIV VQKRHHTRLFCADKNERIGKSGNIPAGTTVDTNITHPFEFDFYLCSHAGIQGTSRPSHYYVLWDDNRFTADELQILTYQLCHTYVRCTRSVSIPAPAYYARLVAFRARYHLVDKEHDSGEGSHISGQS NGRDPQALAKAVQVHQDTLRTMYFAXRQNAVTSLDRRKLSKPQELCHPNPEEARRREVG hide sequence

Ensembl Acc Id:

ENSP00000501372 ⟸ ENST00000674426

Protein Domains

PAZ Piwi Protein argonaute N-terminal

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q9UL18-F1-model_v2	AlphaFold	Q9UL18	1-857	view protein structure

RGD ID:

6854956

Promoter ID:

EPDNEW_H643

Type:

initiation region

Name:

AGO1_2

Description:

argonaute 1, RISC catalytic component

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H644

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	35,869,807 - 35,869,867	EPDNEW

RGD ID:

6854958

Promoter ID:

EPDNEW_H644

Type:

initiation region

Name:

AGO1_1

Description:

argonaute 1, RISC catalytic component

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H643

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	1	35,883,215 - 35,883,275	EPDNEW

RGD ID:

6785105

Promoter ID:

HG_KWN:1987

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, K562, Lymphoblastoid, NB4

Transcripts:

OTTHUMT00000019337

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	1	36,121,134 - 36,121,634 (+)	MPROMDB

RGD ID:

6785108

Promoter ID:

HG_KWN:1988

Type:

Non-CpG

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

Lymphoblastoid

Transcripts:

UC009VUY.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	1	36,132,254 - 36,132,754 (+)	MPROMDB

Database	Acc Id	Source(s)
COSMIC	AGO1	COSMIC
Ensembl Genes	ENSG00000092847	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000373204	ENTREZGENE
	ENST00000373204.6	UniProtKB/Swiss-Prot
	ENST00000373206	ENTREZGENE
	ENST00000674426	ENTREZGENE
Gene3D-CATH	3.30.420.10	UniProtKB/Swiss-Prot
	3.40.50.2300	UniProtKB/Swiss-Prot
	paz domain	UniProtKB/Swiss-Prot
GTEx	ENSG00000092847	GTEx
HGNC ID	HGNC:3262	ENTREZGENE
Human Proteome Map	AGO1	Human Proteome Map
InterPro	ArgoL1	UniProtKB/Swiss-Prot
	ArgoL2	UniProtKB/Swiss-Prot
	Argonaute_Mid_dom	UniProtKB/Swiss-Prot
	Argonaute_N	UniProtKB/Swiss-Prot
	PAZ_dom	UniProtKB/Swiss-Prot
	PAZ_dom_sf	UniProtKB/Swiss-Prot
	Piwi	UniProtKB/Swiss-Prot
	Piwi_ago-like	UniProtKB/Swiss-Prot
	RNaseH-like_sf	UniProtKB/Swiss-Prot
	RNaseH_sf	UniProtKB/Swiss-Prot
KEGG Report	hsa:26523	UniProtKB/Swiss-Prot
NCBI Gene	26523	ENTREZGENE
OMIM	606228	OMIM
PANTHER	EUKARYOTIC TRANSLATION INITIATION FACTOR 2C	UniProtKB/Swiss-Prot
Pfam	ArgoL1	UniProtKB/Swiss-Prot
	ArgoL2	UniProtKB/Swiss-Prot
	ArgoMid	UniProtKB/Swiss-Prot
	ArgoN	UniProtKB/Swiss-Prot
	PAZ	UniProtKB/Swiss-Prot
	Piwi	UniProtKB/Swiss-Prot
PharmGKB	PA27693	PharmGKB
PROSITE	PAZ	UniProtKB/Swiss-Prot
	PIWI	UniProtKB/Swiss-Prot
SMART	DUF1785	UniProtKB/Swiss-Prot
	PAZ	UniProtKB/Swiss-Prot
	Piwi	UniProtKB/Swiss-Prot
Superfamily-SCOP	SSF101690	UniProtKB/Swiss-Prot
	SSF53098	UniProtKB/Swiss-Prot
UniProt	A0A0U1RQZ8_HUMAN	UniProtKB/TrEMBL
	A0A6I8PTZ8	ENTREZGENE, UniProtKB/TrEMBL
	A0A8V8TNY0_HUMAN	UniProtKB/TrEMBL
	A0A8V8TPF2_HUMAN	UniProtKB/TrEMBL
	A0A8V8TQA7_HUMAN	UniProtKB/TrEMBL
	A0A8V8TQN5_HUMAN	UniProtKB/TrEMBL
	AGO1_HUMAN	UniProtKB/Swiss-Prot
	B2RAD8	ENTREZGENE, UniProtKB/TrEMBL
	B3KME0	ENTREZGENE, UniProtKB/TrEMBL
	Q5TA57	ENTREZGENE
	Q5TA58	ENTREZGENE, UniProtKB/TrEMBL
	Q6P4S0	ENTREZGENE
	Q9UL18	ENTREZGENE
UniProt Secondary	Q5TA57	UniProtKB/Swiss-Prot
	Q6P4S0	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2019-02-19	AGO1	argonaute RISC component 1	AGO1	argonaute RISC catalytic component 1	Symbol and/or name change	5135510	APPROVED
2018-11-29	AGO1	argonaute RISC catalytic component 1	AGO1	argonaute 1, RISC catalytic component	Symbol and/or name change	5135510	APPROVED
2015-12-01	AGO1	argonaute 1, RISC catalytic component	AGO1	argonaute RISC catalytic component 1	Symbol and/or name change	5135510	APPROVED
2013-02-20	AGO1	argonaute RISC catalytic component 1	EIF2C1	eukaryotic translation initiation factor 2C, 1	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD

Imported Disease Annotations - OMIM

RGD Manual Annotations

Imported Human Phenotype Annotations - HPO

Imported Human Phenotype Annotations - ClinVar

Send us a Message

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD

Imported Disease Annotations - OMIM

RGD Manual Annotations

Imported Human Phenotype Annotations - HPO

Imported Human Phenotype Annotations - ClinVar